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Abstract 
Human embryonic stem cells (hESCs) possess 2 unique properties (1) 
pluripotency and (2) self-renewal, and therefore, hold great promise for biomedical 
application and regenerative medicine. In vitro differentiation of hESCs is a vital tool 
to generate unlimited human hepatocytes. To date, several multi-step protocols have 
been established to generate hepatocyte-like cells from undifferentiated hESCs via 
definitive endoderm (DE) formation. However, hESC derived-hepatocytes in these 
systems exhibit some immature characteristics, thus it remains a challenge on how to 
further improve hepatic differentiation. In addition, the molecular mechanisms 
regulating the differentiation are still ambiguous, making  in vitro differentiation a 
difficult task. The ultimate aim of this project is to improve the differentiation of 
hESCs to functional hepatocytes. In this thesis, the work includes two main parts: (1) 
modulating signalling pathways to explore molecular mechanisms controlling DE 
differentiation; (2) developing a 3-dimensional (3D) culture system to improve the 
functionality of hESC-derived hepatocytes.  
DE formation is a critical step for the production of hepatocytes. In the first part 
of this thesis, I showed that suppression of PI3K signalling using the LY 294002 
inhibitor (LY) during hESC differentiation significantly improves Activin A (AA)-
induced DE generation, which subsequently augments hepatocyte production. Further 
mechanistic interrogation of this phenomenon has revealed that dual treatment of 
hESCs with AALY enhances the Activin downstream signalling, Smad2/3 
phosphorylation and their nuclear translocation with Smad4. Furthermore, dual 
treatment with AALY also affects the disruption of β-catenin/E-cadherin complexes, 
which cooperatively contribute to distinctive morphological changes that may signify 
the occurrence of EMT and hence improved specification of DE. These findings 
suggest that suppression of PI3K/Akt modulates both Nodal/Activin and β-catenin 
pathways, the two most important signalling involved in mesendoderm and DE cell 
fate specification, therefore improved DE differentiation of hESCs. 
Liver development in vivo is regulated by cell–cell contacts in a 3D environment 
and the absences of this may account for, at least partly, some of the immature 
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features of hESC-derived hepatocytes. In the second part of my thesis, based on initial 
encouraging results obtained from HepG2 cells, I applied alginate based 3D culture 
system to hESCs after they are differentiated into DE cells and optimised culture 
conditions. The results confirmed that 3D culture microenvironment enhanced hepatic 
differentiation and functionality of hESC-derived hepatocytes in compared to the 
monolayer format.  
Collectively, this study has demonstrated a significant cornerstone in the 
strategies to improve hepatic differentiation of hESCs by addressing the molecular 
signalling and micro-niche cues that govern hepatocyte lineage commitment. Hence, 
this will pave the way for the use of these hepatocytes in future regenerative therapies 
and biomedical applications.   
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1. Introduction  
1.1 The Liver 
The liver is one of the therapeutically important organs, where it plays a central 
role in metabolism, detoxification and maintenance of homeostasis in the body. The liver 
is composed of several cell types such as hepatocytes, bile duct cells, kupffer cells and 
sinusoids. Most of specialised functions of the liver are carried out by hepatocytes, which 
represent 70-80 % of its cytoplasmic mass and exhibit more frequent polyploidy. These 
parenchymal cells secrete serum proteins, express enzymes for toxin neutralisation, 
produce bile acids to aid in digestion and control the bulk of intermediary metabolism. 
The unique feature of this organ is that it can regenerate upon the destruction of 
the cells by certain short-term injuries or diseases. However, this partial growth ability is 
insufficient to permit complete recovery from liver failure caused by chronic liver 
diseases and severe liver damage. Owing to the essential requirement to restore the 
partially or completely failed liver, cell therapy using hepatocytes is imperative. This 
could be achieved by hepatocyte transplantation or by a hepatocyte-embedded bioartificial 
liver device. While these treatments have shown to be remarkably effective when used to 
correct metabolic liver diseases or to support the function of a failed liver (Fox and 
Chowdhury, 2004), demand for transplantable hepatocytes is ever-increasing. However, 
the most important issue affecting transplantation is the shortage of available donors. In 
addition, lack of established methodology to grow and expand hepatocytes in cell culture 
while maintaining their functionality is another major obstacle. Not only useful for cell 
therapy, but hepatocytes are also instrumental for pharmaceutical drug development, as 
they are important in assessing the metabolism of xenobiotics. The recent progress in the 
embryonic stem cell (ESC) field has raised the hope for their potential use in liver related 
treatments to overcome the problem of donor shortage.  
1.1.1. In vivo liver development  
The use of ESCs for various applications ranging, from regenerative medicine, 
developmental studies to biomedical applications, relies on an understanding of the in 
vivo lineage specification, in order to precisely control ESCs differentiation. Our 
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understanding of in vivo liver development owes much to the studies of murine, chick, 
zebrafish and frog embryos. Liver development is a multistage process as depicted in 
Figure 1.1, which will be discussed in the following sections.  
 
Figure 1-1: Liver development.  
A) Gastrulation in the blastocyst will initiate differentiation into the three primary germ layers - 
endoderm, mesoderm (via mesendoderm) and ectoderm. Endoderm derivative organs, which 
form the gastrointestinal tract, are grouped into foregut, mid gut and foregut (Adapted from Zorn 
and Wells, 2009) B) Chronological order of mouse liver development (marked in red) from the 
endoderm tissues; endoderm, hepatic specification, liver bud growth and hepatic maturation at 
indicated timeline of mouse development.  (Adapted from Zorn 2008) 
 
1.1.1.1. Formation and patterning of the endoderm  
During gastrulation, the morphogenetic process causes cells in the inner cell mass 
(ICM) to be partitioned into three groups called germ layers, which are ectoderm, 
mesoderm and definitive endoderm in an early embryo. The definitive endoderm, which 
initially lines the ventral surface of an early embryo, beneath the ectoderm and mesoderm 
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will form the gut tube. The anterior and posterior invaginations of the gut tube 
subsequently develop into the embryonic foregut and hindgut pockets. Foregut endoderm 
eventually gives rise to the liver, pancreas, thyroid, lung and stomach.  
However, a crucial question in gut organogenesis is how these endodermal cells 
are developmentally competent to form different tissues. Some evidence suggests the 
existence of different spatial domains in the embryonic foregut. Fate-mapping 
experiments have shown that the liver-specifying domain arises from lateral domains of 
endoderm in the developing ventral foregut as well as from a small group of endodermal 
cells tracking down the ventral midline (Tremblay and Zaret, 2005). 
 
1.1.1.2. Establishing the competence to express hepatic genes  
In mouse, liver development in mouse initiates at around gestation day 8.5 (7-8 
somites), corresponding to about 3 weeks of human gestation (Zaret and Grompe, 2008), 
following the formation of ventral foregut from definitive endoderm (Lemaigre and Zaret, 
2004). The study to identify liver-enriched transcription factors at various phases of 
development has led to some understanding of the transcriptional and developmental 
regulatory networks that are implicated in organogenesis.  
In the establishment of the endoderm, SRY (sex determining region Y)-box 17 
(SOX 17), an early endodermal factor that is located downstream of the nodal signalling 
pathway in zebrafish, plays a crucial role (Alexander and Stainier, 1999). The sox17 null-
mutant mice produced a depleted definitive gut endoderm (Kanai-Azuma et al., 2002). 
Another important factor in endoderm development is Forkhead box A2 (FOXA2), also 
known as Hepatocyte-nuclear factor (HNF) 3beta, a winged-helix factor, which is 
expressed throughout the definitive endoderm. FoxA2 acts in both initiation of definitive 
endoderm and hepatic fate programming. It has been shown that FoxA2 regulates polarity 
and epithelialisation in the endoderm germ layer and suppresses a mesenchymal fate, 
thereby promoting an epithelial fate (Burtscher and Lickert, 2009). It also functions as a 
competency factor for hepatic fate adaptation (Ang et al., 1993) through chromatin 
occupancy. It is demonstrated that a strong FoxA binding site located upstream of the 
albumin gene is occupied by FoxA2 before induction of albumin expression (Bossard and 
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Zaret, 1998; Gualdi et al., 1996) Thus, this factor that engages a DNA-binding site in a 
highly compacted chromatin, creates a local open domain of nucleosomes (Cirillo et al., 
2002). However, FoxA2 binding and its resulting chromatin change is insufficient to 
activate transcription of the albumin gene (Bossard and Zaret, 1998). For this, the binding 
of CCAAT/enhancer binding protein-β and nuclear factor 1 (NF1) at the enhancer and 
promoter of albumin gene is required (Zaret, 2002). Therefore, binding of FoxA2 is 
proposed to impart developmental competence for a gene to be later activated by the 
binding of other transcription factors. In addition, Crowe et al (1999) showed that FoxA2 
binding can release chromatin-mediated repression of alpha-fetoprotein gene 
transcription. Therefore, FoxA2 acts as a competence factor in an early developmental 
context to ease the binding of other factors to chromatin when they could not bind stably 
alone (Zaret, 2002) .  
 
1.1.1.3. Hepatic lineage specification 
Hepatic lineage specification occurs following acquisition of hepatic competency 
in endodermal tissue. Studies in model organisms have shown that hepatic endodermal 
domains are patterned by interactions with overlying mesodermal tissue (Jung et al., 
1999). This has been supported by the classic tissue transplant studies performed by 
LeDouarin, using chick embryos. Cardiogenic mesoderm and septum transversum (STM), 
which is transiently opposed to the prospective hepatic endoderm during early embryo 
development, provide signals for development of liver progenitors in the endoderm (Le 
Lievre and Le Douarin, 1975). Bone morphogenetic protein (BMP) signalling and 
fibroblast growth factors (FGF) signalling from STM and cardiac mesoderm are two 
critical cues that induce the ventral foregut tube to be specified to the hepatic lineage 
(Jung et al., 1999; Rossi et al., 2001). BMP, a member of the TGF-β superfamily together 
with FGFs, have many morphogenetic roles in the developing embryo (Hogan, 1996). 
Inhibition of either FGF or BMP, by FGF inhibitor and Noggin respectively, will affect 
liver bud formation (Jung et al., 1999; Rossi et al., 2001). 
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1.1.1.4. Development of the liver bud and hepatoblast specification  
The next phase in liver development is liver bud development. Hepatic endoderm 
progresses through the columnar cell stage and becomes proliferative in the E9.5 mouse 
embryo (~26-somite stage) (Sosa-Pineda et al., 2000). These precursor cells, called 
hepatoblasts, possess the capability of bipotential differentiation either into hepatocytes or 
bile duct cells (cholangiocytes) (Germain et al., 1988). They are considered to be the 
hepatic progenitors that exist during liver development and express some defining 
markers of fetal hepatocytes and bile duct cells, such as alpha-fetoprotein (AFP), albumin 
and cytokeratin 19 (CK19). Morphogenesis of liver buds is regulated by soluble factors 
(such as HGF and VEGFR2) and transcription factors (such as Hex, Prox1, Hlx and c-
met) (Zaret, 2002).  Despite the complex regulation of lineage commitment, some recent 
studies have found that certain signalling pathways are instrumental for hepatoblast 
segregation (Figure 4). Clotman et al., (2005) reported that a gradient of Activin/ TGF-β 
signalling governs the lineage commitment of hepatoblasts. High levels of Activin/ TGF-
β signalling around the portal vein facilitates biliary cell specification while Onecut 
family transcription factors, HNF6 and OC-2, inhibit Activin/ TGF-β signalling, resulting 
in hepatocyte differentiation distal to the portal vein. Tanimizu and Miyajima (2004) 
showed that activation of notch signalling in cultured hepatoblast cells increases the 
expression of biliary cell markers and inhibits hepatocyte markers, suggesting that notch 
signalling stimulates biliary differentiation while repressing hepatocyte differentiation.  
1.1.1.5. Hepatocytes maturation  
The maturation of the hepatoblast into a hepatocyte is primarily controlled by the 
activation of several hepatic transcription factors. The HNF3 factor, which is implicated 
in the nucleasomal organisation of the albumin gene, has also been found to regulate the 
hepatocyte-nuclear factor 4 alpha (HNF4α) promoter following insulin stimulation 
(Duncan et al, 1998). HNF4α is a central regulator of hepatocyte differentiation and 
function. More than 40% of active hepatic promoters are bound by HNF4α/HNF6 which 
are also controlled by HNF4α (Odom et al., 2004; Watt et al., 2003). In addition to these 
factors, two external soluble factors, Oncostatin M (OSM) and hepatocyte growth factor 
(HGF), produced by migrating hematopoietic cells in the liver (Kamiya et al., 1999) and 
non-parenchymal liver cells (sinusoidal, stellate
 
and endothelial cells) respectively, are 
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required for hepatocyte maturation.  This suggests a role for non-parenchymal cell types 
in the hepatocyte maturation process. Thus, this may give an insight into possible co-
culture systems for an improvement of the in vitro hepatic differentiation and maturation 
process. Functional hepatocytes secrete serum proteins, express enzymes that neutralise 
toxins, produce bile acids to aid digestion and control the bulk of intermediary 
metabolism.  
1.1.2. Liver failure and treatment  
Liver is a very unique organ which has the capacity to regenerate upon injury. 
Despite a low level of cell turnover normally, the liver has a rapid regenerative capacity 
following an abnormal loss of cells which restores the organ to its functional state. This 
could occur in the absence of any external source of cells. Facultative stem cells, which 
are located within the intra-hepatic biliary tree, are activated to re-enter the cell cycle 
rapidly, and then differentiate into the hepatocytes and the bile ducts cells. Upon 
persistent liver injury, however, the liver gradually loses the ability to regenerate 
completely, which leads to liver failure. Another type of liver failure is acute liver failure 
in which liver cells are massively damaged in a short period of time. Although the trace 
residue liver cells may be able to regenerate to restore liver function eventually, this needs 
time.  In these situations, external support to maintain liver function is critical to treat 
liver failure patients.  
1.1.2.1. Treatments for liver failure 
Existing treatments for patients with end stage liver diseases or acute liver failure 
are reliant upon donor organ transplantation. However, due to the scarcity of donors, it is 
necessary to explore alternative hepatocyte resources and approaches to support human 
liver function during liver failure. 
Cell based therapies 
One alternative way to overcome the shortage of liver donors is by applying stem 
cell technology to liver disease. While obtaining primary hepatocytes is challenging, the 
pluripotent developmental potential of hESCs could make them an ideal source for liver 
treatment [discussed in 1.1.2.2.1]. A number of animal studies have shown that 
transplantation of stem cell-derived hepatocytes can replace and restore the function of 
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diseased tissue in the liver (Agarwal et al., 2008; Basma et al., 2009; Duan et al., 2007; 
Touboul et al., 2010). These in vitro differentiated cells could either be transplanted to 
repopulate the liver or used in bioartificial liver devices to provide extracorporeal support 
for liver function.  
Bioartificial liver devices 
A recent development in liver therapy is the introduction of extracorporeal devices 
utilising hepatocytes to provide support for patients who are suffering from acute liver 
failure. These are known as bioartificial liver (BAL) devices. Currently, the purpose of 
BAL-type devices is not to permanently replace liver function, but to serve as a 
supportive device. This is by either allowing the liver to regenerate naturally following 
acute liver failure, or to bridge the individual's liver functions until a transplant is 
possible.  
Efforts to achieve this feat have been focused on the emerging fields of stem cell 
research and tissue engineering. There are three key criteria to consider in the 
development of stem cell-derived liver technology; (1) an expandable cellular resource, 
(2) an efficient directed differentiation and (3) high fidelity function.  While use of stem 
cell derived hepatocytes seems to be very promising for cell-based therapy and 
bioartificial liver devices, characterisation of function and properties of the stem cell 
derived hepatocytes, unlimited sourcing of these cells and the safety and post 
transplantation complications need to be taken into consideration. 
1.1.2.2. Alternative cell sources for liver treatment 
Although primary human hepatocytes are the most ideal source of the cells that 
could be used for liver treatment, their phenotypic instability and restricted accessibility 
mean that alternative cell sources that are potentially unlimited are required together, with 
minimally invasive procedures for hepatocyte replacement and regeneration.  
Human hepatoma cell lines, such as HepG2 and its clonal derivative C3A, have 
been used in extracorporeal liver-assist devices in clinical trials in patients (Ellis et al., 
1996).  However, this has shown no significant effect, which could be due to the fact that 
HepG2 cells have very poor function with regards to ammonia detoxification and mixed 
oxidase activity (Nyberg et al., 1994). In addition, the outgrowth of tumour nodules which 
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transmigrate through a cut-off membrane from BAL raised concerns on the safety of the 
patients. Currently, in spite of their scalable properties, HepG2 cells need a drastic 
improvement in liver-specific functions and safety aspects before being considered 
feasible for BAL support.  
Hepatic stem cells are multi-potent cells which, in some studies have been shown 
to be responsible for liver regeneration. These cells are the elementary form of 
hepatoblasts, resident in the ductal plates of fetal livers, and in the Canals of Hering in 
mature adult livers. Taking into consideration the role that these cells play in liver 
regeneration, their utility for BAL or cell-based therapy seems to be a feasible way to 
repopulate the liver. Studies on the isolation of hepatic stem cells from fetal and postnatal 
donors has been reported using several cell surface markers such as EpCAM, E-cadherin, 
CD133 and CD29 and transplantation of these cells has shown some engraftment in liver 
tissue in an animal model (Schmelzer et al., 2007). Though this seems to be a good 
approach, such cells are present in minute quantities in the liver and it becomes a 
challenge to make them scalable to be used in BAL devices or cell transplantation. 
Another method that has been shown to produce hepatocyte-like cells is through 
the trans-differentiation of bone marrow (BM) stem cells or so-called mesenchymal stem 
cells. Several studies have showed that rat, mouse, and human BM–derived multipotent 
adult progenitor cells were able to differentiate into cells expressing several liver-specific 
markers using a cocktail of growth factors such as EGF, FGF2, HGF and DEX, 
nicotinamide and OSM (Lee et al., 2004b; Schwartz et al., 2002; Snykers et al., 2006). 
These cells had few of the functional characteristics of hepatocytes as judged by 
expression of transcription factors, albumin and urea secretion and CYP activity. Human 
BM-MSCs engrafted into the liver of various types of intoxicated rats differentiated into 
human hepatocytes, which express liver-specific markers (Sato et al., 2005) and improved 
liver fibrosis (Zhao et al., 2005). However, some researchers postulate that this event is 
not transdifferentiation but, rather, a cell fusion between BM-derived stem cells and 
recipient hepatocytes (Vassilopoulos and Russell, 2003). Another problem relating to the 
use of these adult stem cells in hepatic differentiation is that they are not consistent in 
their differentiation capacity (Rountree et al., 2007; Vig et al., 2006), while others claim 
that MSC can trans-differentiate towards hepatocytes without cell fusion (Sato et al., 
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2005). Further studies need to be conducted in order to validate this and to make these 
cells of a greater benefit for liver disease treatment. 
The recent progress made in pluripotent stem cell differentiation into hepatocytes 
provides great promise for the treatment of liver failure. Varieties of cell types have been 
shown to differentiate from these cells. This will be discussed further in section 1.3.   
 
1.2. Human Embryonic Stem Cells 
The successful isolation and culture of mouse and human embryonic stem cells 
(hESCs) several years ago has opened a new avenue of potential cell sources for 
developmental biology studies, cell therapy and other biomedical applications. 
 
1.2.1. Characteristics of human embryonic stem cells  
The first ESC line was isolated in 1981 from the inner cell mass (ICM) of pre-
implantation mouse embryo (Evans and Kaufman, 1981). Since then, hundreds and 
thousands of mESC lines have been established. mESCs grow in colonies which exhibit a 
compact and dome-like structure and can be propagated in culture continuously on a 
feeder layer of MEFs or in the presence of LIF without feeders (Williams et al., 1988). 
MESCs are able to generate teratoma, a well-organised derivative of three germ layers, 
when implanted into SCID mice (Kaufman et al., 1983). The most fascinating attribute of 
mESCs is that, even after extended propagation and manipulation in vitro, they retain the 
capacity to produce chimeric offspring when injected into mouse blastocysts. In this case, 
mESCs can contribute to every tissue, including the germ line, but not the placenta 
(Tanaka, 2008).  
Several decades after the establishment of mESCs, non-human primate and human 
ESC lines have since been isolated. The first hESC lines were derived from the isolation 
and culture of the human ICM (Thomson et al., 1998). The methodology for deriving 
hESCs has remained the same as the original one for the derivation of mESCs. Since then, 
the methods have been modified to avoid potential contamination with xenoproteins and 
xenogenic tissues, such as replacing the MEF feeder layers and bovine serum with their 
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human counterparts (Richards et al., 2002). In addition, the reports of successful 
derivation of pluripotent stem cells from human embryos without the use of feeder layers 
have also emerged, which eliminates the risk of contamination with pathogenic agents 
capable of transmitting diseases to patients (Klimanskaya et al., 2005). Undifferentiated 
hESCs also grow in colonies. These colonies, however, are morphologically different 
from mESC colonies and exhibit flat rather than a domed structure. However, they are 
also more difficult to propagate in culture. hESCs can form teratoma following the 
injection of cells into nude mice (Lensch et al., 2007; Tzukerman et al., 2003).  
Both human and mouse ESCs possess two unique properties: (i) an unlimited 
capacity to generate themselves, termed self-renewal and (ii) developmental potential to 
differentiate into all derivatives of the three primary germ layers: ectoderm, mesoderm 
and endoderm, named pluripotency (Thomson et al., 1998). Because of these two 
properties, hESCs hold great promise in regenerative medicine and in other biomedical 
applications. The unique characteristics of hESCs could be defined by several markers 
including expression of intrinsic transcription factors OCT4, Nanog, Sox2 and Rex-1 and 
cell surface markers; Stage Specific Cell Surface antigens (SSEA)-3 and -4, TRA-1-60 
and -1-81.  However, the ultimate examination is their capacity for differentiation to three 
germ layers, pluripotency, which can be tested by embryoid body formation, teratoma and 
chimera generation (for mESCs). 
 
1.2.2. Regulation of self-renewal and pluripotency in undifferentiated human 
embryonic stem cells 
The main focus of hESCs research is their derivation, maintenance and 
differentiation. ESC fate choice is controlled by a complex set of signals dictated by the 
cellular microenvironment, which includes soluble factors, extracellular matrices, 
biophysical environment and cell-cell contacts. The stem cell niche determines whether 
these cells maintain their pluripotent state or pursue lineage commitment, which is still a 
fundamental question in developmental biology and stem cell biology. Therefore, 
attention has been given to the study of the underlying mechanisms of stem cell 
pluripotency/self-renewal and differentiation. ESCs pluripotency is regulated by both 
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intrinsic and extrinsic factors. The understanding of how these factors determine cell fate 
will facilitate the expansion and use of these cells in cell-based therapies and biomedical 
applications, and will allow understanding of early developmental processes. 
Intrinsic factors 
Pluripotent ICM cells exist only transiently in embryos, as they quickly 
differentiate into various somatic cells through development. To maintain self-renewal 
and the pluripotent nature of ESCs, understanding of both extrinsic and intrinsic factors is 
critical. The most studied intrinsic factors are OCT4, Nanog and Sox2. These are common 
in both human and mouse ESCs and form the core of the transcription factor network 
which controls the pluripotency of ESCs. 
Oct4, a POU domain transcription factor, is the gatekeeper of pluripotency in vivo 
and in vitro. Oct4 knockout mice exhibited inner cell mass cells of the blastocyst which 
were not pluripotent and their differentiation potency was restricted along the 
extraembryonic trophoblast lineage (Nichols et al., 1998). Furthermore, using transgenic 
technology, Niwa et al (2000) showed that Oct4 expression levels have to be tightly 
regulated to maintain cell pluripotency. Either an increase or decrease of Oct4 expression 
of 1.5 fold will lead to primitive endoderm/mesoderm and throphoectoderm 
differentiation, respectively (Niwa et al., 2000). Similarly, in hESCs, knockdown of Oct4 
by RNAi led them to differentiate into extra-embryonic endoderm lineages (Hay et al., 
2004). Recently, Oct4 has been found to regulate expression of itself as well as other 
pluripotent factors, such as Sox2 and Nanog (Chew et al., 2005; Rodda et al., 2005). 
These results indicate that Oct4 is a key factor in regulating pluripotency.  
Sox2 is a Sry-related transcription factor. Together with Oct4, they synergistically 
act to activate Oct–Sox enhancers, which regulate the expression of pluripotent stem cell-
specific genes, including Nanog, Oct3/4 and Sox2 itself and cooperative regulation of 
additional downstream genes (Boyer et al., 2005; Loh et al., 2006). While Sox2 is shown 
to be dispensable for activation of these Oct-Sox enhancers, it plays an essential role in 
stabilising ES cells to a pluripotent state by maintaining the requisite levels of Oct3/4 
expression (Masui et al., 2007).  
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Nanog is an important factor for the maintenance of self-renewal in human ESCs. 
This NK2-family homeobox transcription factor is regulated by the binding of Oct3/4 and 
SOX2 to the Nanog promoter (Loh et al., 2006). However, Nanog is not absolutely 
essential for the maintenance of mESCs. Mouse ESCs deficient in Nanog gene expression 
are able to self-renew in culture and to generate chimeras when injected into blastocysts, 
but they fail to differentiate into germ cells (Chambers et al., 2003). These results suggest 
that Nanog is still a critical factor for pluripotency, and is particularly necessary for germ 
cell differentiation.  
Recently, it has been proposed that these factors may also function as lineage 
specifiers, in which each of these factors plays a role in directing a specific lineage 
commitment and repressing differentiation to other lineages [speculated in Loh and Lim, 
2011]. More work needs to be done to further investigate the roles these factors play in 
cell fate determination, in order to direct the differentiation in an appropriate way.  
Extrinsic factors 
A number of signalling pathways have been demonstrated to be involved in the 
self-renewal and pluripotency of ESCs. They are interdependent and display a range of 
cross-talk mechanisms. Unlike intrinsic factors, the extrinsic factors required for mouse 
and human embryonic stem cells are different (Figure 1.2).  For example, leukemia 
inhibitory factor (LIF) is critical for mouse ESCs pluripotency but is not sufficient for 
human embryonic stem cell maintenance. On the other hand, BMP, which induces the 
differentiation in human embryonic stem cells, is another critical factor for the 
maintenance of mouse ESCs. This shows a different requirement for the signalling 
pathways of human and mouse embryonic stem cell maintenance, although both are 
generally supported on mitotically inactivated MEFs.  
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Figure 1-2 : Signalling pathways required for maintaining pluripotency.  
Pluripotency and self-renewal maintenance in a) MESCs: LIF binding to its receptor activates 
STAT3 and AKT signalling whereas the BMP triggers Smad1/5/8, which both subsequently 
promote self-renewal of these cells. Activin/Nodal supports the proliferation of these cells but not 
pluripotency b) HESCs: MEF-secreted FGF2 and Nodal/Activin activate their downstream 
signalling; MAPK and Smad2/3 respectively to govern self-renewal and pluripotency. While 
IGF/Insulin promotes the undifferentiated state via PI3K/Akt signalling, BMP antogonises the 
pluripotency of hESCs. (Adapted from Ohtsuka and Dalton, 2008) 
 
The most common growth factor supplements for hESCs culture media that 
promote self-renewal are fibroblast growth factor-2 (FGF-2) (Dvorak et al., 2005; 
Levenstein et al., 2006), Activin A (Beattie et al., 2005; Vallier et al., 2005; Xiao et al., 
2006), transforming growth factor β1 (TGFβ1) (Amit et al., 2004), and Wnt1 and 3 
(Dravid et al., 2005). Several studies suggest that both FGF and TGF-β/Activin/Nodal 
signalling are important for self-renewal and pluripotency of hESCs, in which FGF acts as 
a competence factor and its function depends on the Activin/Nodal pathway to maintain 
pluripotency (Amit et al., 2004; Vallier et al., 2005; Wang et al., 2006; Xu et al., 2008a).   
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Nodal/Activin signalling:  plays a major role in maintaining self-renewal of 
hESCs through SMAD2/3 activation. The SMAD2/3 pathway is also required for positive 
regulation of several factors of TGF-β signalling such as Nodal, Cripto, Lefty1 (Left-right 
determination factor-1) and Lefty2 (Left-right determination factor-2). Cripto encodes an 
EGF-CFC co-receptor that is essential for response to Nodal, and Lefty1 and Lefty2 are 
both inhibitors of Nodal signalling. Expression of Nodal, Lefty1 and Lefty2 remain high 
in undifferentiated hESCs and are reduced upon differentiation (Besser, 2004; James et 
al., 2005; Xiao et al., 2006). The role of Nodal in the maintenance of pluripotency has 
been implicated in both in vivo and in vitro studies. Nodal null mutant mice, which exhibit 
early lethality, display a very
 
low level of Oct4 expression (Brennan et al., 2002; 
Takenaga et al., 2007a). The expression
 
of the pluripotent markers, Oct4 and SSEA1 
persists in sustained
 
Nodal-expressing cells or grafts. Activin, a surrogate of Nodal, is 
widely used in the maintenance of hESCs, as it can signal through the same receptor and 
affects Smads phosphorylation but is not affected by Lefty (Chen and Shen, 2004). 
Recently, it has been shown that Smad2/3 binds directly to the Nanog proximal promoter 
in hESCs, thereby modulating its expression (Vallier et al., 2009; Xu et al., 2008a), which 
indicates an indispensable role of this signal to support pluripotency.  
Basic fibroblast growth factor (bFGF, also known as FGF-2), a member of the 
FGF family, is well-known for its function to promote self-renewal in hESCs. In the 
absence of serum and feeder cells, exogenous FGF2 is competent to maintain hESCs. 
FGF pathway activation leads to activation of several other intracellular signalling 
cascades, including the Ras/ERK (Extracellular Signal-Regulated Kinase) pathway, PLC-
Gamma (Phospholipase-C-Gamma)/Ca2+ (Calcium) pathway, and PI3K 
(Phosphoinositide 3-Kinase) pathway. However, it is not yet fully understood how FGF2 
promotes self-renewal of hESCs. FGF2-dependent PI3K/Akt activation is required for 
efficient expression of extracellular matrix (ECM) proteins, which protect hESCs from 
stress-induced cell death, and induce hESCs adhesion and cloning efficiency (Eiselleova 
et al., 2009). Although PI3K may function to mediate hESC survival, its role in 
maintaining hESC self-renewal requires further investigation.  
Although other growth factors have been reported to have a positive effect on 
hESC growth, including Wnt (Sato et al., 2003), IGF1 (Bendall et al., 2007) and PDGF 
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(Pebay et al., 2005), there are clearly additional important pathways yet to be identified. 
Defining the molecular mechanisms of hESC self-renewal and pluripotency will enable 
the growth of hESCs under defined conditions and aid controlled differentiation of cells 
into specified lineages, thus providing cells suitable for therapeutic applications.  
1.2.3. Potential applications of hESCs 
Owing to their unique properties, hESCs are a very good cell model for the study 
of developmental biology, since the limited accessibility of early embryos and the scarcity 
of stage and tissue-specific cells currently limit research into developmental changes. In 
addition, hESCs provide a cell resource for the generation of various cell types that could 
be utilised in many biomedical and cell therapy applications. Specifically, important
 
applications related to differentiated hepatocytes from hESCs include:
 
 (1) drug discovery 
and toxicology; and (2) development
 
of cell-based therapies to treat liver diseases.  
Toxicity screening for drug discovery 
An efficient in vitro hepatic differentiation that generates functional cells could 
greatly improve the competence of drug development. Drug development is an expensive 
process with thousands of compounds failing at the preclinical stage, and the estimated 
costs of bringing a drug to the market range between $800 million and $2 billion (Orloff 
et al., 2009). Assessing the safety of new drugs is mainly conducted by measuring liver 
toxicity, as the liver is the vital organ in xenobiotic metabolism.  
The pharmaceutical industry uses either animal models or primary hepatocyte 
culture for the prediction of drug hepatotoxicology. However, both these systems are 
lacking several critical aspects for safe drug development. Although animals are a good 
model for in vivo drug testing, human hepatocytes are still in great demand for 
overcoming the species differences in liver function, including cytochrome P450 
induction (Lake, 2009). In addition, there is an emphasis on the 3R agenda (refinement, 
reduction and replacement) and we need to find an alternative way to cut down the use of 
animals in drug testing. On the other hand, the availability of human hepatocytes is 
limited. Thus, the generation of human hepatocytes from hESCs may hold the key to 
overcome the problems associated with toxicity screening for drug discovery. Efficient 
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hepatic differentiation from hESCs could be a very useful and unlimited source of 
hepatocytes for toxicity screening in the pharmaceutical industry.  
Cell-based therapy for liver diseases  
In addition to toxicity screening, hESCs derived hepatocytes would also be a 
promising resource for cell-based therapy. Due to the scarcity of donor livers, cell-based 
therapy would be an alternative treatment for liver failure patients to either bridge the gap 
before organ transplantation or to allow the recovery of liver regeneration capacity. As 
discussed in section 1.1.2.2, hESC-derived hepatocytes would be the ideal choice for both 
bioartificial liver devices and tissue transplantation. A number of animal studies have 
suggested that transplantation of stem cell derived hepatocytes to replace lost or diseased 
tissue may be possible (Agarwal et al., 2008; Basma et al., 2009; Duan et al., 2007). 
 
1.3. Development of an in vitro hepatic induction system of embryonic 
stem cells 
Biomedical applications of embryonic stem cells, such as drug screening, require 
differentiation of these cells to functional adult hepatocytes. This is unlike the cell therapy 
used for transplantation which may require progenitor cells rather than terminally 
differentiated functional cells. Nevertheless, for both applications, efficient in vitro 
differentiation of hESCs has been the main focus in this research field since the isolation 
of hESCs.  Directed differentiation of pluripotent embryonic stem cells into hepatocytes is 
the translation of endodermal and hepatic developmental biology into an in vitro system. 
In the last decade, progress has been made in the differentiation of ES cells into 
hepatocyte-like cells and various differentiation protocols have been developed, which 
can be generally be categorised into two strategies; (1) spontaneous differentiation (via 
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1.3.1. Spontaneous differentiation by embryoid bodies 
Embryonic stem cells are able to aggregate into a sphere and can form embryoid 
bodies (EBs), which, to a certain degree, mimics early embryo development in vivo and 
yields many different cell types. A population of such derived cells has been shown to 
express early hepatocyte specific markers, such as AFP, ALB, HNF4-α, transferrin (Jones 
et al., 2002), FoxA2, GST (Miyashita et al., 2002), and TDO2 and to perform certain 
hepatocyte functions, such as ICG uptake (Yamada et al., 2002). However, they are still 
categorised as early endodermal-hepatic cells as they either have not been tested or they 
were unable to exhibit terminal hepatic differentiation and functionality, such as CYP 
enzyme activity or steroid metabolism. This may be due to the factors from other cell 
types which are absent, thereby hindering hepatocyte differentiation. Furthermore, a 
mixed population of many cell lineages yields a relatively small population of hepatic 
cells. To overcome this limitation, some researchers have been able to demonstrate that 
sorting of EB-derived hepatic cell populations followed by cytokine-mediated 
differentiation, yields higher percentages of mature hepatic cells. Gouon-Evans et al. 
(2006) reported such a system that derived more mature hepatocytes from FACS-sorted 
mouse EB cells. These cells developed into a highly enriched population (45-75%) of 
functional hepatocyte-like cells, characterised by the expression of cytochrome p450 
(CYP), major enzymes involved in drug metabolism and bioactivation, such as CYP7A1, 
CYP3A11, ALB production and glycogen storage upon addition of Activin A, BMP-4 
and FGF2. This finding has demonstrated the vital roles of cytokines and growth factors 
in directing and controlling stem cell differentiation to a particular lineage.  
The EB system offers the advantage of providing a 3D structure, mimicking in 
vivo embryo development and organogenesis as well as providing some valuable lessons 
for lineage-specific differentiation. However, induction of hepatic differentiation is 
inefficient as the differentiation process is spontaneous and stochastic, resulting in the 
formation of mixed cell types originating from all three germ layers (Karp et al., 2006).   
Therefore, the complexity of EBs and particularly the presence of other cell lineages are 
the limitations in this system for the development of an ideal in vitro hepatic 
differentiation system, since a sequential differentiation of hESCs via multiple stages is 
crucial to enrich the desired population. 
 - 32 - 
 
1.3.2. Directed hepatic differentiation 
Directed differentiation is mainly achieved by 1) supplement with cytokine and 
growth factors (Cai et al., 2007), 2) constitutive expression of hepatic transcription factors 
(Kanda et al., 2003), 3) co-culture with other cell types (Ishii et al., 2005 and Sato-
Gutierrez et al., 2007) and 4) application of a suitable extracellular matrix (Levenberg et 
al., 2003) and 3D culture based on biodegradable scaffolds, or a combination of these 
strategies. These strategies have been shown to yield differentiated cells that exhibit 
typical hepatocyte morphology, express almost all the hepatocyte markers and perform a 
degree of hepatocyte function. 
1.3.2.1. Directed hepatocyte differentiation by growth factors and small chemicals 
Control of embryonic stem cell differentiation to a specific lineage in an efficient 
and controllable manner has been one of the key research areas of stem cell biology. Since 
liver development is a multi-stage process (as discussed in 1.2), several protocols have 
been developed to differentiate hESCs into hepatocytes by sequentially treating hESCs 
with various cytokine/growth factor cocktails based on the study of liver development in 
animal models. Differentiation from ESCs to hepatocytes in this way recapitulates liver 
development in vivo, which includes the following stages: (i) formation of definitive 
endoderm, (ii) hepatoblast specification, (iii) hepatocyte maturation. 
Definitive endoderm (DE) differentiation is critical for the generation of endoderm 
derivatives such as hepatocytes, pancreas and intestine cells (D’Amour et al., 2005, Hay 
et al., 2008; Lewis and Tam, 2006 and Agarwal et al., 2008). The Nodal signalling 
pathway has been shown to play a critical role in DE differentiation. Hence, Activin, a 
surrogate of Nodal, is the most well established factor used in the DE induction protocol. 
After treatment of hESCs with a high dose of Activin A, expression of DE specific 
transcription factors, such as Sox17, Mix, GATA4 and GATA6 factors, is significantly 
upregulated (further discussed in section 1.4). It has also been reported that the generation 
of DE from hESCs is Activin A dose-dependent; only high levels of Activin A leading to 
DE differentiation, whereas a lower concentration favours the mesoderm lineage 
(D’Amour et al., 2005, Cai et al., 2007; Takenaga et al., 2007; Hay et al., 2008 and 
Agarwal et al., 2008). DE differentiation from hESCs is found to be initiated through a 
transient bipotent progenitor stage, called mesendoderm which resembles the primitive 
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streak in vivo.  After one day of treatment, cells co-express both mesoderm markers 
(brachyury, goosecoid and Mixl1) and endoderm markers (FoxA2 and Sox17). By day 3-5 
of differentiation, the majority of cells only express endoderm markers, while mesoderm 
markers are downregulated. Furthermore the cell surface marker CXCR4 is highly 
expressed in DE cells. 
In addition to Activin, other signalling pathways or small molecules are also 
reported to enhance Activin-induced DE differentiation, such as the Wnt/β-catenin 
signalling activation factors Wnt3a, BIO and LiCl (Hay et al., 2008b; Sumi et al., 2006). 
Treatment of ESCs with a combination of these factors along with Activin can increase 
DE differentiation efficiency (Sumi et al., 2008; Hay et al., 2008b). Sodium butyrate, a 
histone deacytylase inhibitor, is another molecule reported to enhance the homogeneity of 
Activin A-induced definitive endoderm differentiation from hESCs (Jiang et al., 2007), by 
selectively ablating the undifferentiated hESCs (Hay et al., 2008b). Additionally, 
suppression of PI3K using the LY-294002 inhibitor has been used in some studies to 
improve Activin-induced DE differentiation (McLean et al., 2007; Touboul et al., 2010). 
To date, direct differentiation from ESCs to DE using these methods can generate up to 
80% DE cells (D'Amour et al., 2005; Hay et al., 2008a; Hay et al., 2008b; Touboul et al., 
2010).  
Hepatic specification following DE formation is mainly achieved by 
supplementing medium with growth factors, FGF4 and BMP-2 (Agarwal et al., 2008; Cai 
et al., 2007; Touboul et al., 2010). Both these factors have been shown to provide signals 
to specify definitive endoderm into a hepatic fate, to become hepatic progenitors (Deutsch 
et al., 2001) by regulating hepatic endodermal genes, FoxA and Gata factors (Cirillo et al., 
2002). In addition to the protein factors, the treatment of DE with chemicals such as 
dimethylsulfoxide or sodium butyrate has also been reported to enhance hepatocyte 
formation (Hay et al., 2008b; Rogler, 1997), most likely by affecting chromatin mediated 
transcription. Hepatic specification is assessed by the expression of hepatocyte genes, 
such as AFP, ALB, HNF4α and CK19.  
Hepatocyte maturation is the next step in the generation of functional cells. A 
defined combination of cytokines, HGF and OSM, have been used in hepatocyte 
maturation of ESC-derived hepatoblasts (Agarwal et al., 2008; Cai et al., 2007; Hay et al., 
 - 34 - 
 
2008b; Touboul et al., 2010). HGF facilitates hepatoblast maturation selectively into 
hepatocytes via the hepatic regulator, CCAAT/enhancer binding protein (C/EBPα)(Suzuki 
et al., 2003). Moreover, it controls hepatocyte proliferation in the fetal liver (Uehara et al., 
1995). Dexamethasone, a steroid hormone, is also used in some cases (Agarwal et al., 
2008; Basma et al., 2009), as it is reported to up-regulate expression of CYP2A6 by 
increasing the binding of HNF4α to the proximal promoter (Onica et al., 2008)..  
  The sequential differentiation of hESCs via developmental stages can normally 
differentiate hESCs to hepatocytes in a duration range of 15-28 days, depending on the 
hESC lines, and can produce up to 70% of the final cell population as hepatocytes. It not 
only can produce hepatocytes for potential applications but also provides a good in vitro 
model system to elucidate the molecular mechanisms underlying DE and hepatocyte 
differentiation. However, hepatocytes produced by this strategy do not have a complete 
functional capacity when compared to primary hepatocytes. Further improvement is 
needed to produce scalable and functional hepatocytes for potential applications.  
1.3.2.2. Over-expression of hepatic enriched transcription factor 
Since cytokines/growth factors promote the differentiation of pluripotent stem 
cells into hepatocytes, probably by activation of downstream transcription factors that are 
necessary for hepatic differentiation, recent studies have investigated the effect of ectopic 
expression of these transcription factors and showed that they have similar effects in 
differentiating ESCs along the hepatic lineage. Expression of FoxA2, a transcription 
factor in hepatic specification, has enhanced hepatic differentiation in both mouse and 
human ESCs (Kanda et al., 2003; Lavon and Benvenisty, 2005). Constitutive expression 
of Sox17 is sufficient to induce a stable expandable endodermal phenotype in hESCs 
(Séguin et al., 2008).  In the absence of exogenous Activin A, Sox17-transgenic cells have 
shown a dramatic increase in the expression of liver specific markers. In addition to in 
vitro differentiation, it has been reported that a successful cell therapy for  mice with liver 
fibrosis has been achieved by transplantation of HNF-4 alpha over-expressing hepatic 
progenitor cells (Suetsugu et al., 2008). This adenovirus-mediated HNF4 transduction 
induced differentiation from hepatic progenitor cells to hepatic parenchymal cells in vitro, 
and increased albumin, cholesterol and glucose levels in mice transplanted with these 
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cells. Therefore, over-expression of liver-enriched transcription factors facilitates the 
proliferation and differentiation of hepatic cells. 
1.3.2.3. Co-culture system with other cell types 
As the liver micro-architecture displays both homotypic and heterotypic 
interactions between cells, it has been proposed that these interactions may play roles in 
hepatocyte functionality. Indeed, compelling evidence shows that several non-hepatocyte 
cell types in the liver can improve hepatocyte maturation and functionality in co-culture 
systems. For example, co-culture of AFP-producing ESC-derived hepatocytes with Thy-1 
positive mesenchymal cells isolated from mouse foetal liver increased gene expression in 
mature hepatocytes (Ishii et al., 2005) . Similarly, Imarhura et al., (2004) have shown that 
the regenerative liver can drive ES cell differentiation into a hepatic phenotype. These 
studies suggest that liver-specific cues from co-cultured cells could potentially drive ESCs 
towards a hepatic fate. Another group of researchers have used a double sequential co-
culture of ESCs with hepatocytes and fibroblast cells, resulting cells of which exhibited 
good hepatic morphology, gene expression and functionality (Cho et al., 2008). The liver 
consists of approximately 70-80% hepatocytes and the rest are non-parenchymal cells and 
cholangiocytes. Hepatoblasts purified from fetal mouse liver have been shown to require 
non-parenchymal cells for proliferation and expression of hepatocyte markers (Nitou et 
al., 2002).  
Liver regeneration requires the proliferation of both parenchymal and non-
parenchymal cells and this process involves highly orchestrated cellular interactions and 
signalling events (Fausto, 2001). Furthermore, several studies indicate that Kupffer, 
sinusoidal endothelial and stellate cells release factors that are mitogenic to hepatocytes in 
vivo and in vitro (Malik et al., 2002). Studies by Mitaka et al., (1999) and Michalopoulos 
et al., (2005) showed that the number of hepatocytes increased when co-cultured with 
non-parenchymal cells. Soto-Gutierrez et al. (2007) also reported that mESC-derived 
endoderm cells produced better functional hepatocytes when co-cultured with non-
parenchymal cells. Kupffer cells are able to micropattern the hepatocytes in order to affect 
their function (Zinchenko et al. 2006).  
However, several questions remain: (1) which non-parenchymal cell types are 
important for efficient maturation and functionality of hepatocytes? (2) How do they 
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affect hepatocyte differentiation and function; via soluble factors released from these cells 
or via cell-cell contact? More research is needed to answer these questions to achieve a 
better understanding of how this complex environment functions. 
 
1.4. Signalling pathways regulating definitive endoderm 
differentiation  
Several studies have suggested that efficient generation of definitive endoderm 
(DE) is the key step in leading to good hepatocyte differentiation from hESCs (D'Amour 
et al., 2005; Hay et al., 2008a; Hay et al., 2008b; Hay et al., 2007). Although progress has 
been made on determining the signalling pathways that control the generation of 
definitive endodermal cells from embryonic stem cells, it remains unclear precisely how 
these signalling pathways regulate differentiation in a timely manner. The duration, level 
and precise timing of particular signals could specify a particular cell fate. This also often 
involves crosstalk between different signalling pathways. Understanding this complex 
network will facilitate the differentiation of DE from hESCs.  
1.4.1. Nodal/Activin signalling  
Nodal and Activin are growth factors of the TGF-β-superfamily. Nodal signalling 
has been implicated in numerous cellular processes including proliferation, 
differentiation, apoptosis, cell migration and adhesion in relation to embryogenesis and 
tumorigenesis (Massague and Chen, 2000). Nodal/Activin signalling is initiated upon the 
binding of the ligand, nodal, to a corresponding type II receptor along with the EGF-CFC 
co-receptors (crypto and criptic) which then activates a type I receptor (Wrana et al., 
1992; Shi and Massague 2003; Massagué and Chen, 2000) (Figure 1.3). The intracellular 
domain of the ligand-activated receptor then phosphorylates receptor-regulated SMADs, 
Smad2 and Smad3 (R-Smads) (Massagué and Chen, 2000). Once phosphorylated, the R-
Smads can bind to Smad4 (co-Smad) and translocate to the nucleus. This R-Smad/co-
Smad complex then acts as a transcription factor to activate Nodal/Activin responsive 
genes. Activin, a surrogate of nodal, can signal through the same receptor as nodal but 
without the EGF-CFC co-receptor requirement.  
 - 37 - 
 
 
Figure 1-3 : Nodal/Activin signaling.  
Upon binding of Nodal to Activin receptors (ActRIIB,ALK4) and EGF-CFC coreceptors (Cripto, 
Cryptic), Smad2/3 is activated and translocated into the nucleus together with Smad4. Activin 
activates the same signalling pathway without the requirement of EGF-CFC co-receptors. Nuclear 
Smad2/3 then acts as a transcription factor to induce target gene expression (such as FoxH1). 
(Adopted from Hou and Hoodless, 2010) 
 
Nodal signalling is known to play an important role in embryo development 
including the regulation of embryonic axis formation, induction of mesoderm and 
endoderm formation and determination of left-right asymmetry
 
in vertebrates (Schier, 
2003a). Mouse Nodal mutants fail to form the primitive streak and are embryonic lethal 
(Conlon et al., 1994; Zhou et al., 1993). Also in Xenopus, inhibition of Nodal signalling 
by its antagonists, Cer-S
 
and Lefty, blocks mesendoderm formation (Agius et al., 2000; 
Chen and Shen, 2004; Takahashi et al., 2000). These lines of evidence strongly suggest 
that Nodal/Activin signalling is required for gastrulation and establishment of the 
mesendoderm/primitive streak during early development.  
In embryonic stem cells, Nodal/Activin seem to play contrasting roles, they are not 
only important for the maintenance of hESC self-renewal and pluripotency (described in 
section 1.2.2), but are also vital in the differentiation of both mesoderm and definitive 
endoderm. Activin has been widely used to induce the differentiation
 
of mesendoderm and 
thereafter definitive endoderm in both mouse (Kubo et al., 2004; Tada et al., 2005; 
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Yasunaga et al., 2005) and human ESCs (D'Amour et al., 2005; McLean et al., 2007). 
Nodal/Activin controls cell fate choice from mesendoderm to either definitive endoderm 
or mesoderm in a concentration-dependent manner. This has been shown in the in vitro 
ES cell differentiation system, in which mesendoderm is committed to definitive 
endoderm when a high level of Activin is applied, otherwise to mesoderm at lower 
concentration (Tada et al., 2005; Tremblay et al., 2000; Vincent et al., 2003). It is also 
reported that Nodal/Activin signalling can only specify definitive endoderm cell fate 
when PI3K signalling is low (D'Amour et al., 2005; McLean et al., 2007). This suggests 
that, in addition to Nodal/Activin pathways, other pathways may also be involved in 
regulating mesendoderm and subsequent lineage differentiation.  
It is worth noting that while Nodal/Activin signalling pathways promote 
mesendoderm and definitive endoderm differentiation, they also play a negative role in 
suppressing differentiation along other lineages. For example, Nodal/Activin signalling 
has been demonstrated to inhibit neuronal specification. Ectopic expression of Nodal in 
presumptive ectoderm alters cell fate into either mesoderm or endoderm, indicating an 
exclusive role of this pathway in mesendodermal lineages (Schier and Shen, 2000; 
Whitman, 2001). Moreover, nodal-expressing ES cells differentiate into mesendoderm at 
the expense of anterior visceral endoderm and neuroectoderm (Takenaga et al., 2007b).  
Concurrently, both in vivo and in vitro studies suggest that Nodal/Activin 
signalling pathways have multiple roles during early development as well as in the culture 
and differentiation of embryonic stem cells, depending on timing, concentration and 
duration. 
 
1.4.2. Wnt/ β -catenin signalling 
Wnt signals have diverse roles in regulating fundamental biological processes 
including cell fate, proliferation, migration and polarity during development (Moon et al., 
2004) (Tam and Loebel, 2007a). Wnt ligands, which consist of more than 15 closely 
related secreted glycoproteins, signal via transmembrane receptors of the Frizzled family 
together with 2 co-receptors; Lrp (Lipoprotein Receptor-related Protein)-5 and Lrp-6. 
Structurally, the Frizzled receptors are composed of 3 elements; an extracellular Wnt-
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binding domain, seven transmembrane-spanning regions and an intracellular C-terminal 
tail. Wnt signals are transduced through at least three distinct intracellular pathways, 
including the canonical Wnt/ β-catenin signalling pathway and the 'non-canonical' 
Wnt/Ca2+ (Calcium) pathway and Wnt/PCP (Planar Cell Polarity) pathway (Komiya and 
Habas, 2008) . The most studied so far is the canonical Wnt/ β-catenin pathway, which 
plays a critical role during development (Klaus and Birchmeier, 2008) .  
In the absence of a Wnt signal, β-catenin in the cytoplasm is constitutively 
phosphorylated by the coordinated action of glycogen synthase kinase-3β (GSK-3β) and 
casein kinase 1 (CK1) in the APC/Axin/GSK-3β-degradation complex, resulting in its 
ubiquitinisation by β-Trcp, a E3 ubiquitin ligase and subsequent proteasomal degradation 
(Logan and Nusse, 2004) . Binding of the Wnt ligand to its receptors, Frizzled and Lrp5/6, 
causes activation and recruitment of Dishevelled, a cytoplasmic protein, to the cell 
membrane, which then inhibits the activity of glycogen synthase kinase-3β (GSK-3β) by 
displacing this multifunctional kinase from the APC/Axin/GSK-3β-degradation complex 
leading to β-catenin cytosolic accumulation and nuclear translocation (Kohn and Moon, 
2005); (Willert and Jones, 2006). After nuclear localisation, β-catenin binds to nuclear 
proteins from the T cell factor/lymphoid enhancer factor (TCF/LEF) family and activates 
expression of Wnt signalling target genes (Behrens et al., 1998). β-catenin, which 
mediates cell fate determination during development,  was originally identified as a 
component of cell–cell adhesion complexes and was found to play an important role in 
calcium-dependent cell adhesion (Ozawa et al., 1989). In addition to Wnt signalling and 
cell adhesion, β-catenin has other signalling roles by anchoring actin and cytoskeleton  
(Tao et al., 1996).  
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Figure 1-4 : Wnt/β-catenin signalling.  
In the absence of Wnt (A), the β-catenin degradation complex, consisting of Axin, APC and GSK3 
lead to phosphorylation of β-catenin by Ck 1 and GSK3 and subsequently its degradation. If Wnt 
signalling is active (B), β-catenin degradation is reduced. This subsequently leads to its 
cytoplasmic accumulation and then to nuclear translocation, where it binds to the TCF 
transcription factor to activate expression of Wnt-responsive genes. Adapted from Deal C (2008).  
 
In vivo gain and loss functional studies of Wnt/-catenin signalling have led to a 
better understanding of how this pathway regulates cell fate. Homozygous inactivation of 
β-catenin results in a defect in anterior-posterior axis formation (Huelsken and Behrens, 
2002) and embryonic lethality (Haegel et al., 1995; Huelsken et al., 2000), at embryonic 
day 5.5 and 6.5–7 respectively. In early embryogenesis, Wnt/β-catenin signalling have 
pivotal roles in the formation of mesendoderm, mesoderm and endoderm (Lickert et al., 
2002b; Tam and Loebel, 2007b). Over-expression of stabilised β-catenin leads to 
premature EMT in the mouse embryo (Kemler et al., 2004), a process required for 
mesendoderm differentiation. Moreover, ablation of β-catenin in embryonic endoderm 
changes cell fate from endoderm to pre-cardiac
 
mesoderm (Lickert et al., 2002a) 
indicating β–catenin is required for the establishment of cell fate segregation into DE 
from mesendoderm. Apart from –catenin, functional knockdown of the Wnt/-catenin 
signalling components have also shown a similar observation. In mouse, a Wnt3a 
homozygous
 
knockout promotes primitive streak into neuralisation rather than formation 
of paraxial mesoderm (Yoshikawa et al., 1997). Also, double-homozygous mutants of 
Wnt
 
co-receptors Lrp5 and Lrp6 embryo fail to establish the mesendoderm (Kelly et al., 
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2004). Collectively, these findings show that Wnt signalling
 
is indispensable for the 
differentiation of PS and segregation of PS into mesoderm and endoderm.  
In ESCs, Wnt signalling has been shown to promote both self-renewal and 
differentiation, depending on concentration gradient and presence of other signalling 
pathways (Dravid et al., 2005; Hay et al., 2008a). Expression of mesendoderm/endoderm 
markers has been shown to be markedly diminished when Wnt signalling is inhibited 
(Glinka et al., 1998). Conversely, sustained activation of the Wnt pathway, using Wnt3A 
ligand, stabilised β-catenin overexpression or an inhibitor of GSK3, induces temporal 
emergence of primitive streak/mesendoderm in mouse (Bakre et al., 2007) and human 
ESCs (Sumi et al., 2008). 
Cooperation of signalling pathways: Nodal/Activin and Wnt/ β-catenin signalling 
Signal transduction controls a spectrum of regulatory gene networks, which in turn 
fine-tunes cell fate to a particular cell type. A comprehensive analysis of the regulatory 
gene networks responsible for endoderm differentiation has elucidated endoderm 
formation to a certain degree using Xenopus (Davidson et al., 2002; Loose and Patient, 
2004) and zebrafish (Stainier, 2002) models. Several studies have highlighted the 
crosstalk and cooperation between 2 major signalling elements in endoderm, 
Nodal/Activin and Wnt/β-catenin, through multiple levels of gene regulation.  
Both Wnt3 and Nodal are reported to mutually activate each others signals  (Ben-
Haim et al., 2006; Brennan et al., 2001; Liu et al., 1999a) for proper mesendoderm 
induction, since the absence of either one of these signals leads to a failure in 
mesendoderm formation in mouse embryos (Conlon et al., 1994; Huelsken and 
Birchmeier, 2001). Several transcription factors, which are known to govern endoderm 
formation, act downstream of these two signals, although the direct regulatory 
mechanisms are still largely unknown. For example, Gata4 and Gata6, which are induced 
by both Nodal/Activin and Wnt/β-catenin signalling (Sinner et al., 2006), play partially 
redundant roles in endoderm development in most species (Afouda et al., 2005; Jacobsen 
et al., 2002; Koutsourakis et al., 1999) and both Gata4 (Jacobsen et al., 2002) and 6 
(Koutsourakis et al., 1999) knockout mice show impaired definitive endoderm 
development;  Sox17, which is directly activated by Nodal/Activin signalling, physically 
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interacts with β-catenin to activate HNF1β, FoxA1, FoxA2 and Endodermin in Xenopus 
(Ahmed et al., 2004; Sinner et al., 2004a). Collectively, these data suggest that 
Nodal/Activin and the canonical Wnt pathway act in synergy to specify definitive 
endoderm.   
Both in vivo and in vitro studies have shown that canonical Wnt signalling 
specifies mesendoderm/endoderm induced by Activin in the ES cell system (Gadue et al., 
2006; Tam and Loebel 2007). Sustained activation of the Wnt pathway in mouse and 
human ESCs has enhanced Activin-induced expression of mesendoderm/endoderm 
markers (Bakre et al., 2007; Sumi et al., 2008). This is mainly due to the fact that Wnt3a 
accelerates the transition of hESC through mesendoderm in the presence of Activin (Hay 
et al., 2008a). Both Activin/Nodal and Wnt/β-catenin signalling pathways induce the 
mesendoderm/endoderm transcription factors Sox17 (Sinner et al., 2004b) and brachyury 
(Yamaguchi et al., 1999).  
 
1.4.3. Phosphoinositide 3- kinase (PI3K) signalling  
PI3K is a family of related intracellular signal transducer enzymes capable of 
phosphorylating phosphoinositides and are divided into three classes, based on their 
structure and substrates (Cantley, 2002). The best studied is Class Ia which includes three 
catalytic subunits, p110a, p110b and p110d, and one p85 regulatory subunit. Each PI3K 
contains one catalytic and one regulatory subunit to form a heterodimeric complex 
(Cantley, 2002). The PI3K/Akt signalling pathway consists of many activators, inhibitors 
and second messengers. Due to having many leads and branches, this pathway is very 
complex and far from understood.  
In general, the PI3K/Akt  pathway can be activated by several growth factors 
(Karakas et al., 2006). Upon activation, PI3K phosphorylates phosphatidylinositol-3,4-
bisphosphate (PIP2) to phosphatidylinositol (3,4,5)triphosphate (PIP3), which then 
recruits serine-threonine kinase Akt and PDK1  (phosphoinositide-dependent  kinase  1) 
to the  plasma membrane. PDK1 activates AKT by phosphorylation (Franke et al., 2003; 
Klippel et al., 1997). Akt then mediates many of the downstream actions of PI3K.  This  
includes (i) regulation of cell cycle and cell survival through direct inhibition of pro-
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apoptotic signals such as GSK3, Bad and the Forkhead family of transcription factors 
(Franke et al., 2003), (ii) activation of protein synthesis through mTOR/ p70
S6Kinase
 
pathway (Richardson et al., 2004; Sarbassov et al., 2005)  and  (iii) by acting as a key 
regulator of insulin signalling and glucose metabolism, through inhibition of GSK3 and 
FOXO (Berwick et al., 2002; Cohen and Frame, 2001).  
In mESCs, the PI3K/Akt pathway has been shown to be important in maintaining 
self-renewal through LIF-activated signalling (Paling et al. 2004). On the other hand, 
insulin
 
and serum, which activate PI3K signalling in hESCs, were shown to be potent
 
inhibitors of mesoderm and DE lineages (Freund et al., 2008; McLean et al., 2007). Thus, 
inhibition of PI3K could drive hESCs into both endoderm and mesoderm cell fate. 
Consistent with this, several studies have shown that lowering the serum concentration 
elevates expression of mesendoderm and definitive endoderm markers in the presence of 
Activin. In addition, inhibition of mTOR, which is downstream of the PI3K pathway, 
impairs pluripotency, prevents cell proliferation, and enhances mesoderm and endoderm 
differentiation in hESCs (Zhou et al., 2009), but meanwhile impairs the cell 
differentiation potential to become ectoderm. However, the mechanisms underlying this 
phenomenon are as yet largely unidentified. Further studies are required in order to 
address the negative role of PI3K signalling on mesendoderm and DE differentiation.  
In summary, many signalling pathways have been demonstrated to affect 
differentiation of DE from pluripotent stem cells. Deciphering these pathways holds 
promise for generating improved methodologies and therefore efficient DE 
differentiation.  
 
1.5. Three dimensional culture system for hepatocytes 
1.5.1. Maintaining functional hepatocytes in culture  
In order to make drug toxicity screening a successful event, having a scalable, 
functional source of hepatocytes is a critical concern. The key challenge in both primary 
and stem cell-derived hepatocytes is maintaining their differentiated characteristics, as 
they tend to undergo a rapid loss of the differentiated function in culture (Guguen-
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Guillouzo, 1986b; Steward et al., 1985), which is often associated with loss of polygonal 
morphology and cell polarity. It has been shown that in cultured hepatocytes, the lack of 
sufficient contacts between neighbouring cells may cause decreased expression of hepatic 
genes and loss of hepatocyte functionality (Ben-Ze'ev et al., 1988; Yuasa et al., 1993). 
Currently, hepatocytes are often cultured in conventional two-dimensional (2D) culture 
formats, in which they do not mimic the cell response in the three-dimensional (3D) 
milieu of tissues in vivo (Abbott, 2003; Sun et al., 2006). Hence, these cells undergo a 
significant reduction in their functionality, such as a decrease in cytochrome P450 (CYP) 
activity (Hu et al., 1997; Rodriguez-Antona et al., 2002) and loss of both membrane 
transport activities and canalicular structures (Jigorel et al., 2005; Liu et al., 1999b; 
Maurice et al., 1994). This phenomenon is known as dedifferentiation, a process in which 
fundamental changes in gene expression concomitant with a diminished transcription of 
the relevant liver-specific genes. The major factor contributing to dedifferentiation is the 
lack of a specialised tissue microenvironment, also called the cellular niche, which 
provides an apt microenvironment for tissue generation, survival and function. This niche 
contains 3 key aspects, namely; (i) soluble factors (ii) extracellular matrix components 
and (iii) cell-cell contacts (Discher et al., 2009; Scadden, 2006). 
Therefore, the most spectacular improvement of both cell survival and function 
may be obtained by recreating an in vitro 3D configuration to recapitulate the niche in 
liver (Guguen-Guillouzo, 1986a). Creation of a 3D cell culture system is vital for 
obtaining and maintaining functional hepatocytes. Furthermore, a better understanding of 
how cell-cell contacts could modulate hepatocyte behaviour in vitro is an essential 
prerequisite for a better culture system.  
1.5.2. Three-dimensional culture improves cell polarity and ECM production    
 A 3-D culture system aims to recapitulate certain aspects of normal development 
in order to stimulate and maintain cell differentiation and functionality in vitro 
(MacArthur and Oreffo, 2005). It provides a micro-niche to enhance both homotypic and 
heterotypic cell-cell contacts, which eventually leads to (i) modulation of tissue-specific 
extracellular matrix expression and (ii) cell polarity within a cluster of cells. Both these 
factors are crucial for directing the cellular signalling relationships which governs cell 
fate. 
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With respect to the in vivo tissue niche, one key way that a 3D configuration can 
mimic with  the reconstruction of tissue specific extracellular matrix (ECM) is through 
enhanced cell-cell contact. ECM is highly organised structure and is composed of proteins 
such as collagen (type I, II, IV, and V), glycoproteins (fibronectin, laminin, tenascin, and 
osteonectin), proteoglycans (heparin sulfate, and chondroitin sulfate), elastins and 
glycosaminoglycans (hyaluronan) and has been implicated as an important modulator of 
various cellular events, including homeostasis, cell polarity, differentiation, function and 
repair (Amenta et al., 2007; Oda et al., 2008). ECM provides structural support to cells 
and regulates the dynamic behaviour of cells (Amenta and Harrison, 1997). The role of 
ECM in gene expression regulation and cell differentiation is through integrins, which 
heterodimers that span the cell membrane. Integrins are capable of modulating 
communication between the ECM and cytoskeleton proteins (Horwitz et al., 1986; 
Ruoslahti, 1997).  
Due to its importance in hepatic homeostasis, functionality and its prominent role 
in cirrhosis, the hepatic ECM has been widely assessed (McClelland et al., 2008). It has 
been shown that optimisation of 3D hepatocytes can be achieved by carefully controlling 
the physical and chemical properties of ECM (Ng et al., 2005). In addition, isolated ECM 
from liver tissue has been shown to maintain the phenotype of hepatocytes in culture 
(Ohno et al., 2008).  
Another key element supplied by using a 3D culture is the re-establishment of cell 
polarity. The hepatocyte performs multiple functions which include protein synthesis, 
metabolism, detoxification, and excretion.  To achieve this, hepatocytes establish 
apicobasal epithelial polarity during liver organogenesis (Sasse et al., 1992). Highly 
polarised hepatocytes exhibit a distinct distribution of plasma membranes, namely 
sinusoidal– basolateral and canalicular–apical domains. This division of plasma 
membranes is required for proper hepatocyte function (Sasse et al., 1992). Integrins are 
localise at the basolateral membrane, where they mediate ECM interactions (O'Brien et 
al., 2002). Therefore, one approach is to restore the polarity associated with an in vivo-like 
tissue structure and this has been shown to be feasible with 3D culture (Bierwolf et al., 
2011; Dunn et al., 1991). 
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Collectively, these studies show that maximised cell-cell contact modulates cell 
polarity and ECM assembly, which could ultimately provide the appropriate signalling to 
govern the hepatic functionality.  
1.5.3. Methodology and functionality improvement in three-dimensional culture  
Knowing the importance of the 3D microniche for maintenance of cell function, a 
range of methodology has been developed to establish physiologically relevant models in 
a controllable and reproducible manner. These methods mainly using 2 strategies; 
suspension cultures or biomaterial- based scaffolds/hydrogels.  
Spheroid formation in suspension cultures 
In 1961, Moscona observed spontaneously formed aggregates in vitro by using a 
rotational technique. More than twenty years later, 3D aggregates were first produced by 
plating cells in a non- or ultra-low adherent culture dish using serum free medium. The 
resulting aggregates were called ‘spheroids’ (Landry et al., 1985). The spheroids formed 
using this method exhibit histotypic (one cell type) reorganisation, deposition of 
extracellular matrix consisting of laminin, fibronectin and collagen, as well as prolonged 
survival and enhanced metabolic and plasma protein production, such as ALB secretion 
and induction of transferrin (Sakai et al., 1996; Tong et al., 1992). The use of non-
adhesive surfaces for producing the spheroids is inexpensive and simple to perform, 
although these spheroids showed variations in size, cell number and shape (Yuhas et al., 
1977). 
Another method that can produce inexpensive, homogenous and fast spheroid 
formation has been achieved by several groups using the hanging drop technique (Kelm et 
al., 2006; Kelm and Fussenegger, 2004; Lin et al., 2006a). This method was initially 
developed for cultivating stem cell embryoid bodies. The microgravity environment in 
each drop concentrates a defined cell numbers at the liquid-air interface. Although this 
method is not suitable for the scalable production of 3D cells, it has been used for 
studying cellular or molecular events during the interaction of two different cell types  as 
well as tumour spheroid-induced angiogenesis (De Ridder et al., 2000; Timmins et al., 
2004). To overcome this drawback in stationary culture methods, many rotary culture 
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systems have been established. These make a massive production of cells feasible while 
providing an enhancement in 3D induced functionality (Khaoustov et al., 1999). 
Biomaterials scaffold/hydrogel based 3-D formation 
Another widely used 3D modelling system is using biodegradable 
scaffolds/hydrogels. Biomaterial-based scaffolds/hydrogels support the formation of 
organoids or tissue like structures, which recapitulates the in vivo milieu, allowing cells to 
influence their own microenvironments. Cells are often encapsulated or seeded in this 
artificial structure matrix to support tissue formation.  3D scaffold-based culture has been 
shown to enhance osteogenesis (Du et al., 2009), haematopoiesis (Liu and Roy, 2005) , 
and neural differentiation (Nisbet et al., 2009; Sykova et al., 2006), and provide greater 
support for hepatocyte proliferation and functionality than routine 2D tissue culture 
(Falasca et al., 2001; Glicklis et al., 2000a). 
Biodegradable biomaterials, both natural and synthetic, closely resemble the 
consistency of the native tissue and make an attractive scaffold material for soft tissue 
engineering. The properties of the scaffolds, such as their chemistry and internal 
morphology (porosity and pore size) have an impact on functionality improvement and on 
the nature of the regenerating tissue since the nature of the cell-cell interaction depends on 
the property of the scaffolds. Biomaterial scaffolds provide one of these two fundamental 
steps; acting as the extracellular matrix (exogenous) or promoting lineage-specific ECM 
expression (endogenous) (Turner et al., 2007) through enhanced cell-cell contact. 
Therefore, understanding biomaterial suitability and their influence on cell functions are a 
critical issue in creating the optimal cell niche. Several 3D cellular model systems have 
been widely employed using scaffolds or hydrogels which are made of biomaterials such 
as collagen (Baharvand et al., 2006; Imamura et al., 2004), hyaluronic acid (Turner et al., 
2007), chitoson (Eser et al., 1998), matrigel (Ishii et al., 2008; Schug et al., 2008) and 
alginate (Augst et al., 2006; Elkayam et al., 2006; Fang et al., 2007b; Glicklis et al., 
2000b). Among various biomaterials, alginate is of special interest for hepatic tissue 
engineering. 
Alginate, a polysaccharide derived from brown seaweed, is a biocompatible 
polymer widely used in 3D scaffolds for liver cells. Not only as a scaffold for tissue 
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engineering, it has also been used as a delivery system for drugs and as extracellular 
material for basic biological studies (Atala et al., 1993; Augst et al., 2006; Lanza et al., 
1999). The alginate based capsulation has been widely used in liver tissue engineering 
using different cell types such as primary hepatocytes (Falasca et al., 2001; Glicklis et al., 
2000a), hepatoblasts (Cheng et al., 2008), human hepatocarcinoma cell lines (Coward et 
al., 2009a; Khalil et al., 2001b; Selden et al., 1999a) and embryonic stem cell-derived 
hepatic cells (Fang et al., 2007a; Gerecht-Nir et al., 2004; Maguire et al., 2006). This 
biomaterial has shown better functionality improvement of hepatocytes via maximised 
cell–cell interactions (Glicklis et al., 2000b). This is due the nature of the biomaterials and 
ECM modulation induced by it. Unlike some of the other scaffolds which act as an 
extracellular matrix, collagen for example, alginate acts to promote extracellular matrix 
production by the cells in a 3-dimensional milieu. As a result, these hepatospheres showed 
prolonged viability in culture and improved liver-specific functions, as judged by albumin 
secretion and urea synthesis (Glicklis et al., 2000b).  
While the stem cell-derived hepatocyte is a promising choice for liver-based 
technology, providing a fully functional hepatocyte resource remains a challenge. 
Although the 3-D culture has been shown to be a very promising method for improving in 
vitro hepatocytes functionality, research on its application for stem cell-derived 
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1.6. Aims of this study 
The ultimate aim of this project is to efficiently generate functional hepatocytes 
from hESCs, which could be applied to biomedical applications and regenerative 
medicine. The current goals are to explore the molecular mechanisms underlying 
definitive endoderm differentiation of hESCs and to improve the maturation and 
function of hESC-derived hepatocytes.  
Specific objectives:  
(1) Investigate the role of PI3K signalling in definitive endoderm differentiation of 
hESCs and the possible underlying molecular mechanisms. 
(2) Develop a 3D culture system to improve the maturation and functionality of 
hESC-derived hepatocytes. 
 
The knowledge gained from this work will provide new insights into the molecular 
mechanisms underlying the signalling pathways that control the in vitro hepatic 
differentiation of ESCs as well as new information for tissue engineering to generate 
functional hepatocytes and even liver tissues. 
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Chapter 2: 
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2. Materials and methods 
2.1. Materials: Cell culture and differentiation 
2.1.1. Materials   
Cell lines   Supplier  
H1 (WA-01) Male human ES cell line (Thomson et al., 1998) 
H9 (WA-09) Female human ES cell line (Thomson et al., 1998) 
HepG2  from the European Collection of Cell Cultures     
(ECACC) 
MEFs Mouse embryonic fibroblasts isolated from wild type  
CF-1 embryos (E13.5). 
 
Inhibitors/ Growth Factors Supplier  
Activin A Peprotech 
bFGF Peprotech 
HGF Peprotech 
LY-294002 inhibitor Sigma 
OSM R&D 
Y-27632 ROCK inhibitor Sigma  
  
Medium   
2-mercaptoethanol  Invitrogen  
100X L-Glutamine  Invitrogen  
100X Non Essential Amino Acids (NEAA)  Invitrogen  
30% Bovine serum albumin (BSA)  Sigma  
B27 Supplement (minus Vitamin A) Invitrogen  
Dulbecco’s modified eagles medium 
(DMEM)  
Invitrogen  
Fetal bovine serum (FBS)  Sigma  
Knockout Dulbecco’s modified eagles 
medium (KO-DMEM)  
Invitrogen  
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Knockout serum replacement (KSR)  Invitrogen  
L-15 medium Sigma 
RPMI1641 Invitrogen 




Dissociation enzymes  
Accutase  Innovative Cell Technologies 
Collagenase Invitrogen 
Trypsin EDTA Sigma 
  
Chemicals   
Algimatrix dissolving buffer  Invitrogen  
Alginate  Sigma  
Ascorbic Acid  Sigma  
DMSO  Sigma  
FDA Sigma  
Fungizone invitrogen  
Hydrocortisone 21-Hemisuccinate Sigma 
Insulin  Sigma  
phosphate buffer saline (PBS)  Invitrogen  
PI Sigma  
Pluronic acid  Sigma  
Reagent A100 – lysis buffer  Chemometec 
Reagent B – stabilising buffer  Chemometec 
Sodium butyrate  Sigma 
Sodium chloride Sigma  
Sodium hydroxide Sigma  
Tryphan blue  Sigma  
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Matrices  





2.1.2. Cell culture stock solutions  
Mouse embryonic fibroblast (MEF) medium/HepG2 (Algimatrix) 
DMEM (440 ml) 
10% , FBS (50 ml) 
1X 100X L-Glutamine (5 ml) 
1X 100X P/S (5 ml) 
 Knockout Serum-Replacement (KSR) medium 
KO-DMEM (400 ml) 
20% , KO-SR (100 ml) 
4 ng/ml, 10 ng/ml FGF2 (0.2 ml) 
1X , 100X NEAA (5 ml) 
0.1 mM, 2-mercaptoethanol (1 ml) 
1X, 100X L-Glutamine (5 ml) 
1X 100X P/S (5 ml) 
 Collagenase (200 U/ml) 
Collagenase IV (20,000 units ) in  
KO-DMEM (100 ml ) 
 HepG2 culture medium (complete culture medium - Alginate beads) 
α-MEM with ribonucleosides and deoxyribonucleosides 
10% FCS 
100 U/ml Penicillin/0.1 mg/ml Streptomycin  
1.25 mg/ml Fungizone 
50 mg/ml Linoleic Acid BSA 
0.04 mg/ml Hydrocortisone 
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0.04 mg/ml Thyroid Releasing Hormone  
9.5 mg/ml Insulin  
0.002 mg/ml Sodium Selenite  
 RPMI:B27 medium (Stage 1/DE differentiation) 
RPMI:1640 (500 ml) 
2X, 50X B27 (10 ml) 
1X, 100X L-Glutamine (5 ml) 
1X 100X P/S (5 ml) 
 SR/DMSO medium (Stage 2 ) 
KO-DMEM (400 ml) 
20% , KO-SR (100 ml) 
4 ng/ml, 10 ng/ml FGF2 (0.2 ml) 
1X , 100X NEAA (5 ml) 
0.1 mM, 2-mercaptoethanol (1 ml) 
1X, 100X L-Glutamine (5 ml) 
1X 100X P/S (5 ml) 
1%, DMSO (5 ml) 
 L-15 medium (Stage 3) 
Leibowitz L15 (500 ml) 
8.3 %, Tryptose phosphate broth (50 ml) 
8.3% , Foetal bovine serum (50 ml) 
1X, 100X L-Glutamine (5 ml) 
1X 100X P/S (5 ml) 
1ml of ascorbic acid (only add prior to use) 
 2% Alginate – pH 7.4 
0.15 M Sodium chloride 
1M Sodium hydroxide 
15 mM HEPES buffer 
 Polymerisation Buffer – pH 7.4 
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0.15 M Sodium chloride 
1 M Sodium hydroxide 
15 mM HEPES buffer 
0.204 M Calcium chloride 
0.05 % w/v Pluronic acid  
 
2.2. Methods: Cell culture and differentiation 
2.2.1. Maintenance and propagation of hESCs 
Generation of mouse embryonic fibroblast-conditioned medium  
Mouse embryonic fibroblasts (MEF) were grown and expanded in MEF culture 
medium to passage 3 or 4. Cells were then trypsinised and collected into 50 ml Falcon 
tubes and the cell number counted. Cells were irradiated at 40 grays followed by 
centrifugation at 800 rpm for 4 minutes. Meanwhile, T225 flasks were coated with gelatin 
by adding 10 ml of 0.5% gelatin to each flask and leaving in a culture hood for 10 
minutes. Cells were resuspended in MEF medium after centrifugation and 2 x 10
7
 cells 
plated into each gelatin-coated T225 flasks. After 24 hours, MEF medium was replaced 
with 150 ml KSR medium, supplemented with 4 ng/ml FGF2, and incubated overnight 
prior to collection. This medium, termed mouse embryonic fibroblast-conditioned 
medium (MEF-CM), was collected daily, for 7 continuous days and stored at -80
o
C. Fresh 
KSR medium was added into the flasks for collection the next day on daily basis. Upon 
use, MEF-CM was defrosted and mixed with L-glutamine and P/S before being filtered 
and kept at 4
o
C.  
Preparation of matrigel coated plates  
Stock matrigel was slowly thawed at 4
 o
C overnight and diluted 1 in 2 with cold 
KO-DMEM. This solution was aliquoted to 1 ml working volume into 15 ml tube and 
stored at -20
o
C. Upon use, the matrigel was gently defrosted at 4
 o
C and diluted with 14 
ml cold KO-DMEM. The diluted matrigel was plated onto 6-well plates, 1 ml/well and 
incubated overnight at 4
o
C. In some instances, the coating could be shortened to 1 hour at 
room temperature.  
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Culture of hESCs  
H1 and H9 (passage number between 40 to 80) hESCs were cultured in MEF–CM 
supplemented with 4-8 ng/ml FGF2 in matrigel coated plates and medium was changed 
daily. Cells were routinely passaged at a 1:3 dilution by treatment with 200 U/ml 
collagenase IV prior to mechanical dissociation.  
2.2.2. Differentiation of hESCs to hepatic lineages 
Differentiation of hESCs was initiated at a confluence level of approximately 50% 
to 70% by replacing the MEF-CM with RPMI:B27 containing 1 mM sodium butyrate 
(NaBut) and 100 ng/ml Activin A. After 24-48 hours, the medium was changed using the 
same base medium, RPMI:B27, but with a reduced concentration of sodium butyrate of 
0.5 mM and cells were cultured for a further 48 hours.  
At stage 2 of differentiation, if confluent, the cells were then split 1 into 2 into new 
matrigel coated plates, but otherwise culture was continued without splitting. These cells 
were cultured in SR/DMSO medium for 4-7 days. Finally, the cells were cultured in 
maturation medium: L15 medium (stage 3 medium) containing 10 ng/ml hepatocyte 
growth factor (HGF) and 20 ng/ml Oncostatin M (OSM) for another 4-5 days. The 
medium was changed daily during differentiation. 
2.2.3. Differentiation of definitive endoderm by Pl3kinase signalling suppression 
by LY-294002 inhibitor and time course signalling study 
Treatment was performed when hESCs reached a confluence level of 
approximately 50-70%. Cells were washed twice with PBS prior to treatment with 
RPMIl640 medium containing 1xB27. LY 294002 (LY) and/or 100 ng/ml Activin A (AA) 
were maintained in cultures over the duration of treatment at the indicated concentrations. 
For DE differentiation, treatment was initiated at a confluence level of approximately 
60% to 70% by replacing the MEF-CM with RPMI:B27 containing AA at 100 ng/ml and 
Ly inhibitor at 20 µM for 24 hours. The cells were treated for another 48 hours with the 




 - 57 - 
 
2.2.4. HepG2 cells in 3D alginate culture  
2.2.4.1. Alginate capsulation of HepG2 cells 
Monolayer cultures of HepG2 cells were maintained in 175 cm
3
 vented tissue 
culture flasks in α-MEM complete culture medium. Medium was changed every 2-3 days 
and cells were passaged once per week by trypsinisation when 70-80% confluent.  On the 
day of capsulation, cells were removed from flasks by trypsinisation at 70–90% 
confluency and cell number and viability were determined using trypan blue exclusion of 
non-viable cells prior to mixing. The cell suspension was then resuspended at a density of 
0.5 × 10
6
 cells/ml in a mixture of one part 2% alginate to one part culture medium. This 
solution was then drawn up through a 50 µm filter into a 50 ml syringe and attached to the 
syringe pump of an Inotech IER-20 encapsulator (Inotech, Dottikon, Switzerland). The 
cell suspension was passed at a flow rate of 5 ml/min through the encapsulator using a 
200 µm nozzle vibrating at 1295 Hz, yielding spherical beads of average 400 µm 
diameters. The resulting flow of beads fell into gently stirred polymerisation buffer. 
Cross-linking of the alginate chains with divalent cations caused the beads to ‘gel’. . After 
10 min in polymerisation buffer, the beads were separated from the polymerisation buffer 
by pouring them into a beaker containing a 200 µm mesh bottom.  The beads were 
washed twice with DMEM to remove any remaining polymerisation buffer. The beads 
were resuspended in a 175-cm
3
 tissue culture flask with α-MEM culture medium at a ratio 
of 0.25 ml beads to 8 ml culture medium. A suspension of beads and culture medium 
(8 ml) was transferred into each well of a 6-well culture plate containing 100 µm mesh 
filters. The culture medium was changed every 48 hours by removing the beads from the 
plate containing mesh filter and by placing in a new plate with new medium. 
2.2.4.2. Assessment of cell viability by confocal microscopy of FDA/PI-stained cells 
Approximately 250 µl alginate beads were transferred to a 1.5 ml microfuge tube, allowed 
settling and the medium aspirated.  Beads were then washed and resuspended with PBS.  
20 µl Propidium Iodide (PI) (for non-viable cells) and 10 µl Fluorescein Diacetate (FDA) 
(for viable cells) were added, gently mixed and incubated for 90 seconds.  After this, PBS 
was aspirated and beads washed a further 2 times as before.  Beads were resuspended in 
500 µl of PBS and transferred to a microscope slide.  The beads were then visualised 
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using a fluorescence microscope.  Phase contrast, live and dead images were captured 
using a Biorad Radiance 2100 confocal microscope (Biorad, Hertfordshire, U.K.) and 
Lucia imaging software (Biorad, Hertfordshire, U.K.).  FDA and PI images were captured 
at exposures of 64 and 250 ms respectively.       
2.2.4.3. Release of cell spheroids from alginate beads 
Beads removed from culture were incubated in 1.6 ml of 16 mM EDTA and beads were 
incubated for 10 minutes at 37°C until dissolved. Beads were centrifuged at 13200 g for 5 
minutes to pellet the spheroids. Released spheroids were directly used for CYP3A4 assay 
(as described in section 2.4.2.2). For nuclei or total protein estimation, released spheroids 
were disrupted by repeated passage through a 23G needle, pelleted in a microfuge, 
washed, and resuspended in an appropriate solution.   
2.2.4.4. Total cell counts 
Cell numbers were quantified using the Nucleocounter System, an integrated fluorescence 
microscope.  Cell samples were lysed using acid provided before the pH was neutralised 
and samples loaded into Nucleocassettes.  Nucleocassettes contain propidium iodide (PI) 
within their flow channels which stain the lysed cell nuclei.  A fluorescent image of a 2 µl 





cells/ml) to be determined.   
 
2.2.5. Hepatic intermediates cells in Algimatrix 3D culture  
2.2.5.1. Cell seeding and differentiation of hepatic intermediates cells in Algimatrix 
3D culture 
Day 1 or 2 of stage 2 cells from monolayer differentiation (as described in Hay et al., 
2008) were treated with 10 µM ROCK inhibitor Y-27632 (ROCKi) in SR/DMSO medium 
for 2 hours prior to dissociation. The cells then were single-cell dissociated using accutase 
and were counted using an improved Neubauer hemocytometer for viable cells by trypan 
blue. A suspension of these cells in SR/DMSO medium with 10 µM ROCKi was 
transferred into each well of a 24-well Algimatrix plate at the indicated cell density, 
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followed by a centrifugation stage of 200 rpm for 3 min. The medium was then added to a 
total volume of 1 ml/well. These cells were cultured in the Algimatrix plate and medium 
was changed every day, as in monolayer differentiation, to proceed further to stage 2 and 
stage 3 differentiation (as described in Hay et al., 2008). 
2.2.5.2. Release of cell spheroids from Algimatrix sponge 
On the day of spheroid harvest, the media from the well of Algimatrix plate was aspirated 
and 1 ml of dissolving buffer was added directly onto the sponge. This was then incubated 
for 5 minutes, while examining the sponge under a microscope. Typically, the sponge 
visibly degrades within 5 minutes after adding Algimatrix dissolving buffer. The contents 
of the well was then gently aspirated and transferred to a sterile centrifuge tube or 
multiple tubes. Then, medium was added to the centrifuge tube to pellet the released cells, 
the spheroid suspension was centrifuged at 200 rpm for 4 mins to release cells, the 
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2.3. Materials: Gene expression analysis and functional assay 
2.3.1. Materials  
Items  Supplier  
Glycine  BDH  
100 BP DNA ladder  Invitrogen  
40% Polyacrylamide solution  Merck  
Acrylogel 3 solution  VWR  
Agarose Invitrogen  
Ammonium persulfate (APS)  VWR  
BCA protein assay kit  Pierce  
Chemiluminescence western blotting detection reagent  Pierce  
CL-XPosure film Fisher  
DNase I  Sigma  
dNTPs Invitrogen  
Ethanol  VWR  
Ethidium bromide  Sigma  
Immobilon-P membrane, PVDF  Millipore  
Isopropanol Sigma  
Large flagment of DNA Pol I  Invitrogen  
Oligo dT 12 18 Primer  Invitrogen  
Orange G  VWR  
PCR-grade water  Invitrogen  
Phosphatase inhibitors Sigma  
Protease Inhibitor  Sigma  
Protein ladder  Fermentas  
Resolving gel buffer  BioRad  
Restore Western blot stripping buffer  Pierce  
RNase OUT  Invitrogen  
Separating gel buffer  BioRad  
skimmed milk  Sigma  
SuperScript II RT  Invitrogen  
 - 61 - 
 
SYBR GREEN  Sigma  
Taq DNA polymerase  Invitrogen  
  
Assay Kits   Supplier  
Bicinchoninic acid (BCA) protein assay kit  Themo scientific 
CYP3A4 P450-Glo™ Assays  kit Promega  
DIUR-500 - QuantiChrom™ Urea Assay Kit BioAssay systems 
  
2.3.2. Stock solutions  
Component ( Final concentration, Component, amount) 
10X Orange-G loading buffer 
750 μg/ml Ficoll (7.5 g) 
10 mg/ml Orange G (100 mg)  
dH2O  
 2.5 mM dNTP mix for PCR 
2.5 mM  dATP (10 μl ) 
2.5 mM dCTP (10 μl ) 
2.5 mM dGTP (10 μl ) 
2.5 mM dTTP (10 μl ) 
dH2O (360 μl)  
 10 mM dNTP mix for reverse transcription 
2.5 mM  dATP (10 μl ) 
2.5 mM dCTP (10 μl ) 
2.5 mM dGTP (10 μl ) 
2.5 mM dTTP (10 μl ) 
dH2O (60 μl)  
 10X TE buffer 
10X 1 M Tris-HCL (pH 7.5) (100 ml)  
10X 500 mM EDTA (pH8.0) (20 ml) 
dH2O 880 ml  
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 10X TAE buffer 
400 mmol/l Tris base (48.4 g)  
50 mM 0.5M EDTA (20 ml) 
0.2 mM  Glacial acetic acid (11.42 ml ) 
dH2O (968.58 ml ) 
 8% (w/v) resolving gel 
40% Acrylamide (2.7 ml ) 
Resolving gel buffer (2.5 ml ) 
0.1% , 10% SDS (100 μl ) 
0.05%, 10% APS (50 μl ) 
TEMED (5 μl ) 
dH2O (4.7 ml ) 
* Resolving gel buffer is 1.5M Tris-HCl buffer pH8.8. 
 4% (w/v) stacking gel 
40% Acrylamide (1.3 ml) 
Stacking gel buffer (2.5 ml) 
0.1%, 10% SDS (100 μl) 
0.05%, 10% APS (50 μl) 
TEMED (5 μl) 
dH2O (6.1 ml) 
* Stacking gel buffer is 0.5M Tris-HCl buffer pH6.8 
 10 x SDS-running buffer 
250 mmol/L, Tris Base (30.3 g) 
1.9 mol/L, Glycine (144.2 g) 
1%, 20% SDS (50 ml) 
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Western transfer buffer 
48 mM, Tris Base (5.82 g) 
39 mM, Glycine (2.93 g) 
0.04% of 10% SDS (3.75 ml) 
20% Methanol (200 ml) 
 FACS Staining Buffer 
PBS (48 ml) 
2%, FBS (1 ml) 
2 mM, 0.5M EDTA (200 μl) 
 nuclear buffer  
10 mM HEPES 
10 mM KCl 
0.1 mM EDTA 
0.1 mM EGTA 
2 mM DTT 
1% NP40 (v/v)  
400 mM NaCl 
phosphatase inhibitors 
 Non-nuclear buffer 
10 mM HEPES 
10 mM KCl 
0.1 mM EDTA 
0.1 mM EGTA 
2 mM DTT 
1% NP40 (v/v)  
phosphatase inhibitors 
 
RIPA buffer  
150 mM NaCl 
50 mM Tris pH 8.0 
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0.5% Deoxycholic acid 
0.1% sodium dodecyl sulfate (SDS) 
1% NP-40 
1.5 mM PMSF  
phosphatase inhibitors 
 
2.4. Methods: Gene expression analysis and functional assay 
2.4.1. Gene expression analysis  
2.4.1.1. Reverse transcription and polymerase chain reaction  
 
Preparation of total RNA from cultured cells 
Total RNA was extracted using TRI reagent according to the manufacturer’s guidelines. 
Briefly, cells grown on a monolayer were directly harvested by 500 μl TRI reagent and 
collected into RNase-free tube. Samples were allowed to stand for 5 minutes at room 
temperature prior to the addition of 100 μl chloroform. These were then covered tightly 
and vortexed vigorously and then allowed to stand at room temperature for 10 minutes. 
The resulting mixture was then centrifuged at 12,000g for 15 minutes at 4ºC. The 
resulting upper aqueous phase containing RNA was transferred to an RNase-free tube and 
20 μl isopropanol added and mixed. After 10 minutes at room temperature the mixture 
was spun by centrifugation at 12,000g for 10 minutes at 4ºC. The supernatant was 
discarded, and the RNA pellet was washed by addition of 500 μl 75% ethanol. 
Centrifugation was applied to the mixture at 7,500g for 15 minutes at 4
o
C. After briefly 
air-drying, the RNA pellet was resuspended in an appropriate volume of dH2O. The RNA 
solutions were then stored at -80ºC. The quantity and quality of RNA preparations was 
measured using NanoDrop according to the manufacturer’s instruction.  
First strand cDNA synthesis  
Super Script II Reverse Transcriptase (RT) was used to catalyse the synthesis of 
single-stranded cDNA from total isolated RNA. A total reaction volume was prepared 
using the following components: 2 μg RNA diluted to a final volume of 11 μl using 
RNase-free water, 4 μl 5x RT buffer, 1 μl oligo (dT) primer, 1 μl 10 mM dNTP, 1 μl DTT 
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and 1 μl RNase inhibitor. This mixture was then pre-heated at 42ºC for 2 minutes prior to 
the addition of 1 μl RT. A reaction mixture without the enzyme was also set up as a non-
RT negative control. The total 20 μl mix was incubated at 42ºC for an hour followed by 
the inactivation step at 70ºC for 15 minutes. Samples were diluted 1:10 in dH2O, 
centrifuged briefly and stored at -20ºC. cDNAs of interest were then detected by semi-
quantitative PCR or real-time PCR. 
PCR analysis (RT-PCR)  
PCR analysis was performed in 50 μl reaction volume with 500U of Taq DNA 
polymerase using 0.4 μM specific primers, with the following program: 95°C for 15 min, 
then cycles of 94°C for 15 sec, Ta (annealing temperature) for 30 sec, 72°C for 30 sec for 
25-35 cycles. PCR products were separated by electrophoresis on 1.5% agarose gels and 
visualised by ethidium bromide staining. Gapdh or β-actin was used to normalise input. 
The primers used for this analysis can be found in Appendix I. As negative controls, 
reverse transcriptase was omitted at the cDNA synthesis step and the samples were then 
proceeded to the PCR reaction in the same manner as above. These control experiments 
gave no positive amplification for OCT4 and β-actin. This step was performed for all the 
RNA samples used in this study to exclude the possibility of genomic DNA 
contamination. 
Quantitative-reverse transcription polymerase chain reaction (qRT-PCR)  
The qRT-PCR was prepared with a mixture of 2 μl cDNA template, 15 μl of 
SYBR green mixed solution, 9 pmol each of 5’ and 3’ primers and topped up with dH2O 
to 30 μl. PCR reactions were carried out on DNA Engine OpticonTM II (Biorad) using 
Opticon Monitor 3 software (MJ Research Inc., Waltham, MA). The reaction was run 
using this program for all the genes: denaturation at 95°C for 15 sec, annealing at 60°C 
for 30 sec and elongation at 72°C for 30 sec for 40 cycles. Target gene expression data 
were normalised to the average for β-actin (housekeeping gene), which is the ΔCt. This 
then converted to a fold difference by; fold difference is 2-
ΔΔCt 
. The fold difference value 
of experimental samples was normalised by a reference target gene (hESCs). The 
reference sample was changed according to a target gene of interest in order to provide a 
feasible value. The target gene primers used are listed in the Appendix II. 
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2.4.1.2. Flow cytometry analysis 
The analysis of the cell surface antigen CXCR4 was performed as follows: cells 
were harvested by trypsinisation and 50,000 cells were resuspended in blocking buffer for 
15 minutes. The cells were then resuspended in PE-conjugated CXCR4 or PE-conjugated 
antibody (as unspecific binding control) diluted in FACS buffer and incubated for 30 min 
on ice. Finally, cells were washed twice and then resuspended in 100 μl of FACS buffer 
for analysis. Cells were washed twice and resuspended in 500 μl of FACS buffer before 
analysis on a FACS calibur flow cytometer (BD Biosciences) using CellQuest software. 
The profile of the stained cells was compared to unstained cells and cells stained with the 
secondary antibody only.  
2.4.1.3. Immunocytochemistry 
 4% Paraformaldehyde (PFA) was prepared by dissolving 4 g of paraformaldehyde 
in 90 ml of PBS and heated to 58-60
o
C in a fume hood while 10M NaOH was added drop-
wise until the solution became clear. After cooling, the pH was adjusted to pH 7.2-7.4. 
The PFA solution was aliquoted and stored at -20
o
C. Cells were fixed at room 
temperature with 4% paraformaldehyde for 15 minutes, washed with PBS, and incubated 
with blocking buffer [10% goat serum (sigma) and 0.1% Triton X-100] for 1 hour at room 
temperature. Cells were then incubated with primary antibody at the appropriate dilution 
for 1 hour at room temperature. Secondary antibody was applied for 30 minutes in the 
dark, after washing with PBS. The cells were finally mounted with Mowiol mounting 
media and then visualised and captured using florescence (Nikon TE2000-U) or confocal 
(Leica Sp5) microscopy. The list of primary antibodies and secondary antibody used in 
project is provided in the Appendix III. 
2.4.1.4. Isolation of nuclear and non-nuclear extract  
Preparation of non-nuclear/nuclear protein fractions was performed as described 
by Schreiber et al (1989). Monolayer cells were washed in PBS, and then scraped and 
lysed in non-nuclear buffer. Cell lysates were incubated on ice for 20 min and NP-40 
(final concentration of 1 % (v/v)) was added. Lysates were vortexed for 10 secs and 
centrifuged for 30 secs at 13 000 rpm at 4
o
C. The supernatants were retained as the non-
nuclear protein extracts. The pellets were resuspended in nuclear buffer and incubated for 
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15 min on ice with shaking, followed by centrifugation at 13 000 rpm for 5 min at 4
o
C. 
The supernatants were retained as the nuclear protein extracts. All extracts were stored at 
-80°C, and processed for protein quantification. 
2.4.1.5. Western Blotting Analysis 
 Whole cell extracts were prepared by direct lysis of cells by scraping with cold 
Radio Immuno Precipitation Assay (RIPA) buffer.  Cells were scraped, incubated on ice 
for 20 min and their supernatant was collected after centrifugation at 13,000 rpm for 20 
min at 4°C. The protein solution was quantified using bicinchoninic acid (BCA) protein 
assay kit and stored at -80°C.  
 Quantified protein samples (10-30 μg) were diluted 1:1 with Laemmli sample 
buffer (BioRad) with 5% β-mercaptoethanol or 3x sample loading buffer (50 mM Tris-
HCl pH 6.8, 25% glycerol, 2% SDS, 50 mM DTT, 5% β-Mercaptoethanol and 0.1% 
bromophenol blue) and heated at 95˚C for 5 min. Cell lysates were resolved on 8% SDS 
polyacrylamide gel electrophoresis (SDS-PAGE) gels with 11 μl Novex Sharp protein 
ladder (Invitrogen).  
 Resolved acrylamide gels were blotted to Polyvinylidene fluoride (PDVF) 
membranes (Chemicon/Milipore) using a wet-blot method at 200 mA for 1 hour in 
transfer buffer. The membranes were then blocked with 5% skimmed milk in Tris-
Buffered Saline with 0.1% Tween20 (TBS-T) for 1 hour at room temperature, followed 
by primary antibody incubation diluted in blocking buffer or 5% BSA in TBS-T, 
overnight at 4˚C, with agitation. Membranes were washed three times, to remove any 
excess antibody, for 10 min in TBS-T under agitation before incubating with the 
appropriate HRP-conjugated secondary antibody in blocking buffer, for 1 hour at room 
temperature. Excess secondary antibody was then removed by washing the membrane 
three times for 10 min in TBS-T buffer under mild agitation. The blot was treated by 
enhanced chemiluminescence western blotting detection reagent for HRP-conjugated 
antibody detection before being exposed to X-ray films (CL-XPosure Film) and using the 
OPTIMAX IGP developer. A list of primary and secondary antibodies used for WB and 
suppliers is shown in Appendix III.   
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2.4.2. Functional assays 
2.4.2.1. Sandwich Enzyme-Linked Immuno-sorbent Assays (ELISA) 
Cells were cultured in 6-well plates in 5 ml appropriate media and after 24 hours 
supernatants were collected for the protein secretion assay. The albumin was measured 
using sandwich enzyme-linked immunosorbent assays (ELISA) essentially as described 
by the manufacturer (DAKO, Ely, U.K.). High binding EIA 96-well plates (Corning 
Koolhovenlann, Netherlands) were coated with rabbit anti-human albumin antibody 
(DAKO, Ely, U.K.) overnight at 4
o
C using 1:1000 dilution. Sample supernatants were 
serially diluted at of 1:2, 1:4, 1:8, 1:16, 1:32, 1:64, 1:128 and 1: 256, then added to 96-
well plates in triplicates. The plates were incubated for 1.5 hour at 37
o
C. Peroxidase-
conjugated rabbit anti-human antibody (Abcam, U.K.) directed against the appropriate 
protein was added and the plates were incubated for 1 hour at room temperature. The 
substrate o-phenylenediamine was added and the reaction stopped with 0.5 M sulphuric 
acid. Plates were read at 490 nm with a reference wavelength of 630 nm using a MRX II 
plate reader (Dynatech, Billinghurst, U.K.) and the concentration of the appropriate 
protein in each sample was calculated from standard curves using the MRX II Endpoint 
software. HepG2-conditoned medium was used as the positive control.  
2.4.2.2. CYP3A4 assay  
Cells grown in monolayer or in 3D culture in Alginate beads and Algimatrix were treated 
for 48 hours with 10 μM rifampicin or with vehicle, 0.1% DMSO (basal) supplemented in 
culture medium. Next, cells were released from 3D culture system as described in section 
2.2.1.3 or 2.2.2.2 accordingly and were used in the CYP3A4 activity assay. Cyp3A4 
activity assay was measured in triplicate using the P450-Glo CYP3A4 assay (Luciferin-
IPA) kit (Promega) according to the manufacturer’s instructions, but with some 
modifications. The cells on monolayer or those released from spheroids/Algimatrix were 
washed once with PBS. Cells were incubated with 3 µM Luciferin-IPA in phenol free- 
DMEM supplemented with 10% FBS and 1% Pen/Strep antibiotics for 1 hour at 37
o
C. To 
stop the P450 CYP3A4 reaction and initiate the light generating reaction with luciferase 
the reconstituted luciferin detection reagent with esterase was then added. This incubation 
continued at room temperature for 30 minutes to allow for signal stabilisation and then 
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light output was measured using a luminometer. Activity was measured by subtracting the 
light unit of the sample from blank media control, and was normalised by dividing by the 
cell counts of the appropriate samples.  
Formula:  
  
2.4.2.3. Urea synthesis assay 
Culture supernatants were collected on the day of cell harvest and were stored at -80
o
C till 
the assay day. Urea secretion was assessed by colorimetric assay (DIUR-500 BioAssay 
Systems) according to the manufacturer’s instructions.  Briefly, upon a quick thaw of the 
frozen supernatants, 50 µl water (blank), 50 µl standard (50 mg/dL or 5 mg/dL) or 50 µl 
samples were transferred into triplicate wells of a clear bottom 96-well plate. Then 200 μl 
working reagent was added and samples were mixed by gentle tapping. These were then 
incubated for 20 mins (50 mins for low urea samples) at room temperature. A 
spectrophotometer plate reader was used to read absorbance at 520 nm.  
Calculation:  
Urea concentration (mg/dL) of the sample is calculated as: 
 
                                   [Urea] =       ODsample–ODblank      x [STD]                (mg/dL) 
                                                        ODstandard–ODblank 
ODsample, ODblank and ODstandard are OD values of sample, standard and water, 
respectively. [STD] = 50 urea standard concentration (mg/dL). 
 
2.4.3. Statistics 
In this thesis, values are represented as mean± SD or mean±SEM for replicates. Microsoft 
Office Excel software was used to perform t-tests for determination of statically 
significant differences in mean. In all the results, if p<0.05, it is considered statistically 
significant.  
CYP3A4 activity= (light units of sample – light unit of blank media) 
                                   Cell number  
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3. Inhibition of Phosphatidylinositol-3-Kinase (PI3K) 
signalling promotes Activin-induced definitive endoderm 
differentiation of hESCs 
3.1. Introduction 
A challenge associated with the application of using hESCs for the development of 
new cell therapies, such as treatment of liver failure, is to efficiently/homogenously 
generate desired cell types. For example, it is still very difficult to reproducibly and 
robustly generate functional hepatocytes from hESCs, in which efficient generation of 
definitive endoderm (DE) is a key step (Grapin-Botton and Melton, 2000; Hay et al., 
2008b), although progress has been made in the recent years. This is largely due to the 
lack of understanding of which signalling pathways regulate endoderm differentiation. 
Therefore, understanding the signalling pathways controlling DE formation is important 
for the robust differentiation of hESCs to hepatic lineages.  
Both DE and mesoderm have been found to be developed from a common 
progenitor cell type, mesendoderm, which functions as an intermediate stage. 
Mesendoderm differentiation is regulated by several signalling pathways, among which 
Nodal/Activin signalling is essentially required (Schier, 2003b; Whitman, 2001). 
Nodal/Activin continues to play an important role after mesendoderm formation, and the 
segregation of the mesoderm and DE lineages depends on the different levels of Nodal 
/Activin 
 
signalling (Tada et al., 2005). High levels of Nodal/Activin signalling lead to DE 
specification, whereas lower Nodal signalling
 
promotes mesendoderm differentiation into 
mesoderm. 
A continuous effort has been dedicated to find how other signals can affect DE 
differentiation using a cost-effective approach for a scalable and reproducible system. In 
such effort, it has been reported that reducing the serum level in Activin-induced DE 
differentiation provides better differentiation efficiency (D'Amour et al., 2005). Insulin 
and IGF are present at biologically active levels in KSR and serum respectively, and both 
activate PI3K-dependent signalling. In line with this, a later study showed that 
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suppression of PI3K enhances hESC differentiation to mesendoderm and then into DE 
(McLean et al., 2007). In this report, they found that, under MEF-conditioned medium 
(MEF-CM) culture conditions, DE specification in hESCs only occurs when PI3K is 
suppressed. Although there was no exogenous Activin added, they reasoned DE 
differentiation is mainly by Activin produced by MEF into the conditioned medium. 
However, the mechanism underlying this phenomenon is unclear. To further study the 
mechanisms, it is necessary to investigate whether this phenotype still appears in 
chemically defined medium, which will exclude the possibility of the interference of other 
signals and growth factors that are present in MEF-CM.  
Our DE differentiation is in a chemically-defined condition, in which the base 
medium is composed of RPMI1641 supplemented with B27. B27 is an auxiliary reagent 
that contains a low concentration insulin, a PI3K pathway activator (Brewer et al., 1993).  
In this context, does the insulin (B27) in the priming medium delay the efficient 
differentiation of embryonic stem cells to endodermal lineage in our culture condition? 
Does inhibition of PI3K signalling pathway in our culture system enhance definitive 
endoderm differentiation? To answer these questions, I planned to examine the effect of 
inhibiting the PI3K pathway on the differentiation of hESCs to DE using a PI3K inhibitor, 
LY294002, in conjunction with Activin A.  
 
3.2. Suppression of PI3K is associated with mesendoderm 
differentiation  
Since PI3K/Akt signalling is important for cell survival (Pyle et al., 2006), I 
optimised the concentration and timing of the treatment for efficient inhibition and 
minimal cell death. HESCs were treated with LY294002 at various concentrations from 
20 to 50 µM in RPMI1641/B27 medium. Cell death was clearly observed 12 hours after 
the treatment and appeared in a LY294002 dose-dependent manner. When the LY294002 
concentration was over 40 µM, almost all cells died within 24 hours. These results 
confirm that the PI3K signalling pathway plays a role in hESC survival. The treatment of 
hESCs with LY294002 on also caused a marked change in cell morphology, even at 12 
hours of treatment (Figure 3.1 a). In contrast to the control cells that were still maintained 
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as the typical, defined, tight hESC colonies after 12 hours culture in RPMI:B27, the cells 
treated with 20 µM LY294002 appeared spiky with cytoplasm projections and more 
spread out  indicating the differentiation (Figure 3.1 A).   
The inhibition of PI3K/Akt was confirmed by Western blotting with phospho-Akt 
antibody. The cells were lysed at various time-points to test the levels of Akt 
phosphorylation. The results showed that the best inhibition was achieved when cells 
were treated at 20-40 µM for 24 hours (Figure 3.1 b). Note that the phosphorylation level 
of the Akt in hESCs under hESC culture conditions is significantly higher than that in 
RPMI/B27 medium, which could be attributed to the possible high levels of PI3K 
stimulators (e.g. insulin) in the knockout SR, a critical component of hESC MEF-CM 
medium. These results suggest that suppression of PI3K indeed promotes hESCs to 
differentiate, which is in line with the finding that PI3K signalling is critical for 
maintenance of mESC self-renewal and pluripotency (Paling et al., 2004).  
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Figure 3-1 : Suppression of PI3K induces differentiation of hESCs in chemically defined 
medium.  
A) Phase contrast images of hESCs cultured for 12 hours in PRMI:B27 medium in the absence (I) 
or presence (II) of LY 294002 (20uM). B) Western blotting showing phosphorylation of Akt 1
S473
 
(pAkt) levels and the levels of indicated proteins in response to LY 294002 treatment at 24 hours. 
Concentrations of LY294002 are indicated. CM, MEF-CM with bFGF. 
 
To further investigate the effects of LY294002 treatment on hESC lineage 
differentiation, I examined the expression of markers of various lineages by western 
blotting. The results showed that the pluripotency markers Oct4 and Sox2 were 
downregulated, whereas the expression of mesendoderm markers FoxA2 and Brachyury 
were increased (Figure 3.1B). As Sox2 is expressed at high levels in both ESCs and 
neural progenitors, these results suggest that inhibition of PI3K in hESCs may enhance 
mesendoderm differentiation from pluripotent status, but not other cell fate. 
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From this preliminary work, I have shown that 20 µM LY294002 may be the 
optimal concentration for the experiments which can efficiently inhibit PI3K signalling in 
hESCs cultured in RPMI1641/B27 and induce hESCs differentiation, but does not lead 
massive cell death. Therefore, I applied this concentration to further investigate the effect 
of PI3K/Akt inhibition on Activin-induced DE differentiation of hESCs. 
 
3.3. Inhibition of PI3K/Akt signalling enhances Activin-induced DE 
differentiation  
3.3.1. Morphological changes in Activin-induced DE differentiation of hESCs with 
or without LY294002 
To further test whether suppression of PI3K signalling has any effect on Activin-
induced DE differentiation of hESCs, I treated the hESCs with Activin in the presence or 
absence of LY294002 for 3 days.  To reduce cell death, I used 20 µM for the first day and 
10 µM for the following 2 days. Both treatments led to changes in morphology of hESCs, 
from a typical, defined, tight hESC colonies to spiky with the cytoplasm projections and 
more spread out (Figure 3.2). However, with combined treatment, the changes appeared 
sooner and were more dramatic. Although both differentiation culture conditions induce 
cell death, the combined treatment exhibited more cell death after the first 24 hours than 
Activin alone. Either treatment had less effect on cell death after 24 hours.  
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Figure 3-2: Morphological changes of DE differentiation in the two treatments.  
Phase contrast images of hESCs treated for indicated days with Activin A (100 ng/ml) in the 
absence (AA) or presence of LY (20 µM) (AALY) in RPMI: B27 basal medium. Morphological 
presence of tight colonies in AA and differentiated spiky type of cells in AALY are indicated by red 
and black arrows respectively.  Scale bar represents 50 µm. 
 
3.3.2. Gene expression during Activin-induced DE differentiation of hESCs with 
or without LY294002  
To validate the changes in morphology, I examined dynamic changes in transcript 
level associated with pluripotency and differentiation markers in these two treatments; 
AA and AALY, by quantitative real time PCR (figure 3.3). In general, compared with 
undifferentiated hESCs, cells treated with AA and AALY lost their
 
expression of the 
pluripotent markers; Oct4, Nanog and Sox2, although cells treated with both factors 
exhibited a transient upregulation Oct4 and Nanog but not Sox2 at day 1. Plausibly, 
although Oct4 and Nanog are the hallmark markers of pluripotency, transient up-
regulation of Oct4 and Nanog in our treatment is in agreement with recent publications 
showing that Activin/Nodal signalling controls the expression of key pluripotent 
transcription factors such as Nanog and Oct4 in hESCs and transient upregulation of Oct4 
and Nanog promotes DE differentiation (Lee et al., 2011b; Vallier et al., 2009; Xu et al., 
2008b). 
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Of the overall diminishing of pluripotency markers, the cells were concomitantly
 
gaining strong transient expression of epiblast and mesendoderm genes. A definite 
upregulation of Fgf5 (epiblast), brachyury, GSC and MixL1 (mesendoderm) expression at 
day1and 2 was evident in cell treated with AALY in contrast to a much inferior induction 
in cells treated with AA. MixL1, an early mesendoderm and DE fate-controlling 
transcription factor was shown to be upregulated more prominently in AALY than in AA 
induced DE differentiation of hESCs. This indicates AALY is potentially promotes hESC 
differentiation into DE through the mesendoderm stage and is more efficient than 
induction by Activin alone.  
The progression of differentiation in AA and AALY is marked by a 
downregulation of pluripotency markers, whilst there is a gradual increase of bona fide 
DE genes, Eomes, FoxA2 and Sox17. Again, induction of these genes was superior in 
cells treated with AALY compared to AA. It is noteworthy that the downregulation of 
brachyury (mesoderm and mesoderm specifying factor) at later differentiation times, in 
conjunction with prominent induction of DE-related transcription factors indicates that 
both treatments favour the DE over mesoderm fate from mesendoderm. However, LY has 
enhanced the generation of mesendoderm and DE more than Activin alone.  
We were then interested in identifying whether the DE formed in these 2 systems 
has ventral foregut identity, which specifies hepatic endoderm (Zorn and Wells, 2009). 
The hHex, a transcription factor specifying hepatic endoderm over pancreatic endoderm, 
is shown to induce slightly in both treatments, yet again, it was superior in AALY (Figure 
3.3). Upon treatment of hESCs in AA and AALY, downregulation of E-cadherin 
concomitant with upregulation of N-cadherin was observed with both treatments but at a 
significant level in the latter treatment. Such a cadherin switch is analogous to that 
occurring in mice during the generation of mesendoderm cells and is termed the 
epithelial-mesenchymal transition (EMT)  (Shook and Keller, 2003).  
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Figure 3-3: Dynamic gene expression changes in hESCs during DE differentiation induced 
by Activin with or without LY.  
Total RNAs were extracted from cells at indicated days of treatment with Activin A alone (blue) or 
combined Activin A with LY 294002 (red), and gene expression levels were analysed by qRT-
PCR. The results are displayed as relative to day 0, which is undifferentiated hESCs, normalised 
to housekeeping gene, β-actin. The standard error is calculated from 6 samples from at least two 
independent experiments (n≥2). 
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We investigated the possibility of the generation of other cell types in these 
differentiation systems. We did not observe any upregulation of markers associated with 
ectoderm (Pax6, Sox2) and a limited level of mesoderm (brachyury at later differentiation 
days) in both culture conditions throughout the differentiation days when compared to 




pattern of gene expression, it was imperative to validate the formation of these 2 distinct 
endodermal lineages (Lavon and Benvenisty, 2005). The undetectable expression of the 
transcription factor
 
Sox7, an exclusive marker for PrE, ruled out the possibility of 
significant PrE generation in both treatments. In addition to this, only DE is differentiated 
through mesendoderm stage, not PrE and this is in line with our observation of transient 
mesendoderm gene expression in both treatments, thus excluding the possibility of 
generation of a significant PrE population. 
 
Figure 3-4: Expression of DE genes at protein level in both AA and AALY induced-DE 
differentiation.  
A). Western blotting showing protein levels in hESCs cultured in the indicated conditions for 24 
hours. Activin at 100 ng/ml; LY294002 at 20 µM. This result is a representative of two independent 
experiments (n=2). B) Immunocytochemistry images of brachyury and Sox17 at day 1 and day 3 
of indicated treatments, respectively. Cells were stained for anti-brachyury or anti-sox17 (green) 
and counter stained with 4,6-diamidino-2-phenylindole (DAPI -blue). Scale bar represents 100 µm.  
 - 80 - 
 
To further confirm mRNA level changes in response to these treatments, some 
mesendoderm and DE genes were analysed at the protein level.  Validation of brachyury 
at the protein level in whole cells lysate after 24 hours treatment showed that the AALY 
treatment had higher protein levels of brachyury, Sox17 and FoxA2 than that in the AA 
treatment (Figure 3.4A). Immunocytochemistry with brachyury antibody confirmed that 
AALY treatment produced more brachyury positive cells than that of AA alone after 1 
day of treatment. Moreover, Sox17 positive cells were also more abundant in AALY 
treatment than AA treatment after 3 days of differentiation (Figure 3.4B). These results 
are in line with the RT-PCR data and indicate that AALY combined treatment did indeed 
promote DE differentiation more than the AA treatment alone.  
 
3.3.3. CXCR4 expression 
With combined treatment of Activin and LY294002, I routinely observed that a 
large number of cells exhibited differentiated cell morphology. To further quantify the 
efficiency of DE differentiation in the two treatments, I analysed the expression of 
CXCR4 by antibody staining and flow cytometry. The CXCR4 chemokine receptor has 
been reported to highly expressed in DE cells and is often used as a DE surface marker 
(D'Amour et al., 2005).  The undifferentiated hESCs and day 3 differentiated cells from 
both conditions were stained with antibody against CXCR4 and analysed by flow 
cytometry. The number of CXCR4-positive cells was below 10% in hESCs cultured under 
MEF-CM/bFGF conditions but increased to over 40% after treatment for 3 days with 
Activin. The increase of CXCR4 was more significant when cells were treated with 
combined Activin and LY294002 (p<0.002, Figure3.5).  
Taken together, the results demonstrate that suppression of PI3K in hESCs induces 
their differentiation to mesendoderm in a chemically defined culture condition and 
promotes DE differentiation significantly when combined with Activin treatment.  
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Figure 3-5 : Suppression of PI3K enriched CXCR4 positive cell population.  
Representative results showing that i) Untreated hESCs or hESCs treated for 3 days with ii) 
Activin A alone (AA) iii) Activin A and LY294002 (AALY) were stained with an anti-CXCR4 
antibody (solid) or  IgG isotype  (open) and analysed by flow cytometry. The percentage of 
CXCR4 positive cells is indicated (iv) Histogram shows average percentage of CXCR4 positive 
cells from three independent experiment (n=3). * indicates the p< 0.005 by student‘s t-test. 
 
3.4. Inhibition of PI3K/Akt signalling in Activin-induced DE 
improves subsequent hepatocyte differentiation and functionality  
Since DE share many markers with primitive endoderm cells, there is a need to 
verify if these DE cells generated from hESCs are functional. Hepatocytes are derived 
from anterior foregut which is formed by DE. Therefore, I further differentiated the 
hESC-derived DE cells following both treatments into hepatocytes with our established 
protocol (Hay et al., 2008). 
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3.4.1. Morphological changes during in vitro hepatic differentiation of hESCs  
To further assess the differentiation potential of hESC-DE cells derived by Activin 
(AA) or Activin and LY294002 (AALY) treatments, I adapted a protocol previously 
developed in our laboratory for hepatocyte differentiation (Hay et al., 2008b), which 
contains three stages: DE differentiation, hepatoblast differentiation and hepatocyte 
maturation (Figure 3.6). The hESC-DE cells from the above treatments were cultured in 
SR/DMSO medium (Stage 2) for 4-6 days and during this period, the cells were notably 
proliferative and appeared in oval in shape, resembling hepatoblast-like cells (Figure 3.5 
b). The cells were then transferred into hepatocyte maturation medium, and cultured for 
another 3-5 days. Following hepatocyte differentiation, the cells then appeared to be 
larger in size, polygonal in shape with distinct round nuclei resembling morphology of the 
primary hepatocyte (Figure 3.5 B&C). Both H1 (Figure 3.6B) and H9 hESC cell lines 
(Figure 3.6C) showed similar results in which hepatocyte-like cells usually accounted for 
about 60-80% of total cells in AALY treated DE cells and 30-50% in AA  treatment, as 
shown in the low magnification images of Figure 3.6C.   
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Figure 3-6 : Sequential morphological changes of hESCs-derived hepatocytes from DE 
cells produced by AA or AALY treatments.  
A) Schematic depiction illustrates the three-stage procedure in differentiation of hESCs to 
hepatocytes.  B) Phase contrast images of sequential differentiation of H1 hESC-DE cells derived 
from AA or AALY treatments. The number of days on top indicates the total days of cell 
differentiation from hESCs. C) Phase contrast images of H9 cells at 11 days of differentiation. Low 
and high magnification are shown in the left and right panels, respectively. Scale bars represent 
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3.4.2. Hepatic differentiation and functionality improvement  
I assessed the differentiation efficiency by examining several hepatic specific 
genes including: (i) synthetic proteins, (ii) hepatic-specific transcription factors and (iii) 
those which affect metabolic and detoxification function.  
Firstly, I examined the generation of α-fetoprotein (AFP) and albumin (ALB) 
positive cells after hepatocyte differentiation from both AA- and AALY-derived DE cells 
by immunocytochemistry (Figure 3.7 A). AALY-hepatic differentiation showed better 
AFP and albumin (ALB) staining than that from AA treated cells in terms of both number 
of positive cells and intensity of fluorescent signal in individual cells.  Interestingly, 
almost all the cells in the AALY-hepatic differentiation co-expressed AFP and albumin, 
while a proportion of cells in the AA treatment only stained positive for AFP. AFP is a 
marker of hepatoblast and fetal hepatocytes, whereas ALB is associated with more mature 
hepatocytes. This indicates that AALY-hepatic differentiation is more potent and 
produces more mature hepatocytes than the AA treatment.  
Secondly, I assessed these cells for the expression of hepatic-specific transciption 
factor, hepatocyte nuclear factor 4-alpha (HNF4α), by immunostaining.  Approximately 
40% of cells produced in AA-hepatic differentiation are positive for HNF4α, while up to 
80% are positive in AALY treated cells (Figure 3.7 b).  
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Figure 3-7: Immunocytochemistry of hepatocytes derived from AA or AALY treated hESCs.  
A) AFP, α-fetoprotein; ALB, albumin; B) HNF4α, Hepatocytes Nuclear Factor 4-alpha. DAPI is 
used as counterstain. Scale bars represents for A) 50 µm and B) 100 µm. 
 
Third, generation of hepatocytes was monitored by hepatic metabolic and 
detoxification function by cytochrome P450 (CYP). The CYP P450 superfamily is a large 
and diverse group of enzymes involved in the metabolism of xenobiotics. Some of their 
members, such as CYP7A1 and CYP3A4, are produced by hepatocytes in the liver 
(Slaughter and Edwards, 1995). CYP7A1 expression was found to be much higher in the 
AALY derived hepatocytes compared to those derived from the AA treatment (Figure 3.8 
A).  In addition to this, the hepatocytes derived from AALY-DE conditions showed three-
fold higher CYP3A4 activity than that from AA treatment (Figure 3.8 B).    
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Overall, the enhancement of DE by AALY treatment is reflected in improved 
hepatic differentiation. Hepatocytes derived from AALY-DE have been shown to have 
better AFP, ALB, and HNF4α expression and higher CYP activity. In conclusion, 
suppression of PI3K enhances Activin-induced DE differentiation of hESCs, which 
subsequentially improves hepatocyte generation.  
 
Figure 3-8: Cytochrome P450 isozymes in hESCs –hepatocytes differentiation via AA or 
AALY –DE stage.  
(A) Immunocytochemistry images show CYP7A1 staining (green) and (B) Relative CYP3A4 
activity, in hepatic differentiation from hESCs via Activin and Activin+LY differentiated-DE. Scale 
bars represent 100 µm. Data are shown as the mean of three independent experiments and 
standard error is indicated (n=3). * p< 0.02 by student‘s t-test.  
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3.5. Discussion  
An efficient differentiation of DE is a prerequisite for any endoderm-derived 
lineages including liver. Differentiation could be achieved by the growth factors which 
modulate signalling that eventually decode the cell fate. Many reported protocols of 
Activin-induced DE differentiation contain very low or no serum/KSR in the culture 
media and higher levels of them inhibit DE differentiation (D'Amour et al., 2005; Hay et 
al., 2008b; Touboul et al., 2010). Since serum and KSR contain IGF and insulin, 
respectively, and both are expressed at biologically active levels and can activate PI3K-
dependent signalling, it is possible that PI3K signalling may have an inhibitory effect on 
DE differentiation of ESCs. Direct evidence came from the finding of Mclean et al (2007) 
in which it was found that the suppression of PI3K signalling promotes DE differentiation 
in MEF-CM condition. Therefore, I verified whether suppression of PI3K improves 
Activin-induced DE differentiation in hESCs in chemically defined medium.  
In this study, I showed that PI3K signalling in hESCs can be suppressed by LY 
inhibitor at 20 µM in chemically defined medium. I found that higher than this 
concentration induce massive cell death since PI3K is well documented to be required for 
cell survival (Pyle et al., 2006).  The preliminary results on gene expression analysis 
suggest that inhibition of PI3K alone in hESCs appeared to enhance mesendoderm 
differentiation from pluripotent status, indicating active Nodal signalling in this process. 
Although there was no exogenous AA added, hESCs are able to produce Nodal at low 
level, which could have influenced cell fate when PI3K signalling is suppressed. This is in 
line with the previously published work in which hESCs could be specified into DE in 
CM-MEF medium when PI3K is suppressed. This is due to the presence of low Activin 
level in the CM produced by MEF (McLean et al., 2007).  
Further study revealed that suppression of PI3K signalling has an enhancing effect 
on Activin-induced DE differentiation of hESCs assessed by gene expression at mRNA 
and protein level. Compared with undifferentiated hESCs, cells undergoing DE 
differentiation by both AA and AALY treatment gradually lost their
 
expression of 
pluripotent markers (Oct4, Nanog and Sox2). The cells differentiated by AALY 
concomitantly
 
gained higher expression of mesendoderm genes (GSC, brachyury and 
Mixl1) than that by AA treatment. Consistent with the mRNA levels, the protein level of 
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brachyury was augmented to a greater extent in cells with combined treatment compared 
with Activin treatment alone. Following this, the increase in expression of DE regulating 
transcription factors, Eomes, Sox17 and FoxA2 was also more apparent in cells treated 
with AALY than with AA alone. Consistent with the mRNA levels, both Sox17 and 
FoxA2 protein levels were higher in combined treatment than single treatment. This 
upregulation of DE gene expression was affiliated with downregulation of brachyury in 
cells from both differentiation conditions, excluding the possibility of mesoderm 
generation from mesendoderm. The downregulation of E-cadherin concomitant with 
upregulation of N-cadherin indicates the occurrence of an EMT event, a key process 
precluding DE specification (D'Amour et al., 2005), much more efficiently in cell treated 
with AALY than of AA. HESCs treated in both conditions did not show any significant 
generation of neuroectoderm and PrE cell type, as assessed by lack of expression of Pax6 
and Sox7 genes respectively.  
One of the differentially expressed surface markers in DE and PrE cells is CXCR4 
(Yasunaga et al., 2005), which is facilitates the isolation and enrichment of DE cells 
produced by in vitro differentiation (D'Amour et al., 2005). In this study, AALY treatment 
is much more efficient than AA treatment in producing a CXCR4-positive cell population, 
which indicates that the former treatment was able to enrich the DE population. In 
summary, hESCs undergo an efficient Activin-induced DE differentiation via 
mesendoderm when PI3K is suppressed.  
I further assessed the hepatocyte differentiation potential of the DE generated from 
hESCs by AALY and AA treatments. The results demonstrated that the marked increase 
in DE generation by AALY treatment subsequently produced a better hepatic 
differentiation than the cells treated with AA alone; evident by prominent hepatocyte 
morphology, hepato-specific gene expression (ALB, AFP, HNF4α) and CYP3A4 activity. 
This indicates that the enhancement of DE has, therefore, improved generation of 
functional hepatocytes.  
In summary, this study has reconfirmed the requirement of two conditions for 
better DE differentiation; a high level of Activin and suppressed PI3K signalling. In this 
study, we have established an efficient DE differentiation protocol using AALY in 
chemically defined medium, which provide a better model for further elucidating the 
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mechanisms underlying the role of PI3K in DE differentiation. Moreover, I have also 
demonstrated that improved DE generation by AAL has augmented the yield of 
hepatocytes.  
Understanding the mechanisms underlying the mechanism by which PI3K blocks 
DE differentiation of hESCs in response to Activin holds a great promise to further 
comprehend cell fate decisions. The most obvious way in which PI3K blocks 
differentiation would be by impacting on the regulation of DE signalling and this is yet to 
be discovered. Therefore, I further investigated the molecular mechanism underlying this 
phenomenon in order to unravel the crosstalk between these signalling pathways and to 
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Chapter 4:  
PI3K signalling modulates Activin/Smad and Wnt/β-
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4. PI3K signalling modulates Activin/Smad and Wnt/β-
catenin signalling pathways in hESCs 
4.1. Introduction 
Development of protocols for DE differentiation from hESCs holds a great 
potential in cell therapy, and is still a very challenging task in the regenerative medicine 
field. This is due to the poor understanding of the signals regulating differentiation, which 
is ultimately crucial to efficiently produce DE and their derivatives in vitro. Despite 
Activin being widely used to induce the DE, it has been used in conjunction with a low or 
no serum/insulin condition, which seems to give better efficiency. In our study and many 
others (D'Amour et al., 2005; McLean et al., 2007; Touboul et al., 2010), the suppression 
of PI3K, a key signalling component activated by serum/insulin, improved Activin-
induced DE differentiation. However, the molecular mechanisms underlying this remain 
unknown. Therefore, we investigated mechanisms by which PI3K antagonises DE cell 
fate. We showed by gene expression kinetics that the release of cells from PI3K has 
mainly enhanced Activin-induced gene expression. This indicates the PI3K signalling 
partially blocks DE differentiation induced by high concentration of Activin. Taking this 
into consideration, the most plausible mechanism by which PI3K blocks differentiation 
would involve a direct or indirect inhibition of signalling involved in DE formation. The 
major pathways governing endoderm differentiation are Activin/Nodal and Wnt/ β-
catenin signalling. These two pathways have been shown cooperatively to specify DE fate 
(Gadue et al., 2006; Hay et al., 2008a; Sinner et al., 2004a). Therefore, we investigated 
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Part I: Effect of PI3K in Activin/Smad signalling 
Activin/Smad signalling has been implicated in governing many cellular 
processes. Duration and intensity are important determinants for the signalling specificity 
of TGF-β family members, as they operate as morphogens, inducing distinct cell fates at 
different ligand concentrations at a correct spatial relationship to each other. 
As discussed earlier, different gradients translate the hESC cell fate determinants 
into either self-renewal or differentiation into mesendoderm, mesoderm or definitive 
endoderm (Beattie et al., 2005; James et al., 2005; Takenaga et al., 2007a). In a recent 
study, it was reported that Activin decodes different cell fates in a dose-dependent manner 
via different pSmad2/3 levels, which in turn recruit a set of genes that determine cell fate 
(Lee et al., 2011b). To achieve this, tight regulation of Activin/Smad is necessary to 
control a subset of genes which interpret lineage commitment. Thus, the events involved 
in Smad-dependent gene regulation in response to Activin can be levelled at four 
functional modules; receptor activation, Smads nucleocytoplasmic dynamics, 
transcriptional regulation by Smads and negative feedback control (Itoh and ten Dijke, 
2007). Each of these modules involves complex processes involving many other effectors 
and modulators capable of influencing the outcome from the phosphorylation event to 
gene expression control.  This multi-level regulation determines the duration and intensity 
of the Smad signal. 
Receptor activation is achieved by Activin binding to the receptor and activates R-
Smads. The serine residues of the SSXS motif on the extreme carboxyl terminus are 
specifically phosphorylated by Nodal/Activin signalling. This phosphorylation is 
important for the translocation of Smad2/3 to the nucleus in association with Smad4.  
Although Smads contain other phosphorylation sites; their function and signals 
responsible for these phosphorylation events are still largely unknown. In the presence of 
ligand, phosphorylated Smads remain stable in the nucleus as nuclear export signals are 
masked and/or nuclear import signals become exposed. The active nuclear Smad complex 
binds to promoter regions of target genes together with other transcription factors in a 
cell-context and cell-type dependent-manner. In this work, I aimed to address how Activin 
signalling orchestrates the DE fate in conjunction with PI3K suppression mainly through 
impact on Smad phosphorylation.  
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4.2. Phosphorylation of Smad2/3 is Activin gradient-dependent  
To address how different concentrations of Activin affects Smad2/3 
phosphorylation in chemically-defined medium, hESCs were treated for 1 hour with 10 
ng/ml and 100 ng/ml Activin A in RPMI:B27 medium. Then phosphorylation of Smad2 
and Smad3 at carboxyl ends Serine465/467 and Serine 423/425, respectively were 
analysed by Western blotting (Figure 4.1). The results showed that both pSmad2 and 
pSmad3 were detectable with no exogenous stimulation, which may contribute to the 
endogenous TGF-β/nodal signalling. However, upon Activin treatment, the levels of 
pSmad2 and pSmad3 were increased and the increase was in a dose-dependent manner. 
These results indicate that the Activin concentration is important in controlling pSmad2/3 
levels, which support the findings that morphogen concentration is a vital factor 
controlling the level of downstream signalling activation which eventually controls the 
gene expression that governs cell fate (Guzman-Ayala et al., 2009; Lee et al., 2011b).  
 
Figure 4-1: Phosphorylation of Smad2/3 in hESCs treated with different concentrations of 
Activin A.  
HESCs were treated with indicated concentration of AA (ng/ml) for 1 hour in RPMI:B27 medium 
and lysed and immunoblotted for indicated proteins. β-actin serves as loading control. Data are 
representative of two independent experiments (n=2). Abbreviation: p= phospho. 
 
4.3. Effects of PI3K suppression on Activin-induced phosphorylation 
of Smad2/3.  
I next examined if suppression of PI3K/Akt signalling has any effect on Activin 
induced phosphorylation of Smad2/3. For this purpose, hESCs were treated with PI3K 
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inhibitor LY294002 (LY) in the presence (AALY) or absence of Activin A (AA) for an 
hour. Control cells were treated with 0.1% DMSO in which LY was dissolved.  Cells 
were lysed and pSmad2 and pSmad3 were examined by western blotting (Figure 4.2). 
Phosphorylation of Smad2 and Smad3 was considerably activated when treated with AA. 
However, there was no significant difference whether LY was present or absent.  
 
Figure 4-2: Phosphorylation of Smad2/3 in hESCs after treament with Activin A (AA) or/and 
LY294002 (LY) for 1 hour.  
HESCs were treated for 1 hour with AA (100 ng/ml) or/and LY (20 µM) as indicated in RPMI:B27 
medium. (A) pSmad2 and (B) pSmad3. Images are representative of three independent 
experiments (n=3). Abbreviation: p= phospho. 
 
However, when comparing the pSmad2 and pSmad3 levels dynamically over a 
range of duration from 1 to 12 hours in AA- and AALY-treated hESCs (Figure 4.3), we 
found that the differences in pSmad2 and pSmad3 levels between AA and AALY treated 
cells were gradually increased in the first several hours, peaking at 6 hours, at which time 
pSmad2 and pSmad3 levels were higher in AALY dual treated cells than in cells treated 
with AA alone. Conversely, no difference was detected in the total Smad2 and Smad3 
levels, (Figure 4.3 A&B), ruling out the possibility that this difference is due to the total 
Smad2/3 levels. Our results also showed that the PI3K/Akt signalling pathway had been 
inhibited during the entire course of treatment (Figure 4.3 C).  
A)                                                                          B) 
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Figure 4-3: Temporal dynamics of pSmad2/3 in hESCs treated with various combinations of 
AA and LY.  
HESCs were treated with AA (100 ng/ml) and AA (100 ng/ml) LY (20 µM) for indicated time hours 
in RPMI:B27 medium, lysed and immunoblotted for (A) pSmad2 and pSmad3 (B)  Smad4 (C) 
pAkt. β-actin were used as protein loading control in (A), (B) and (C) and Lamin B2 in (D). The 
western blotting aspect of these experiments was performed with assistance from Jason Yu in our 
laboratory. Abbreviations; t= total and p= phospho. 
+ 
+ 
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To further verify the initial results, we repeated the experiments of 6 hours 
treatment several times. The results were reproducible (Figure 4.4 as representative 
images). The result showed that, at 6 hours, the levels of pSmad2 and pSmad3 were 
higher in cells with dual treatments than in those of single treatments. The treatments did 
not affect the expression of Smad4 (Figure 4.3 B). Overall, these suggest that suppression 
of PI3K by LY has enhanced Smad2/3 phosphorylation in hESCs in temporal manner. 
 
Figure 4-4: Phosphorylation of Smad2/3 at various combinations of AA and LY for 6 hours.  
HESCs were treated with various combinations of AA (100 ng/ml) and LY (20 µM); LY, AA and 
AALY for 6 hours in RPMI:B27 medium, lysed and immunoblotted for the indicated proteins (A) 
pSmad3 and (B) pSmad2. Cells in RPMI:B27 without any factors serves as untreated control. β-
actin serves as loading control. Data are representative of three independent experiments (n=3). 
The western blotting aspect of these experiments was performed with assistance from Jason Yu 
in our laboratory. Abbreviations; t= total and p= phospho. 
 
4.4. Suppression of PI3K enhances Activin-induced pSmad2 and 
pSmad3 nuclear translocation 
Both pSmad2 and pSmad3 can only exhibit transcriptional function upon their 
nuclear import. To verify that the increased pSmad2/3 by AALY treatment also affected 
their localisation in the nuclear compartment; we performed western blotting in both 
nuclear and non-nuclear fraction of treated cells. The results showed very little Smad2 and 
Smad3 phosphorylated forms in the non-nuclear compartment even though total Smad2/3 
proteins were abundant.  By contrast, considerable amounts of both phosphorylated forms 
appeared in the nuclear fraction (Figure 4.5).  These data are in line with previous studies 
A B 
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that phosphorylated Smad2/3 is imported into the nucleus. Consistent with the results in 
total cell lysates, LY treatment alone does not affect the phosphorylation of Smad2 and 
Smad3; Activin A treatment activated Smad2 and Smad3 phosphorylation and increased 
their nuclear translocation, and dual treatment with both Activin A and LY enhanced 
Activin-induced Smad2 and Smad3 phosphorylation and nuclear translocation (Figure 
4.5). Meanwhile, the data also showed that Smad4 protein was mainly localised in the 
nuclear compartment and its expression was not significantly affected by either Activin A 
or LY treatment. This indicates that LY not only increases Activin-induced Smad 
phosphorylation but also enhances their nuclear translocation, which could further have an 
effect on their function.  
 
Figure 4-5: Non-nuclear and nuclear levels of Smads.  
HESCs were treated with various combinations of AA (100 ng/ml) and LY (20 µM); LY, AA and 
AALY for 6 hours in RPMI:B27 medium and fractioned  into (A) non-nuclear (B) nuclear extract. 
Fractioned lysates were immunoblotted for the indicated Smads. Lamin B2 and β-tubulin were 
used as loading controls for nuclear and non-nuclear fractions respectively. The western blotting 
aspect of these experiments was performed with assistance from Jason Yu in our laboratory.  
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4.5. Enhanced pSmad2/3 is coordinated with increased mesendoderm 
and definitive endoderm transcripts 
Having established that pSmad2/3 is more enriched in the nucleus at 6 hours when 
PI3K is suppressed, we then opted to determine their nuclear activity. This could be 
reflected by gene transcription levels that are associated with Smad-dependent 
differentiation. Therefore, we examined the changes in genes which are direct targets of 
pSmad2/3, in addition to Activin responsive genes which are implicated in mesendoderm 
and DE differentiation.  
We found that the Sox17, an authentic DE marker which is the direct target of 
Activin (Howard et al., 2007), showed an apparent upregulation in cells treated with 
AALY compared with either factor alone at 6 hours (Figure 4.6). However expression of 
Foxa2, a well-known mesendoderm and DE governing gene which was recently 
recognised as a Smad3 target gene (Zhang et al., 2011b) did not appear to be affected by 
any specific treatment we tested.  
Since the direct gene targets of Activin/Nodal specific to mesendoderm and DE are 
still largely unknown, we analysed some of the Activin responsive genes, such as Eomes, 
GSC and MixL1 (Blum et al., 1992; Hart et al., 2002; Izumi et al., 2007). I found that the 
expression of GSC and MixL1, two early mesendoderm-specifying factors (Blum et al., 
1992; Hart et al., 2002), showed similar efficiency in both AA and AALY, however, 
expression of Eomes was higher in AALY treatment at 6 hours. Eomes is expressed in 
response to Activin signalling, which in turn interacts with Smad2/3 to initiate a 
transcriptional network governing endoderm formation (Izumi et al., 2007; Russ et al., 
2000; Teo et al., 2011).  
Overall, enhanced pSmad2/3 following AALY treatment has demonstrated their 
impact on both direct target and responsive genes, if not all, at least in a few genes. This 
implicates their contribution to more efficient DE specification as described by others 
(D'Amour et al., 2005; McLean et al., 2007; Touboul et al., 2010) and demonstrated in 
this study. 
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Figure 4-6: Temporal dynamics of mesendoderm/DE expression.  
Total RNAs were extracted from cells at the indicated time in hours (h) of treatments of LY alone 
(blue), Activin A alone (red) or combined Activin A with LY294002 (green), and gene expression 
levels were analysed by qRT-PCR. The results are displayed relative to undifferentiated hESCs, 
after normalised to housekeeping gene, β-actin. The standard error is calculated from 6 samples 












 - 100 - 
 
Part II: Effect of PI3K suppression on Wnt/β-catenin signalling 
β-catenin activity is controlled by a large number of binding partners that affect the 
stability and the localisation of β-catenin enabling it to participate in such processes such 
as gene expression and cell adhesion (Bienz, 2005; Gottardi and Gumbiner, 2001). β-
catenin is thought to mediate cell fate specification events by localizing to the nucleus 
where it controls gene expression. β-catenin is downstream of Wnt canonical pathways in 
which GSK-3 regarded as an important controlling point. GSK-3β is a common 
downstream target for both canonical Wnt and PI3K pathways (Naito et al., 2005; 
Woodgett, 2001). Activation of Wnt signalling and PI3K signalling have been shown to 
inhibit GSK-3β activity and therefore stabilise the β–catenin, a well-known common 
event reported in wide range of cell types (Cong et al., 2004; Lee et al., 2010; Naito et al., 
2005).  
Apart from the major role of β-catenin in Wnt signal transduction, β-catenin is also 
abundantly present in the cellular adhesion complex with E-cadherin (Gottardi and 
Gumbiner, 2001). This complex functions to maintain the epithelial structure of cells and 
is involved in many processes regulated by cell-cell contact. When β-catenin is not 
assembled in the complex with E-cadherin, it can form a complex with Axin. While 
bound to Axin, β-catenin can be phosphorylated by GSK-3, which creates a signal for the 
rapid ubiquitin-dependent degradation of β-catenin by the proteosome (Bienz, 2005). This 
indicates that β-catenin stabilisation depends on its localisation. Therefore, examination of 
β-catenin distribution is one possible way investigate the crosstalk between PI3K and β-
catenin signalling.  
4.6. Suppression of PI3K enhances cytoplasm stabilisation of β-
catenin  
Immunocytochemistry was performed in order to examine the β-catenin 
distribution after treating cells with LY, AA and AALY for 24 hours (Figure 4.7). 
Interestingly, suppression of PI3K was shown to modulate the β-catenin localisation to 
various degrees depending on the treatments. In hESCs cultured in CM conditions, a 
defined localisation of β-catenin was detected at the membrane, which co-expressed Oct4 
nuclear protein, a useful marker for hESCs. After 24 hours culture in chemically-defined 
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RPMI/B27 conditions, β-catenin still appeared to be membrane-bound, although the 
levels seemed lower. AA treatment did not alter the expression of β-catenin significantly. 
In contrast, β-catenin localisation appeared to be more cytoplasmic in LY treated cells 
which also lost Oct4 expression. In AALY treated cells, β-catenin exhibited less 
membrane association and Oct4 expression was reduced. These results indicate that 
suppression of PI3K seems to manipulate the β-catenin distribution in hESCs, particularly 
in the cytoplasm. 
 
Figure 4-7: Suppression of PI3K modulates β-catenin localisation.  
HESCs were treated as indicated for 24 hours with LY 294002 at 20 µM (LY), Activin at 100 ng/ml 
(A) and combined treatment (A+LY). Control: RPMI:B27 without any factor and CM: MEF-CM with 
bFGF. Immunostaining analysis of these cells is displayed by indicated antibodies; anti-β-catenin 
(green) and anti-Oct4 (red), counterstained DAPI (blue), and the merged. Destabilisation of 
membrane localised β-catenin is indicated with arrow in A+LY treatment. This is a representative 
of two independent experiments (n=2). Scale bars represent 25 µm. 
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4.7. Total and nuclear β-catenin levels are affected by PI3K 
suppression in GSK3β- independent manner  
The most apparent way of β-catenin stabilisation and nuclear translocation would 
have involved the inhibition of GSK-3β. A classical theory explains that the PI3K 
activation induces phosphorylation of GSK-3β and GSK-3α at Serine9 (Ser9) and 
Serine21 (Ser21) residues, respectively, which may lead to their inactivation. I validated 
this theory following 1 hour treatment with LY, AA and AALY in relation to the Akt 
phosphorylation level in hESCs. The suppression of PI3K by LY either alone or in 
conjunction with AA, led to a decrease in phosphorylation of GSK-3 at these serine sites 
(Figure 4.8). This decrease is not seen in cells treated with Activin, which exhibited a 
similar level of Akt phosphorylation at Ser473 (pAkt) to control.  This indicates that PI3K 
suppression leads to GSK-3β activation, depicted by its lower Ser9 phosphorylation when 
PI3K is inhibited.  
Overall, this indicates that suppression of PI3K/Akt signalling inhibits 
phosphorylation of GSK-3 upon 1 hour treatment in hESCs, which in turn leads to an 
increase in active GSK-3 and is in agreement with other published work in other cell 
types.  
                                
Figure 4-8: pAkt promotes GSK3α/β (S21/S9) phosphorylation.  
HESCs were treated with various combinations of AA (100 ng/ml) and LY (20 µM); LY, AA and 
AALY for 1 hour in RPMI:B27 medium, lysed and immunoblotted for indicated proteins. Cells in 
RPMI:B27 without any factors serves as untreated control. β-actin serves as loading control. 
Abbreviation: p= phospho. 
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 Next, I investigated the levels of both nuclear and total β-catenin in cells treated 
with LY, AA or AALY at various time points over the course of 24 hours in conjunction 
with the level of pGSK-3 (Figure 4.9). It was found that total β-catenin levels were 
gradually reduced and reached the lowest at 6 hours, which is particularly apparent in 
AALY treatment in comparison to AA treatment. This also coincides with the 
downregulation of phosphorylated GSK-3 detected up until 6 hours. However, by 24 
hours of treatment, the β-catenin levels were similar. 
Next, I further investigated the regulation of β-catenin following LY, AA and 
AALY treatment.  For this, I took a further step to characterise the total and nuclear 
localised levels of β-catenin at 6 and 24 hours, the time points where we saw the 
contradictory β-catenin levels (Figure 4.9). Analogous to the decrease in total β-catenin 
following 6 hours of LY and AALY treatment, the nuclear β-catenin was also detected to 
be lower in cells with these treatments than AA alone. Interestingly, at 24 hours, despite 
an equal level of total β-catenin in all the treatments in comparison to control cells, the 
nuclear localised populations of β-catenin seemed to be higher following LY and AALY 
treatment. The LY treatment showed a much higher β-catenin localisation in the nucleus 
and this appeared to support the beta-catenin stabilisation observed in cells treated with 
LY for 24 hours (Figure 4.7). However, the total β-catenin level did not correlate with 
pGSK-3β level, contradictory to the observation at 6 hours. This indicates that the level of 
β-catenin and consequently its nuclear translocation seems to be regulated by a 
mechanism yet to be identified, which is independent of pGSK-3β Ser9 status.  
These results suggest that there is another mechanism involved in β-catenin 
stabilisation and localisation at later time point.  
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Figure 4-9: Temporal changes of beta-catenin expression and their nuclear localisation in 
response to pGSK3β Ser9 level.  
HESCs were treated A) with AA or AALY for the indicated hours and B) LY, AA and AALY at i) 6 
hours and ii) 24 hours in RPMI:B27 medium and lysed for total (A) and (B i) and nuclear 
fractionated (B ii) and immunoblotted for the indicated proteins. β-actin serves as loading control 
for whole cell lysate; LaminB2 and β-tubulin were used as nuclear and cytoplasmic loading 
controls respectively. The western blotting aspect of these experiments was performed with 
assistance from Jason Yu in our laboratory. Abbreviations; t= total and p= phospho. 
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4.8. Suppression of PI3K induces dispersal of E-cadherin and β-
catenin complexes 
Apart from the major role of β-catenin in Wnt signal transduction to regulate gene 
expression that governs cell fate, β-catenin is also abundant in the cell adhesion 
complexes. It forms a complex with E-cadherin to maintain the epithelial structure of cells 
and is involved in many processes that are regulated by cell-cell contact. 
 Based on our observation as indicated in Chapter 3 on DE differentiation, the 
addition of LY induces cellular morphological changes. Although this does not explain 
whether β-catenin is being dissociated from E-cadherin, we have shown the 
downregulation of E-cadherin and up regulation of N-cadherin using RT-PCR (Chapter 
3.3). It is possible that the downregulation of E-cadherin may also affect β-catenin, as 
they are present in a complex. To investigate if β-catenin translocation is correlated with 
dissociation of the E-cadherin complex, I performed a time course observation of changes 
in E-cadherin/β–catenin localisation in conjunction with PI3K suppression by 
immunohistochemistry analysis. 
 There were no changes in both these cell adhesion molecules at the membrane 
until 3 hours of treatment (Figure 4.10). Interestingly, after 6 hours cells appeared to 
acquire the differentiated cellular shape, in which they lost the tight colony appearance 
and acquired a spiky and elongated shape. However, β-catenin and E-cadherin were still 
co-localised with lower a amount of β-catenin found in the periphery of the cytoplasmic 
region without any apparent changes in E-cadherin in a marked number of cells. At 12 
hours, E-cadherin seemed to have partially disappeared from membrane localisation. This 
also coincided with the drastic morphological changes of cells at this time point.  At 24 
hours of LY treatment, E-cadherin had largely disappeared and β-catenin had partially 
translocated  into the cytoplasm. The result showed that LY treatment induces gradual 
loss of E-cadherin localised on the membrane, therefore, the β-catenin may be released 
into the cytoplasm. Moreover, the translocation of β-catenin in hESCs is LY 
concentration dependent, as the amount of β-catenin detected in the cytoplasm is higher 
when hESCs are treated with a higher LY concentration. Taken together, this indicates 
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that the membrane-bound β-catenin translocation into the cytoplasm is mainly due to E-
cadherin disappearance induced by LY during the treatment time in hESCs. 
 
Figure 4-10: Temporal dynamics of the E-cadherin and β-catenin in hESCs upon PI3K 
suppression.  
HESCs were treated with LY 294002 at 20 µM (LY) for 1, 3, 6, 12 and 24 hours (h) in RPMI:B27 
medium. Control is cells treated with RPMI:B27 + 0.1% DMSO for 24 hours and CM represents 
the undifferentiated hESCs. Immunostaining analysis of these cells is displayed by indicated 
antibodies; anti-β-catenin (green) and E-cadherin (red), counterstained with DAPI (blue) and the 
merge of the 3. This is a representative of two independent experiments (n=2). The 
immunostaning aspect of these experiments was performed with assistance from Jason Yu in our 
laboratory.  
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4.9. Discussion  
Development of DE is a Nodal/Activin dependent process, which provides a 
fundamental and conserved mechanism across vertebrates. Having established that this 
signalling is able to control many other cell fates such as pluripotency, mesendoderm and 
primitive endoderm specification, it determines a cell fate depending on parameters such 
as gradient, timing and duration. This is evident in DE cellular commitment by which 
segregation of the early mesendoderm into mesoderm or DE is driven by Nodal/Activin 
morphogenic gradients (Takenaga et al., 2007). While a low quantity of Nodal/Activin 
induces mesoderm, high levels of them lead to DE differentiation. Therefore, many of the 
in vitro protocol for ESCs differentiation towards DE employ high concentration of 
Activin (D'Amour et al., 2005; Tada et al., 2005; Takenaga et al., 2007a). In addition, 
efficiency of DE generation by Activin has been shown to be restricted in low serum 
conditions due to the Insulin/IGF pathway. In common, serum and Insulin/IGF are potent 
inducers of PI3K signalling, which are normally used to promote self-renewal of hESCs 
(Paling et al., 2004).  Therefore, inhibition of PI3K signalling in this and previous studies 
has been shown to improve Activin induced DE differentiation of hESCs. Furthermore, 
given that when Activin was present in MEF-CM conditions could only specify DE fate 
when PI3K signalling was suppressed (McLean et al., 2007), this highlights the 
antagonising activity of PI3K in Activin potency to induce ME and thereafter DE from 
ESCs. Thus, this hints at the cross-talk between these 2 pathways at molecular level.  
In this study, we attempted to identify the molecular basis for the improved DE 
specification as shown in Chapter 3, by investigating the effect of PI3K suppression on 
Activin signalling in a controlled manner. Firstly, we ascertained that the phosphorylation 
of Smad2/3 by Activin is indeed a gradient-dependent event in hESCs. This is an 
important determinant of the signalling specificity, as quantitative Nodal/Activin signals 
which are translated qualitatively into distinct cell fates via controlling the pSmad2/3 
levels (Lee et al., 2011a). 
Having established that Smad2/3 activation is Activin concentration-dependent, we 
opted to investigate if PI3K suppression affects phosphorylation of Smad2/3. Despite 
similar levels of Smad2/3 phosphorylation at 1 hour following both AA and AALY 
treatments, we discovered an apparent increase in Smad2/3 phosphorylation with AALY 
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treatment at 6 hours. Overall, the enhanced pSmad2/3 in AALY has disclosed their impact 
on both direct target and responsive genes such Sox17 and Eomes. However, we did not 
see clear differences between the two treatments in the expression of FoxA2, MixL1 and 
GSC, which are also the target genes of pSmad2/3. Since we analysed the gene expression 
up to 6 hours of treatment, the enhancement of other genes could have occurred after this 
time point as we have shown the enhancement of these genes at later time points of 
differentiation (section 3.3.2). This is also supported by the finding that expression of 
Gsc, FoxA2 and MixL1 requires co-operative action between some pSmad2/3 early-
induced genes (such as Sox17 and Eomes) and β-catenin, therefore, they occur in a 
sequence (Germain et al., 2000; Sinner et al., 2004a; Teo et al., 2011). Taken together, 
knowledge of the sequence of transcription factor expression and regulation is vital in 
order to interpret the observations. In this study, the relative timescale might have been 
too short to reveal any changes in expression, as we have shown differences at later time 
point. In future, a more direct approach could be used to evaluate transcriptional activity 
such as by employing luciferase reporter assay.  
In summary, we have elucidated at least one possible molecular mechanism 
underlying the fact that suppression of PI3K signalling promotes DE differentiation of 
hESCs. We have found that PI3K suppression enhances Activin-induced phosphorylation 
of Smad2/3 in hESCs, which then increases the nuclear import of pSmad2/3 and promotes 
the expression of genes that regulate DE differentiation. This demonstrates that PI3K is a 
negative regulator of the Smad phosphorylation. Further investigation requires on exactly 
how PI3K can affects Activin activation of Smad2/3.  
There are several possibilities that could be suggested for the increase in 
pSmad2/3 when PI3K is suppressed. The Activin/Smad signalling pathway has been 
shown to be negatively regulated through several mechanisms, in particular to control 
Smad2/3 phosphorylation. PPM1A, a nuclear Smad2/3 phosphatase directly 
dephosphorylates phosphorylation at the c-terminus  (Lin et al., 2006b), whilst CLIC4 has 
been found to associate with pSmads and prevent their dephosphorylation by PPM1A, 
hence enriching their levels within the nucleus (Shukla et al., 2009). This seems to be 
worth clarifying since we observed an increase in pSmad2/3, which might due to the 
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defect in dephosphorylation of Smad machinery either by lack of PPMIA or a protective 
effect of CLIC4 when PI3K is suppressed.  
In addition to this, it is possible that PI3K modulates pSmad2/3 levels at the 
receptor level by dephosphorylation and inactivation of receptors via Smad7. Smad7 is 
documented to participate in Activin negative feedback control. This is another 
mechanism, by which Activin signalling controls Smad activation via enhanced Smad7 
transcription, which in turn inhibits Activin signalling though receptor degradation 
(Kavsak et al., 2000).  Although there is no literature on involvement of PI3K in this way, 
it would be interesting to investigate the mechanism further.  
One important mechanism by which PI3K and Smad signalling have been shown 
to interact is the inhibition of Activin/Smad3 signalling by PI3K via binding of pAkt to 
Smad3 to sequester Smad3 from TGF-β/Activin activation (Conery et al., 2004; Remy et 
al., 2004), or involving the Akt substrate mTOR, which inhibits Smad3 phosphorylation 
(Song et al., 2005). However, this mechanism only affects Smad3 activation but not 
Smad2. Therefore, in our study this is unlikely to be the mechanism, or at least not the 
primary one, as we detected that phosphorylation increases in both Smad2 and Smad3. 
Our results will allow further examination of cross-talk between PI3K and Activin, which 
will lead to a better understanding of signals governing mesendoderm and DE formation, 
and could extend to other cellular processes.  
Having investigated the changes of Activin/Smad signalling when PI3K is 
suppressed, we further investigated the effect of PI3K suppression in another signalling 
pathway that governs the mesendoderm and DE fates, Wnt/β-catenin signalling. 
Interestingly, we found that suppression of PI3K undeniably modulates β-catenin 
distribution away from the cell membrane. This was more prominent in cells after 24 
hours treatment with PI3K inhibitor alone and to a lesser extent when dual treatment of 
AALY was applied. The Wnt/ β-catenin pathway is speculated to have a degree of 
crosstalk with the PI3K/Akt pathway, as GSK-3β is a common component of both 
pathways (Maes et al., 2010). Indeed, we found that the suppression of PI3K/Akt 
signalling inhibits phosphorylation of GSK-3α and GSK-3β at ser21 and ser9, 
respectively at 1 hour of the treatment in hESCs, indicating that GSK-3 is a target of 
active Akt. However, from our results was unclear whether the phosporylation of GSK-3 
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at these residues has any effect on β-catenin. The fact that mutations of GSK-3 at these 
residues do not affect their role in forming the destruction complex and degradation of β-
catenin argue that phosporylation of GSK-3 by Akt does not have any role in regulating 
Wnt/ β-catenin signalling (Ng et al., 2009). We further studied the consequence of PI3K 
suppression on total and nuclear β-catenin levels. In theory, the suppression of PI3K and 
subsequently reduced Akt phosphorylation promotes increased GSK-3β levels, which in 
conjunction with Axin and adenomatous polyposis coli (APC) forms the β-catenin 
destruction complex targeting β-catenin for degradation.  However, the clear reduction of 
β-catenin at 6 hours and their equal level at 24 hours was observed when PI3K/Akt 
signalling was still inhibited. Both total level and nuclear localisation of β-catenin at these 
time points did not show a clear relationship to the phosphorylated GSK-3β level. Thus, 
this indicates that the level of β-catenin is not regulated by the pGSK-3β at ser9 which 
was in consistent with the previous report (Yost et al., 1996). Yet, current evidence 
strongly counteracts the classical model of β-catenin regulation by PI3K-induced pGSK-
3β Ser9. Mitogenic activation of PI3K does not result in β-catenin stabilisation (Ding et 
al., 2000). Similarly, a recent study suggests that Axin may serve to isolate a small 
population GSK-3β through sustained association (Ng et al., 2009), which is sufficient to 
insulate and preserve Wnt responsiveness. This coupled with the fact that <10% of 
cellular GSK-3β is associated with Axin (Lee et al., 2003), suggests that the observed 
decrease in β-catenin is likely to be an indirect effect of PI3K/Akt inhibition. Also, 
nuclear β-catenin was markedly increased at the longer treatment time (24 hours) of PI3K 
inhibition, but not at the shorter time (6 hours). This indicates β-catenin stabilisation and 
translocation is likely to be an indirect effect of PI3K suppression.  
Large amounts of β-catenin are typically associated with E-cadherin complexes at 
the plasma membrane of adherent cells in hESCs as in other epithelial cell types. We 
believe that the membrane-localised β-catenin could contribute to the changes in β-catenin 
localisation in our differentiation system. Upon inhibition of PI3K alone, we observed a 
dramatic loss of E-cadherin expression and disruption of co-localisation of β-catenin with 
increasing duration of treatment. This is in conjunction with the observation of E-cadherin 
downregulation and concomitant gain of N-cadherin, as implicated in EMT, shown in the 
Chapter 3 Figure (3.3). This suggests a role for PI3K in the regulation of β-catenin/E-
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cadherin complexes, which may also coincidentally provide another molecular 
explanation for increased DE-specification efficiency. 
The importance of E-cadherin/β-catenin relationship in DE differentiation has 
been established by several studies (Orsulic et al., 1999);(Logan et al., 1999). It has been 
shown that the absence of E-cadherin in E-cadherin-/- embryonic stem (ES) cells leads to 
an accumulation of free β-catenin and its association with LEF-1, thereby mimicking Wnt 
signalling (Orsulic et al., 1999). It has also been reported that E-cadherin can negatively 
regulate the β-catenin nuclear function by binding to it and preventing free β-catenin from 
being imported into the nucleus, in particular with respect to the development of 
endoderm and mesoderm, its over expression has been shown to inhibit formation of those 
lineages (Logan et al., 1999).  This suggests that the structural role of β-catenin is as 
important in germ layer specification as its transcriptional activity role in Wnt signalling. 
It also suggests that delocalisation and downregulation of E-cadherin is required to 
promote occurrence of EMT, a process essential for germ layer specification in vivo. In 
addition to E-cadherin and N-cadherin expression,  upregulation of brachyury, a direct 
target of β-catenin (Arnold et al., 2000) was also shown in the previous Chapter (Figure 
3.3). However, there is a need for assays to measure the transcriptional activity of β-
catenin in the nucleus, which is featured as future work in this study. However, a 
mechanistic basis as to how PI3K interacts and regulates β-catenin/E-cadherin complexes 
is unknown. Despite poor understanding, the relationship between PI3K and E-
cadherin/β-catenin signalling, one study has featured the direct interaction of the p85 
regulatory subunit of PI3K with β-catenin/E-cadherin complexes in human keratinocytes 
(Xie and Bikle, 2007). This has yet to be studied in the hESC differentiation system 
involving PI3K suppression.  
Although LY294002 is known as a specific inhibitor of PI3K, it also targets other 
kinases. In particular, it has been shown to inhibit other non-lipid kinases such as GSK-3, 
mTOR and CK2 at a similar potency to that of PI3K (Bain et al., 2007; Gharbi et al., 
2007). It was shown recently that LY binds GSK-3 (Gharbi et al., 2007) and this could 
have contributed to the β-catenin stabilisation observed upon prolonged treatment of 
hESCs with LY in our case. Therefore, it is essential to consider the contribution of any 
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‘off-target’ effects, due to inhibition of kinases other than PI3K, when investigating the 
effect of LY treatment on hESCs. 
In summary, prolonged Activin signal activity in hESCs is observed with an increase 
in the phosphorylation of downstream effectors, Smad2/3 when PI3K/Akt signalling is 
inhibited. However, this increase is independent of total cellular Smad levels. Prolonged 
persistence of pSmads leads to their increased translocation into the nucleus. This increase 
in activated Smad levels and their translocation will therefore, lead to increases in their 
transcriptional activity in the nucleus. Indeed, several of the direct and indirect target 
genes were upregulated more in cells treated with AALY compared to Activin alone. 
Increases in expression of some mesendodermal and endodermal genes correlated with 
the onset of prolonged pSmad activity, which is also temporally coordinated.   
In addition, PI3K/Akt inhibition has been found to affect β-catenin levels. Further 
investigation indicates that the effect of suppression of PI3K on β-catenin is probably 
indirect by the reduction of E-cadherin and β-catenin complexes. This may indicate EMT  
promotes mesendoderm and subsequently endoderm generation. Understanding the 
molecular basis of PI3K suppression in addition to Activin signalling in DE generation 
represents significant progression in signalling crosstalk, which eventually will help 
endeavours to derive the endoderm population and its derivative cell types from hESCs.   
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Chapter 5:  
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5. HepG2 in alginate three-dimensional culture system 
5.1. Introduction  
The differentiated function of human hepatocytes in monolayer cultures is 
generally short-lived, which is thought to be caused by suboptimal culture conditions that 
cannot recapitulate the environment in the liver. Therefore, development of culture 
conditions that simulate the in vivo environment could improve the function of cultured 
hepatocytes from both stem cells and the liver. To achieve this, a 3-dimensional (3D) 
culture system could improve both the differentiation and functional efficiency. However, 
creation of a successful 3D culture for these cells requires optimisation of several 
parameters such as optimal scaffolding, seeding procedure andcharacterisation of cells’ 
behaviour in this scaffold. 
To date, many scaffolds or biomaterials have been tested for hepatocytes and 
alginate has been found to be best. Alginate, a polysaccharide that is derived from brown 
seaweed, is a biocompatible polymer widely used for 3D scaffolds for liver and other cell 
types. In addition to a scaffold for tissue engineering, it has also been used as a delivery 
system for drugs and as extracellular material for basic biological studies (Atala et al., 
1993; Augst et al., 2006; Lanza et al., 1999). Alginate-based capsulation has been widely 
used in liver tissue engineering and applied to different cell types such as primary 
hepatocytes (Falasca et al., 2001; Glicklis et al., 2000a), hepatoblast (Cheng et al., 2008), 
human hepatocarcinoma cell lines (Coward et al., 2009a; Khalil et al., 2001b; Selden et 
al., 1999a) and embryonic stem cells (Fang et al., 2007a; Gerecht-Nir et al., 2004; 
Maguire et al., 2006). The alginate based method has been shown to facilitate spheroid 
formation (Glicklis et al., 2000b). This, in particular, promotes extracellular matrix 
(ECM) production via cell-cell contact and has the advantage over other scaffolds, which 
are formed partly by specific ECM. These hepatospheres showed a prolonged viability in 
culture and improved liver-specific functions (Glicklis et al., 2004; Glicklis et al., 2000b; 
Kneser et al., 1999).  
Therefore, I planned to optimise the alginate capsulation procedure using the 
hepatocarcinoma cell line, HepG2. HepG2 cells are commonly used for hepatic 
functionality measurement, are relatively easy to produce in scalable quantities and are 
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economical to be utilised for the optimisation purpose. Dr. Clare Selden and her 
colleagues at University College London have previously developed the method with 
HepG2 cells and shown that the procedure could significantly improve hepatic 
functionality in hepatocarcinoma cells (Khalil et al., 2001a). However, the method they 
developed requires a large quantity of cells which would too expensive for testing in 
hESC-hepatocyte differentiation. Hence, in collaboration with them, I modified the 
method to meet the needs of hESCs experiments. 
 
5.2. Alginate capsulation supports the HepG2 cell proliferation and 
viability  
To be able to use this system for hESC-derived cells, I first set out to optimise the 
encapsulation protocol using HepG2 cells (Khalil et al., 2001a). The cells were 
encapsulated at 5×10
5 
cells/ml in 1% sodium alginate/culture medium. The capsulated 
cells appeared as beads with an average diameter of 400 micron at day 1 (Figure 5.2 AI), 
which is controlled by the nozzel size of the capsulator. The cell beads were continually 
cultured and cell proliferation was monitored at several points for 15 days. The cells 
proliferated well in the first several days after encapsulation and cell number increased 
16-fold from the initial seeding by day 10 of post-capsulation (Figure 5.1). The most rapid 
proliferation was observed between day 6 and day 10, with a doubling time of 48 hours. 
Thereafter, the rate of proliferation was markedly reduced, although the survival was be 
maintained.  
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Figure 5-1: Proliferation of HepG2 cells in alginate beads.  
Cells were seeded at 5×10
5 
cells/ml alginate. Cells were dissociated from the spheroid at the 
indicated days after capsulation and stained with crystal violet, and then cell numbers were 
counted based on nuclei staining. The cell counts represent the mean value of three readings.   
 
The viability of cells in alginate was examined by fluorescein diacetate (FDA) 
staining and the results showed that more than 90% of the HepG2 cells were viable in the 
spheroids for the duration of 15 days post-capsulation (Figure 5.2). At day 13, although 
they are no longer proliferative, they display a strong viability. The FDA staining 
appeared throughout the spheroids (Figure 5.2CII). In most of the cases, a small 
percentage of non-viable spheroids (stained for PI) were found which were usually bigger 
in size than the average.  
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Figure 5-2:HepG2 viability in alginate beads.  
(A) and (B) capsulated HepG2 cells in culture at day 1 and day 13, respectively.  (I) phase 
contrast, (II) FDA staining for viable cells, (III) PI staining for dead cells and (IV) overlaid image of 
II and III. Image (C) is the higher magnification of the images in B (I) phase contrast, (II) FDA 
staining and (III) overlay of I & II. The diameter of a typical bead, 400 µm (red) has shown in 
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5.3. Spheroid formation by capsulated HepG2 cells  
The cells were trypsinised into single cells and capsulated into alginate beads, then 
cultured in suspension with HepG2 culture medium. Initially, the cells appeared in single 
cells inside the beads (Figure 5.3), but cell aggregates started to form and the formation of 
spheroids was notable by day 6 of post-capsulation. The spheroids grew markedly and 
increased in size until day 10. Thereafter, they were maintained at a similar size until day 
15, at which point the beads could no longer hold these spheroids. Typically 50-70 % of 
beads were filled by spheroids by day 9 post-capsulation (Figure 5.3 A). These spheroids 
showed a prominent proliferation towards the edge of the alginate beads and formed 
either homogenous or elongated spheres. These cohesive spheroid colonies remained 
intact, even after removal of the alginate beads by chelation of calcium (that aids alginate 
depolymerisation), and can only be disaggregated by repeated mechanical disruption after 
release from the beads (Figure 5.3 A). These results show that alginate capsulation 
facilitates the 3D formation of HepG2 cells and tightly maintains the 3D structure in 
beads. It is noteworthy that formation of these cohesive colonies requires cell proliferation 
as shown in the Figure 5.1.   
The formation and maintenance of the spheroids is a process dependent on cell 
adhesion molecules. Cells within cohesive 3D colonies were tightly held together by 
interaction of a complex adhesion molecule network. E-cadherin, the most common 
calcium-dependent cell adhesion molecule, is expressed predominantly in epithelial cells. 
Therefore, E-cadherin expression was assessed by western blotting. E-cadherin expression 
levels showed a clear and progressive up-regulation over the period of post-capsulation 
compared to the monolayer culture (Figure 5.3).  The formation and the size increment of 
the spheroids in alginate beads, which reflects increasing cell-cell contact, coincides with 
the upregulation in E-cadherin expression. 
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Figure 5-3: HepG2 cells spheroid formation.  
Phase contrast observation of A) HepG2 cells in monolayer, which then were dissociated into 
single cells to be capsulated into Alginate beads for 10 days. Capsulated HepG2 cells at day 1, 
which appeared to be single cells, continuously proliferated. Formed spheroids were noticeable at 
day 6 and apparent at day 9 of 3D alginate beads. The formed spheroids remained intact even 
after their release from beads (depolymerised alginate) shown at day 6 of 3D culture.  Scale bars 
represent 50 µm (left panel) and 100 µm (right panel). B) Western blotting of E-cadherin 
expression in HepG2 cells in alginate at indicated days of post-capsulation compared to 
monolayer (2-D) culture. 
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5.4. Improvement in hepatic functionality of HepG2 cells cultured in 
alginate beads 
In monolayer culture conditions, hepatocytes rapidly lose their ability to perform fully 
differentiated functions (Guguen-Guillouzo and Guillouzo, 1986; Steward et al., 1985). In 
an attempt to evaluate how a 3D culture could augment the hepatic function, we used the 
alginate capsulation to culture HepG2 cells and assess their hepatic functionality, albumin 
production, urea synthesis and inducible cytochrome activity, in comparison to the 
monolayer. 
5.4.1. Albumin production  
I performed indirect ELISA sandwich assays to quantify albumin secretion into 
the culture media by HepG2 cells in these two comparative culture conditions. Culture 
media without cells was used as a negative control. The secreted albumin level was 
approximately 5-fold higher (41 µg per million nuclei) in day 10 alginate culture than that 
in monolayer culture at the same cell density (8 µg per million nuclei) (Figure 5.4). This 
indicates a significant enhancement in albumin production by HepG2 cells in 3D 
compared to monolayers. 
 
Figure 5-4: Albumin secretion.  
Albumin production by HepG2 cells in 2D monolayer and 3D alginate post-capsulation day 10. 
Mean and standard deviation was calculated from three independent experiments (n=3). (* 
p<0.005 compared to 2D monolayer).  
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5.4.2. Urea synthesis 
A sensitive and direct quantification of urea produced by cells in the culture medium 
allowed us to assess the capacity of HepG2 cells to produce urea in alginate culture 
compared with monolayer cells.  Culture media without cells was used as negative 
control. HepG2 cells cultured in alginate beads for 9 days showed an improved urea 
synthesis, 15 mg/dL, about 4-fold higher than that in the monolayer culture, (4 mg/dL), at 
same cell density over 24 hours period (Figure 5.5).                       
 
Figure 5-5: Urea synthesis.  
Urea synthesis by HepG2 cells in 2D monolayer and 3D alginate post-capsulation day 9. Mean 
and standard deviation of three independent experiments (n=3) are shown. (*p<0.005 compared 
to 2D monolayer).  
 
5.4.3. CYP3A4 enzyme activity 
Drug metabolism and detoxification is an essential function of hepatocytes. 
Cytochrome P450 3A4 (CYP3A4) is a member of the cytochrome P450 superfamily of 
enzymes presents in the largest quantity of all the CYPs in the liver. CYPs catalyse many 
reactions involved in drug metabolism and synthesis of cholesterol, steroids, and other 
lipids. CYP3A4 enzyme can be induced by rifampicin, a bactericidal compound. CYP3A4 
activity can be assessed using a sensitive CYP3A4 enzyme-specific assay which measures 
enzyme activity by converting a luminogenic substrate to a luciferin product in a non-lytic 
format. CYP3A4 enzyme-specific substrate incubated without cells was used as negative 
control.  
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Induction of CYP3A4 activity by rifampicin was approximately 2.3-fold higher in 
the monolayer compared to control; while in alginate 3D, rifampicin was capable of 
inducing CYP3A4 activity approximately 3.5-fold higher than control (Figure 5.6). This 
indicates that CYP3A4 activity can be induced upon addition of rifampicin in HepG2 
cells and that the induction in the 3D culture is higher (2.3 vs. 3.5 fold induction). More 
importantly, when comparing the activity levels between the 3D and 2-D culture 
environments, 3D culture showed approximately 2.5 and 3.8-fold increases in un-induced 
and induced, respectively in comparison to the monolayer HepG2 cells. These data 
demonstrate that 3D culture of HepG2 cells increases not only the basal levels of 
CYP3A4 activity in the cells but also improves responsiveness to induction. 
 
Figure 5-6: CYP3A4 activity in HepG2 cells.  
3D culture improves CYP3A4 activity in both control (uninduced) and rifampicin (induced) culture 
conditions than in monolayers at 24 hours at the same cell density. Cells in both control (DMSO 
0.01%) and rifampicin (10 µM) were treated for 48 hours prior to the assay. The data represent 
the mean value of triplicate readings.  
 
The above results demonstrate that alginate 3D culture improves CYP3A4 activity 
in response to rifampicin treatment in HepG2 cells. However, it is unclear whether this 
improvement is a direct result of cell-cell contact or is due to changes in the individual 
cell. To address this question, I first dissociated HepG2 cells from the alginate spheroids 
into single cells and then assessed the CYP3A4 activity, as previously described. The 
results showed that the activity was reduced in both uninduced and induced by 
approximately 2.6 and 2.9-fold, respectively, which is similar to that in the monolayer 
culture. These data suggest that the improvement observed in the 3D culture is mainly due 
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to cell-cell interaction rather than changes in the individual cells and that cellular 
organisation as a tissue and cell-cell communication can influence cellular functions. This 
may reflect the problem reported on function reduction upon liver dissociation and their 
establishment of monolayer cultures.  
 
Figure 5-7: CYP3A4 activity is a spheroid integrity dependent process.  
3D culture improves CYP3A4 activity in both control (uninduced) and rifampicin (induced) culture 
conditions than in monolayers at 24 hours at the same cell density. Cells in both control (DMSO 
0.01%) and rifampicin (10 µM) were treated for 48 hours prior to the assay. Cells were dissociated 
and measured for activity for one hour. The data represent the mean value of triplicate activity 
readings.  
 
5.5. Discussion  
In this study, I have studied the alginate encapsulation of HepG2 cells and alginate 
encapsulation was shown to facilitate the cells to form 3D colonies. I also assessed 
whether 3D culture would improve hepatic functionality. Furthermore, I demonstrated 
that characterising behaviour of encapsulated HepG2 cells, such as proliferation, viability 
and the kinetics of spheroid formation, is essential in order to maximise the effect of 3D 
growth on functionality enhancement.  
 The alginate encapsulation of HepG2 cells supports the survival and proliferation 
of these cells to form 3D cohesive colonies. The exponential proliferation phase showed a 
doubling time of 48 hours compared to 24 hours in the monolayer. This reduced 
 - 124 - 
 
proliferation helps to prevent cells overloading in beads in the short time period, which 
will impair the viability of cells due to nutrient restrictions.  
Cells were viable in the spheroid during the 15 days post-encapsulation period of 
experiment. Important factors that affect the maintenance of cell viability are the size of 
spheroids and number of spheroids per bead, because increases in both features will make 
it harder for the nutrient to get access to the cells in the centre of the beads and spheroids. 
The size and number of spheroids formed by HepG2 cells is reported to be influenced by 
two parameters; the beads size and cell seeding density (Coward et al., 2005; Khalil et al., 
2001a). In most of studies, alginate beads were generated at a diameter size 400-500 
microns (Khalil et al., 2001a; Maguire et al., 2007) . The beads in this study were 
produced at 400 micron diameter, which is reported to approach the upper diffusion limit 
for maintaining hepatocyte viability; above this the cells in spheroids will be non-viable.  
In this study, cells were encapsulated into beads as single cells which proliferated 
to form cohesive colonies over the post-encapsulation days. Formation of 3D structures 
from single cells could be through either aggregation of single cells or multiplication of 
individual cells. Since capsulated single cells were found evenly located in the beads 
rather than concentrated in particular areas, it is unlikely that 3D colonies were formed 
through cell aggregation. Furthermore, the formation of spheroids seemed to be correlated 
with cell proliferation, as they were both enhanced between day 6 and day 10 of post-
encapsulation. Therefore, it seems that the spheroid formation is through 3D growth from 
single cells. 
Expression of E-cadherin, a cell adhesion molecule, is significantly increased in 
the 3D culture system, which indicates that cell-cell contact is considerably improved in 
the alginate culture, compared to the monolayer culture. This is also supported by the fact 
that the spheroids remained intact even after being released from the alginate beads, 
showing that the spheroids do not need physical support to hold cells together after they 
form. In fact, these spheroids can only be disrupted with mechanical forces. E-cadherin 
also functions to mediate cell-cell and cell-ECM communication. It controls and 
maintains the architecture and integrity of epithelial tissues. On the whole, alginate 
supports 3D growth, proliferation and survival as well as enhanced the E-cadherin 
expression.  
 - 125 - 
 
Hepatocytes, a highly specialised cell type, perform a wide range of functions, 
including detoxification, metabolism and maintenance of homeostasis in the body. How to 
retain these functions in hepatocytes when they are in culture is of the great interest for 
both pharmaceutical application and cell therapy. We employed a 3D culture method to 
observe if it could improve the hepatic functions of protein synthesis, detoxification and 
metabolism.  
Albumin is produced by liver and is a major carrier protein in the blood to 
maintain osmotic pressure. Alginate 3D culture has improved HepG2 cell albumin 
secretion markedly compared with monolayer culture. This has been widely shown and is 
in agreement with work published by others (Coward et al., 2009b; Khalil et al., 2001a; 
Selden et al., 1999b). Urea synthesis, one of the detoxification functions by the liver, is 
the primary vehicle for removal of toxic ammonia from the body. I have observed that 
urea synthesis is much higher in 3D culture than that in the monolayer control. A couple 
of studies reported that urea synthesis was not notable in their assay systems. This may be 
due to the assay that was employed and I used a direct and sensitive quantification in this 
study. Although I did not show that the this upregulation is associated with enzymes 
involved in the urea cycle, there is a report showing that arginase, the final enzyme of the 
urea cycle, is more active when HepG2 cells are cultured in 3D conditions (Selden et al., 
1999b). 
Cytochrome P450 (CYP) is a key function of hepatocytes accounting for ~75% of 
the total number of different metabolic reactions of drug metabolism and bioactivation 
(Guengerich, 2007). Of these p450 superfamily isozymes, CYP3A4 is one of the most 
important ones because it is involved in the metabolism of approximately half of the drugs 
in use today. Alginate 3D culture of HepG2 cells increased not only their basal levels of 
CYP3A4 activity, but also improved their responsiveness to rifampicin-mediated 
induction. When the 3D format of these cells was impaired, CYP3A4 activity was rapidly 
diminished. This demonstrates the importance of 3D culture for improvement of 
functionality. Although most of the studies in primary hepatocytes have reported the 
CYP3A4 activity could last for hours or days after culture, I have showed that this 
happened in HepG2 cells in a very short time. This is in agreement with another system, 
in which the CYP3A4 inactivation by inhibitor occurred within minutes (Foti et al., 
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2010). This emphasises the immediate involvement of 3D microenvironment in 
maintenance and induction of improved hepatic function. It seems that cell-cell contact is 
imperative for the improvement and maintenance of CYP3A4 activity, which otherwise is 
shown to decrease upon the 3D disaggregation. Although the 3D improved ECM 
production such as enhanced E-cadherin has been established, intuitively, releasing cells 
from this network will impair the signalling through ECM and cell-cell contact in an 
immediate manner. This demonstrates the close relationship between inter-cellular 
communication and efficient hepatic functionality.   
Characterisation of cell growth, spheroid formation and functionality in HepG2 
cells in alginate 3D culture demonstrates that this system is a good 3D model to improve 
hepatic functionality in these cells. However, whether this system can be applied to stem 
cell-derived hepatocytes needs investigation as the behaviour of stem cell-derived 
hepatocytes is not the same as HepG2 cells. They differ in their molecular phenotype and 
behaviour in culture, for examples proliferation, durability and homogeneity of the cell 
population. In addition, HepG2 cells have a marked proliferative ability compared to stem 
cell-derived hepatocytes. The latter cell type is more similar to primary hepatocytes in 
their proliferation capacity, as most of these cells are in the post-mitotic phase. Therefore, 
studies are required for optimisation of 3D culture conditions that could be used for stem 
cell derived hepatocytes.  
Overall, this study shows that various liver-specific functions can be upregulated 
in HepG2 cells when they are cultured in 3D colonies. The alginate encapsulation system 
supports the proliferation, formation of spheroids and viability of these cells. 
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Chapter 6:   
Differentiation of hepatocytes from human embryonic 
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6. Differentiation of hepatocytes from human embryonic 
stem cells in 3D alginate scaffold 
6.1. Introduction  
Most of the hepatic differentiation protocols for ESCs have been focused on 
sequential differentiation using growth factor cocktails. This provides an advantage for 
producing the most efficient differentiation compared to other strategies (as discussed in 
section 1.3). However, these methods have some downsides in maturation and 
maintenance of the differentiated phenotype, which are important for using the cells in 
drug discovery and in artificial liver devices.  Therefore, it is necessary to further improve 
the current differentiation protocols.   
Research has identified on how to maintain hepatocyte functionality in vitro in 3D 
culture with either enriched hepatocyte populations (Ijima et al., 2009a; Ijima et al., 
2009b) or co-cultures of hepatocytes with non-parenchymal(Yamada et al., 2001) and 
endothelial cells (Lee et al., 2004a). While 3D culture is able to maintain functionality for 
adult primary hepatocytes for an extended time, it has also been shown to induce the 
differentiation of foetal hepatocytes to a mature phenotype and maintain functionality 
(Jiang et al., 2002; Semino et al., 2003). This indicates that 3D culture has the potential 
not only to differentiate cells into mature hepatocytes but also to maintain hepatic 
function of these cells. Hence,  this leads to the prediction that the combination of hESC 
differentiation and 3D culture may have a great potential to provide high quality 
hepatocytes. Therefore, fine-tuning of the culture conditions that mimics the in vivo 
environment could improve maturation by providing both cell-cell contacts and soluble 
factors.  
Several studies have attempted to design 3D systems to generate hepatocytes from 
ESCs (Baharvand et al., 2006; Imamura et al., 2004). These studies were all conducted via 
EB formation by either seeding ESCs into the 3D scaffold to differentiate into EBs or 
after EBs have formed in vitro in suspension culture, then transferring the EBs into the 
scaffold.  The EBs in the scaffolds continued to differentiate into hepatocytes. However, 
despite these efforts, no one has yet succeeded in obtaining fully functional mature 
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hepatocytes with these methods. One of the possible reasons may be the inefficient DE 
differentiation via EB formation. An enriched DE population is imperative for further 
hepatocyte formation as previously discussed (Chapter 3). Therefore, incorporating an 
enriched hESC-derived DE into the 3D scaffold may improve the yield of hepatocytes and 
their maturation from hESCs.  
All differentiation methods, in 2D and 3D, require understanding of the control of 
highly complex cell biology processes. 3D culture produces additional challenges for 
inducing cell attachment, survival, differentiation and organisation, which are still largely 
unknown. More research into this area is necessary to understand the behaviour of cells in 
3D culture format and to improve the differentiation and function of hepatocytes.  
To generate functional hepatocytes, I aimed to investigate whether 3D culture 
conditions would help to improve hepatocyte differentiation and function following 
differentiation from hESCs. Therefore, I designed a strategy to combine 3D culture with 
an established monolayer protocol previously developed in our laboratory for hepatocyte 
differentiation (Hay et al., 2008b), in which hESCs were differentiated in a monolayer to 
enrich DE or early hepatocytes and then incorporated into a 3D culture system, to 
maximise hepatocyte differentiation and improve hepatocyte functions. 
 
6.2. Hepatic differentiation of hESCs in monolayer  
The three-stage protocol for efficient differentiation of hESCs to hepatocytes in a 
monolayer previously developed in the laboratory is illustrated schematically in Figure 
6.1 (A).  In this protocol, hESCs can be differentiated efficiently to definitive endoderm 
(DE) at the end of stage 1 though with a considerable amount of cell death on the first day 
(Hay et al 2008). The resulting DE cells were cultured in SR/DMSO medium for 5 more 
days (Stage 2) and the cells resembled hepatoblast-like cells, expressing early hepatocyte 
markers. In stage 3, the cells were cultured in the medium containing HGF and OSM, 
which helped further hepatocyte differentiation and maturation, resulting in larger, 
polygonal-shape cells with distinct round nuclei, resembling primary hepatocyte 
morphology.  
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Figure 6-1: A three-step protocol to differentiate human embryonic stem cells (hESCs) to 
hepatocytes.  
(A) Schematic representation of the three-stage procedure in differentiation of hESCs to 
hepatocytes. (B) Images showing sequential morphological changes from hESCs (H1) to 
hepatocytes, in which (I) 20x magnification and (II) 60x magnification. Scale bar for B (I) and (II) 
represents 100 µm and 50 µm respectively. Abbreviations: DMSO, dimethyl sulfoxide; FBS, fetal 
bovine serum; HGF: hepatocyte growth factor; KO-DMEM, knock-out Dulbecco's modified Eagle 
medium; NaB, sodium butyrate; OSM, Oncostatin M; KSR, knockout serum replacement.  
 
In designing the 3D experiment, the first question to address was which would the 
best stage at which the cells could be introduced into the 3D culture. As shown before 
(Chapter 3), enriched DE will improve subsequent differentiation into hepatocytes. 
Therefore, I opted to use cells produced after the DE stage in a monolayer. However, the 
yield of stage 1 is a drawback to produce a sufficient cell number for our 3D experiment, 
unless the differentiation is initiated at a huge scale of hESCs. Therefore, hepatoblasts 
(stage 2) could be an alternative option for the 3D culture. When stage 2 cells were 
studied in more detail, I observed that dissociation of cells into single cells from any day 
after day 2 of stage 2 resulted in massive cell death. Therefore, early stage 2 cells seemed 
the best cells from this monolayer culture to be incorporated into the Algimatrix 3D 
culture system. Additionally, these early stage 2 cells may provide a proliferative 
advantage in the 3D culture system, in addition to their stability of the phenotype upon 
single cell dissociation.   
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 The second question was which 3D scaffold to use. Although alginate bead 
hydrogel showed an improved hepatic function in HepG2 cells (see Chapter 5), it requires 
vast amounts of cells to start with, which is unrealistic to use in hESC studies. Therefore, 
I resolved to use Algimatrix, an alginate scaffold that is commercially available 
(Invitrogen). Algimatrix scaffold and alginate bead hydrogel are made of the same 
material, alginate. However, Algimatrix provides an advantage for a small scale trial 
compared to the alginate beads.  
6.3. Effect of ROCK inhibitor on viability and spheroid formation of 
hESCs-derived hepatoblasts 
To construct the 3D culture system, first I differentiated hESCs as monolayers to 
early stage 2 (day 1 or 2 into stage 2) (henceforth named as eS2), then dissociated cells 
into single cells and seeded them at two different densities (0.5 and 1 million per well) 
into a pre-made Algimatrix 24-well plate (Invitrogen). The cells were continuously 
cultured in the Algimatrix plate with SR/DMSO medium for several more days in the 
same media used in the monolayer system. In my initial attempt,  a massive cell death was 
observed after dissociating the early stage 2 cells. Since it is reported that disassociation 
of hESCs into single cells can increase ROCK expression which induces apoptosis 
(Takehara et al., 2008; Watanabe et al., 2007; Zhang et al., 2011a), I tested whether a 
ROCK inhibitor, Y-27632 (ROCKi) could reduce the cell death.  
Briefly, cells were pre-treated with ROCKi at 10 µM for 2 hours prior to 
dissociation. Then cells were disassociated by accutase treatment, a milder reagent than 





 cells) were seeded into Algimatrix plate with ROCKi and inoculated into 
Algimatrix by centrifugal forces to allow better penetration of these cells into 
scaffold. Cells were then continuously cultured with SR/DMSO medium for a further 4 
days with medium changes every other day, and for a further 5 days in L-15 medium 
changed every day. 
Similar cells without ROCKi treatment and the HepG2 cells with and without 
ROCKi treatment were used as controls. The results showed that most early stage 2 cells 
without ROCKi stained positive for non-viable staining with propidium iodide (PI), 
whereas ROCKi treatment noticeably reduced the number of non-viable cells (Figure 6.2). 
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Furthermore, consistent with better survival, 3D spheroid formation became more 
apparent in the ROCKi treated eS2cells. In contrast to eS2cells, HepG2 cells did not 
exhibit clear cell death after disassociation into single cells by trypsin or accutase, 
therefore showing hardly any response to ROCKi treatment. Thus, ROCKi treated cells 
were shown to be mostly viable and form spheroids. 
 
 
Figure 6-2: Effect of ROCKi treatment on viability and spheroid formation of eS2cells.  
Phase-contrast and PI staining (dead cells) images of cells that were seeded (1x10
6
 cells/well) 
into Algimatrix 24-well plates after dissociation into single cells at early stage 2 (eS2) of monolayer 
differentiation and continuously cultured in SR/DMSO medium, in the presence (+) or absence (-) 
of ROCKi,Y-27632 for another 9 days.  Abbreviation: PI, propidium iodide. 
 
6.4. The eS2 cells quickly form 3D structures via cell aggregation 
after culture in Algimatrix scaffold 
The next question is whether 3D spheroid formation in Algimatrix is an immediate 
event through aggregation or a gradual event though proliferation or slow aggregation.  
The results show that the spheroids formed from eS2 cells can be observed as early as 24 
hours after inoculating the cells into Algimatrix scaffold, indicating that this is most likely 
through aggregation (figure 6.3). In contrast, I observed only 1-2 spheroids formed in 
HepG2 cells at day 1 of similar culture conditions, which become significant in number 
after 9 days culture in Algimatrix. While the eS2 cells readily aggregate in the Algimatrix,  
the formed 1-2 spheroid of  HepG2 cells might due to the close proximity of these cells in 
pores of Algimatrix.  
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Figure 6-3: 3D formation of HDHs and HepG2 in Algimatrix.  
A) Phase contrast observation of spheroids of eS2 and HepG2 cells seeded in Algimatrix at day 1 
and day 9 of post-seeding. Note that the day 9 spheroids were released from Algimatrix whereas 
at day 1, cells were in Algimatrix scaffold. Scale bars represent 200 µm B) The histogram depicts 
the spheroid size distribution. The range of size of spheroids, categorised into ≤ 50 µm (small), 
between 50-100 µm (medium) and ≥ 100 µm formed by day 9 of eS2 cells seeded at 0.5 million 
(0.5m eS2), 1 million (1m eS2) and HepG2 cells at 0.5 million cells (HepG2) per well in 24-well 
Algimatrix plate. The data represent the percentage of frequency of size (diameter) range of 100-
200 spheroids counted for each cell category.  
 
The spheroids of eS2 cells appeared to be variable in size, which seems to be 
associated with the cell seeding density (Figure 6.3 B). The lower seeding density (5x10
5
 
cells/well) produced a majority of spheroids (84%) between 50-100 µm, while the higher 
seeding density (1x10
6 
cells/well) produced a larger number of spheroids sized over 100 
µm (about 20% of the spheroids) but also generated more small spheroids (diameters <50 
µm). This indicates that the cell seeding density has an effect on the size of spheroids 
formed. It has been shown that having larger sized spheroids (>100 µm) is unfavourable 
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as it hampers the viability of cells in the centre of spheroids, due to nutrient and oxygen 
depletion (Glicklis et al., 2004; Glicklis et al., 2000b). It was  also shown that the optimal 
size of spheroids from hepatocytes (75-100 µm) is a vital parameter to maintain cell 
viability and functionality.  Taking this into consideration, the lower cell seeding density 
(5x10
5
 cells/well) produced larger number of spheroids within the favourable size range. 
However, there is a need to establish the relationship between spheroid size and behaviour 
of cells in terms of viability and function. HepG2 cells, at a seeding density of 0.5 million, 
seem to have a large population of spheroids in the smaller size category. This may be due 
to the nature of spheroid formation mainly by proliferation, which might take longer to 
increase the size.  
 
6.5. Algimatrix scaffold reduces the proliferation of early Stage 2 
(eS2) cells  
Having shown that Algimatrix can support the 3D formation of eS2 cells and 
HepG2 cells, I next addressed the proliferation capacity of these cells in 3D culture 
format. The cells prior and 9 days after culture in Algimatrix scaffold were stained with 
trypan blue to exclude dead cells and viable ones were counted using a haemocytometer. 
In contrast to HepG2 cells, which proliferate well in the 3D scaffold as indicated 
previously, the eS2 cells were surprisingly did not exhibit any increase in cell number 
(Figure 6.4). In fact, the cell counts in eS2 cells were reduced approximately 20% from 
the initial cell number for both 0.5 and 1 million seeding densities. However, when the 
same eS2 cells were continuously cultured in a monolayer in the same culture media, the 
cells increased in number approximately two-fold in 9 days. These results suggest that 
Algimatrix is not necessary to have a proliferative retardation since HepG2 cells 
proliferate well in it. Also, the culture media do not block eS2 cell division, as they are 
proliferative in the same culture media in 2D culture conditions. However, when eS2 cells 
are cultured in Algimatrix scaffold, their proliferation is decelerated. Since proliferation 
and differentiation are generally known to counteract each other, the reduction in 
proliferation may promote hepatocyte differentiation. 
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Figure 6-4: Proliferation of eS2 cells in monolayer (2D) and Algimatrix 3D culture.  
The eS2 cells were dissociated at day 2 of stage 2 monolayer differentiation by accutase and 
seeded at 0.5 or 1 million cells per well of 24-well Algimatrix plate in the presence of ROCKi. Cells 
were cultured in SR/DMSO media for 4 days followed by maturation media for another 5 days and 
formed spheroids. Cells were then dissociated from the spheroids into single cells by trypsin, 
stained with trypan blue and counted. HepG2 cells were used as reference cells in this 
experiment.  Mean and standard deviation were calculated from three independent experiments 
(n=3).  
 
6.6. Algimatrix 3D culture system improves hepatocyte 
differentiation and function. 
Subsequently, I assessed the efficiency of hepatocyte differentiation of ES-derived 
eS2 cells in both 2D and 3D culture formats, by measuring the expression of hepatocyte-
specific markers (Figure 6.5 A). Expression of AFP, a foetal liver marker which is absent 
in postnatal liver, was augmented in cells cultured in the 3D culture system compared to 
monolayer. In addition, expression of ALB and ApoF genes, markers of more mature 
hepatocytes, showed higher expression in the 3D culture than in 2D culture; although they 
were still much lower than in the adult liver. The cells cultured in the 3D conditions also 
showed a greater increase in the expression of the biliary cell marker CK19 than that of 
2D cultured cells. The expression of the hepatocyte-specific transcription factor HNF4α 
was also shown to be increased in cells differentiated in 3D cultures in compare to the 
monolayer.  These results indicate that 3D culture conditions enhance hepatocyte 
differentiation and maturation of hESC-derived early stage 2 cells. However, they are still 
less mature than adult primary hepatocytes. 
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To further investigate the effect of 3D culture on hepatocyte differentiation, I took 
a closer look into the CYP3A4 activity in these differentiated cells. To carry out the assay, 
I first released the cell-spheroids from Algimatrix by Algimatrix dissolving buffer 
(Invitrogen) and maintained spheroid configuration while incubating them with 
bioluminescent CYP3A4 substrate for an hour. In the 2D culture system, I directly applied 
bioluminescent substrate into the culture for the same duration. The CYP3A4 enzyme 
produced by the cells metabolises the substrate which activates a luminogenic signal, 
detectable by luminometry. (The CYP3A4 enzyme-specific substrate incubated without 
cells was used as a negative control). 
The results (Figure 6.5B and Table I&II) showed that Algimatrix 3D culture 
conditions significantly increased basal levels of CYP3A4 activity by 2.9 fold in eS2 cells 
when seeded at 0.5 million (p <0.01) and 4.1 fold in the HepG2 cells (p< 0.0005), 
compared to in monolayer culture. There is no significant increase in eS2 cells when 
seeded at 1 million. However, Algimatrix 3D and 2D culture conditions exhibit similar 
increases in CYP3A4 activity in response to rifampicin treatment for both hESCs-derived 
hepatocyte differentiation and HepG2 cells. This indicates that 3D culture has enhanced 
CYP3A4 activity in both cell types, but does not significantly improve the response to 
chemical induction. The results also showed that when cells are seeded at higher density 
in 3D culture, there is little improvement in their functionality. These results are 
consistent with the previous finding that eS2 cells seeded at higher density do not produce 
optimal size spheroids, for proper differentiation.  
CYP3A4 induction by rifampicin was approximately 1.5-1.6 in hESCs-hep cells, 
while the HepG2 cells showed an approximate 2.3-2.5 fold increase in activity in 2D and 
3D culture systems. This indicates that CYP3A4 induction by rifampicin in HepG2 cells 
is greater than that of the hESCs-hepatocytes. This may be due to the culture homogeneity 
of HepG2 cells, since they are pure hepatocytes, whereas hepatocyte differentiation of 
hESCs may produce non-hepatocytes in both 2D and 3D culture. Despite the mixed 
population that may have been produced in the hESC-hepatocyte differentiation system, 
overall CYP3A4 activity in cells derived from 0.5m eS2 3D culture is at a comparable 
level to in HepG2 cells in both basal and rifampicin induced conditions. This indicates the 
quality of hepatocyte produced in the former cell type is better than HepG2 cells. 
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Figure 6-5: Effect of Algimatrix 3D culture on hepatocyte differentiation and function.         
A) Reverse transcription-polymerase chain reaction (RT-PCR) analysis of eS2 cell differentiation 
in monolayer and Algimatrix. Total RNA was extracted from cells in the indicated culture systems 
and gene expression levels were analysed by semi-quantitative RT-PCR for named genes. Gapdh 
serves as a housekeeping gene. Abbreviations: AL, adult liver; AFP, -fetoprotein; ALB, albumin; 
APOF, apolipoprotein F; CK19, cytokeratin 19; HNF4α, hepatocyte nuclear factor 4 alpha. B) The 
CYP3A4 activity in cells at SIII. The activities were measured 48 hours after the treatment with 
0.01% DMSO (basal/vehicle control) or 10 µM rifampicin (chemical induced). eS2cells were at 0.5 
and 1 million, respectively, and HepG2 cells were seeded at 0.5 million cells. Mean and standard 
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 0.5m eS2 1m eS2 
Fold change in 
CYP3A4 activity 
induced by 3D 
culture 
basal 2.9** 1.3* 4.1*** 
rifampicin 2.8** 1.2* 4.6*** 
The significant p-value indicates by * p<0.5, ** p<0.01 and *** p<0.0005 
 
Table II: CYP3A4 activity fold induction by rifampicin induction compared to basal 
level. 









0.5m eS2 1m eS2 2D 3D 
















These data demonstrate that hepatocyte differentiation and maturation are 
augmented in sequential 3D culture compared to in monolayer alone, judged by the 
expression of mature hepatocyte markers and CYP3A4 activity. Moreover, the 
differentiation into hepatocytes showed a greater improvement in 3D Algimatrix 
differentiation of eS2 cells seeded at lower density (5x10
5 
cells/well) than at higher cell 
density (1x10
6
 cells/well) used in this experiment. This indicates that cell seeding density 
is a critical factor to be taken into account for favourable spheroid formation and 
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6.7. Discussion  
Human ESCs hold great promise to provide a source of human hepatocytes for 
applications such as cell therapy, drug discovery and toxicology, and extracorporeal BAL 
support. There are, however, limitations to differentiated hepatocytes in conventional 2D 
culture. It has been shown that 3D culture is superior to enhance the hepatic functions of 
primary hepatocytes and HepG2 cells by this and other studies (Lin and Chang, 2008; 
Selden et al., 1999b). Therefore, I investigated into the potential of Algimatrix 3D culture 
to induce hepatic differentiation and maturation of hESCs in comparison to routine 
monolayer culture. 
Early stage 2 cells of hESC-monolayer differentiation were introduced into the 3D 
culture condition, as these cells may have the better yield and differentiation of functional 
hepatocytes when cultured in 3D format. However, these cells were sensitive and 
underwent dissociation-associated cell death. To overcome this, I used a ROCK inhibitor 
because it has been shown that ROCK inhibitor enhances the survival of some primary 
and stem cells after cell dissociation into single cells (Watanabe, Ueno et al. 2007; 
Takehara, Teramura et al. 2008; Zhang, Valdez et al. 2011). The results confirmed that 
ROCKi treatment augmented the viability of eS2 cells with less cell death observed; 
therefore spheroid formation was evident in Algimatrix 3D culture. Recent work by 
Ohgushi et al and Chen et al showed that this dissociation apoptosis is due to the Rho-
ROCK pathway activation (Ohgushi et al., 2010, Chen et al., 2010). This phenomenon is a 
common phenomenon in embryonic and somatic stem cells with an epithelial phenotype 
(Zhang et al., 2011; Watanabe et al., 2007; Koyanaki et al., 2008). This is in agreement  
with our results that eS2 cells, an epithelial cell type, undergo dissociation-associated 
apoptosis, which is not exhibited by HepG2 cells. Despite direct evidence that ROCKi 
enhances cell survival through blocking apoptosis, some studies have led to a hypothesis 
that ROCKi in hESCs may enhance cell-cell interaction and adherence, and that these 
cells have reduced sensitivity to the apoptotic signals from their environment (Krawetz et 
al., 2009). This could be the case in our cells, as the aggregation occurred within 24 hours 
in dissociated-cells treated with ROCKi. However, a further study needs to be conducted 
to study the mechanisms of ROCKi in improving cell survival.   
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Following the establishment of 3D cultures of eS2 cells in Algimatrix, I set out to 
investigate the behaviour of eS2 cells, with respect to 3D spheroid and the relationship 
between cell seeding densities and spheroid size. The results showed that inoculated eS2 
cells were aggregated into clusters of cells within 24 hours and their 3D formation was 
continuously held in Algimatrix throughout the culture course. This is in contrast to the 
HepG2 cells that form 3D spheroids via cell proliferation, similar to that from alginate 
beads (Chapter 5). It seems that eS2 cells mimic primary hepatocyte behaviour, which 
were also shown to form a 3D configuration through aggregation (Glicklis et al., 2004; 
Glicklis et al., 2000b) 
 
Seeding density, I found that it affected the size of spheroids formed. While the lower 
cell density produces spheroid size mostly ranging from 50-100 µm, the higher cell 
seeding density generated a considerable number of spheroids more than 100 µm diameter 
in size. The size of spheroids is one of the key factors in determining cell viability and 
functionality of hepatocytes (Glicklis et al., 2004; Glicklis et al., 2000b). When it is too 
small (<50 µm), it affects the differentiation and maturation due to lack of cell-cell 
contact;  when  too big (>100 µm), it hinders nutrients and oxygen reaching into the core 
of spheroids. These data demonstrate that cell-seeding density and a scaffold with defined 
pore size are two factors that restrict spheroid size to have controlled 3D formation.  
 
Next, I assessed the cell yield in the 3D differentiation culture system. In comparison 
to the monolayer, a significant proliferation and increase in cell number in eS2 cells 
seeded at 5x10
5
 cells/ well (lower density) and 1x10
6
 cells/ well (higher density) in 
Algimatrix was not attained. However, this inhibition of proliferation of eS2 cells is not 
due to the retardation function of Algimatrix or culture media per se, as HepG2 cells 
proliferate well in the Algimatrix and eS2 cells divide fine in the same culture media in 
2D culture conditions. It could be that cell-cell contact in 3D conditions reduces the 
proliferation of eS2 cells, and addition of mitogenic growth factors (e.g. FGF and EGF) 
may improve their proliferation. Nevertheless, since proliferation and differentiation are 
in general known to counteract each other (Nakamura et al., 1983; Xia et al., 2006), the 
reduction in proliferation may facilitate differentiation. 
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Finally, I determined the improvement in functionality achieved by these cells in 3D 
and 2D differentiation culture systems. I found that hepatocyte differentiation and 
maturation of eS2 cells is augmented in sequential Algimatrix 3D culture compared to in 
monolayer alone as judged by the expression of mature hepatocyte markers and CYP3A4 
activity. Moreover, differentiation of these cells at lower density is better than at higher 
cell density used in this experiment. This is most likely due to the spheroid size produced 
in these 2 settings of the experiment.  The higher cell-seeding density produced larger 
spheroids (>100 µm), and may have less mass transfer of nutrients, oxygen and 
differentiation factors to the core of these spheroids. This is in agreement with other 
studies that primary hepatocyte spheroids larger than 100 µm have less hepatocyte 
activity due to the depletion of oxygen and nutrient supplements (Glicklis et al., 2004; 
Glicklis et al., 2000b). Overall, these results demonstrate that 3D cultures provide a better 
differentiation format for the hESCs-hepatocyte differentiation system than the 
monolayer. However, there is a need to characterise the hepatocytes derived from this 3D 
culture in more detail, particularly in terms of the hepatic-specific functionality and their 
yield. This will be a key focus of future work.   
 
A noteworthy phenomenon of the effects of proliferation and differentiation in 2D 
versus 3D indicates they are in a reciprocal relationship. This is consistent with the idea 
that proliferation is poorly compatible with differentiation and that 
proliferation/differentiation switches have been demonstrated for many different cell 
types, including hepatocytes (Nakamura, Nakayama et al. 1984; Xia, Xue et al. 2006). 
However, we did not see this in HepG2 in 3D cultures as this cell has been reported to 
have lost the reciprocal modulation of growth and liver function (Nakamura, Nakayama et 
al. 1984).  
 
Overall, this study has deciphered some of the factors that play key roles in 3D-
improved hESCs differentiation into functional hepatocytes. However, this still holds 
some challenges that must be addressed in future to provide successful translational and 
biomedical outcomes. Firstly, it is a key to source a sufficient amount of hepatocytes 
produced in 3D. This could be achieved by supplementation of proliferation-inducing 
factors such as EGF and FGF to eS2 cells so they can proliferate into a sufficient number 
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before they switch into the differentiation program. Secondly, a controlled differentiation 
protocol must be established which is effective, reproducible and robust. In this study, I 
observed that the differentiation efficiency and reproducibility of differentiating cells in 
stage 3 is not optimum. This is due to the use of serum, which contain numerous factors 
that increase the uncertainties about the process of directed differentiation. Therefore, this 
signifies the necessity for improvement of several aspects of hESC differentiation into 
hepatocytes, to be established by future work. 
In summary, this study provides several results worth highlighting. Firstly, eS2 cells 
were prone to dissociation-associated cell death, which could be rescued by pre-and post-
dissociation treatment with ROCKi. Secondly, the eS2 cells form 3D spheroids through 
aggregation rather than proliferation and that the size of aggregates is controlled by the 
cell seeding density. Thirdly, 3D culture suppresses proliferation and improves hepatic 
differentiation of eS2 cells, which subsequently improves the hepatic function of the 
resulting cells. Hence, this implies the importance of a better understanding of cell 
behaviour in 3D culture in order to mimic in vivo. Thus, this study represents a significant 
differentiation model to produce functional hepatocytes, paving the way towards future 
cell therapy, BAL and toxicology studies.  
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7. General Discussion 
This thesis focused on strategies to improve hepatic differentiation of hESCs by 
addressing the molecular signalling and micro-niche cues that govern hepatocyte lineage 
commitment. Studies of hESCs have demonstrated an enormous potential for the 
generation of various cell types, including hepatocytes, and their application in 
therapeutics, drug screening and other biomedical applications. However, a controllable 
hESCs-hepatocyte in vitro differentiation protocol remains to be established.  
Generation of hepatocytes from early embryos could be categorised into 3 
prominent stages; definitive endoderm (DE), hepatoblasts and hepatocytes, as depicted in 
Figure 7.1. The hESCs represent the ICM of the human embryo in vivo and their 
hepatocyte differentiation recapitulates in vivo liver development. Therefore, 
understanding or mimicking the in vivo environment by both signalling cues and the liver 
niche will further improve the differentiation protocol of hESCs. Of these 3 stages, I 
focused on improvement in 2 stages; DE differentiation and hepatocyte maturation, due to 





 - 145 - 
 
 
Figure 7-1: Schematic presentation of the three stages during in vitro hepatocyte 
differentiation of embryonic stem cells and the in vivo liver development.   
The establishment of a fully functional liver during embryonic development is a multistage 
developmental process and the differentiation of hESCs into hepatocytes recapitulates this 
process in vitro. HESCs, derived from ICM are first differentiated into definitive endoderm by 
Activin, and then to hepatoblasts which is followed by their segregation into hepatocytes or 
cholangiocytes, depending on the indicated signals. The liver architecture shows the different cell 
types and their organisation. 70% of cells in the liver are hepatocytes that provide liver specific 
function in vivo. Abbreviations: BD, bile duct; ICM, inner cell mass; HGF, hepatocyte growth 
factor; OSM, Oncostatin M; TGF-β transforming growth factor. (Adopted from (Snykers et al., 
2009) and (Sharma et al., 2010). 
7.1. Research Summary  
Differentiation of DE is a pre-requisite for its derivative organ such as liver. 
Therefore, signalling governing DE fate has been the focus of the research in this field. 
Hence, an improved DE differentiation will augment hepatocyte generation from hESCs. 
It has been shown that suppression of PI3K signalling in certain culture conditions, such 
as by serum depletion or the use PI3K inhibitor, has been as effective way to promote DE 
differentiation (D'Amour et al., 2005; McLean et al., 2007; Touboul et al., 2010). In this 
study, I have demonstrated that suppression of PI3K enhances the Activin-induced DE 
differentiation via mesendoderm formation in chemically defined conditions, hence 
improving hepatocyte generation from enriched DE.  
Following this encouraging improvement in differentiation, I further interrogated 
this event to unravel the molecular mechanisms underlying it. Most notably, I have 
demonstrated that suppression of PI3K has an apparent impact on both Activin/Smad and 
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Wnt/β-catenin pathways, the two imperative signalling pathways governing mesendoderm 
and DE differentiation. Suppression of PI3K has enhanced Activin-activated regulatory 
Smads, Smad2/3, which was also depicted by an increase in their nuclear localisation. 
This enhanced pSmad2/3 level is temporally concurrent with the increase in the 
expression of mesendoderm and early DE related genes. Furthermore PI3K/Akt inhibition 
also has dramatic effects on β-catenin, which appears to influence its localisation, 
probably by E-cadherin rather than through the classical, yet controversial, GSK3β-based 
β-catenin stabilisation. This structural-based role of β-catenin signifies the occurrence of 
EMT; a key process in DE specification (Ciruna and Rossant, 2001; Shook and Keller, 
2003). Further interrogation on how PI3K promotes Activin-induced pSmad2/3 and the 
dissociation of E-cadherin/β-catenin complexes in hESCs is, however, yet to be explored 
and will be the focus of our future work.  
Achieving functional maturation of hepatocytes remains one of the key challenges 
for hESC–derived hepatocytes (Agarwal et al., 2008; Cai et al., 2007; Hay et al., 2008b; 
Touboul et al., 2010), and even in primary hepatocytes, as they lose their in vivo niche 
when growing in monolayer (Baker et al., 2001; Gomez-Lechon et al., 2003). Thus, 
recreating the niche in vitro is the key step needed to improve the maturation of hESC-
derived hepatocytes, as this has been successfully shown in studies using primary and 
foetal hepatocytes (Hanada et al., 2003; Hanada et al., 2008; Huang et al., 2006; Jiang et 
al., 2004). Therefore, I explored the potency of 3D culture using alginate based 
biomaterials to improve the differentiation and maturation of hESC-derived DE into 
functional hepatocytes, based on the previously established monolayer differentiation 
protocol (Hay et al., 2008b). I first used HepG2 cells to prove the concept that 3D culture 
aids functionality improvement. Alginate beads, a hydrogel based 3D material, has 
provided a platform for the 3D formation, while supporting proliferation and spectacularly 
improving the liver-specific functions of HepG2 cells, as shown by us and in some other 
studies (Coward et al., 2005; Elkayam et al., 2006).  
Following this, I then translated the concept into hESC differentiation and 
combined our hESC-hepatocyte monolayer differentiation system with the 3D culture. I 
chose to switch the format of 3D material from bead to Algimatrix scaffold, which is also 
based on alginate to compensate the demand on the cell number required for the former 
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format, since resourcing hESC-derived hepatoblasts is relatively expensive. I set out to 
selectively induce 3D formation in early stage 2 cells (es2) derived from monolayers to 
provide a timely requirement for cell-cell contact, rather than via an EB formation step 
which has been widely reported as an incompetent method for efficient hepatocyte 
generation. The viability of eS2 cells was severely affected by dissociation, which was 
then rescued, if not fully at least to a significant level by ROCKi treatment. This was not 
seen with HepG2 cells. I also found that cell seeding density affects the size of spheroids 
in Algimatrix 3D culture. While cells in monolayer format are proliferative, we did not 
see proliferation in the 3D culture system. On the other hand, hepatic differentiation of 
eS2 cells into hepatocytes was superior when cultured in 3D culture. This reciprocal 
switch of proliferation and differentiated function was not exhibited by HepG2 cells in the 
3D culture system. This is in line with findings showing that primary hepatocytes are 
subjective to the proliferation/differentiation switch, whereas this reciprocal modulation is 
lost in hepatoma cells (Nakamura et al., 1984b; Nakamura et al., 1983). Our findings 
underscore the feasibility of 3D-induced hepatic function, and reveal the behaviour of 
hepatocyte differentiation of hESCs in 3D culture and, for the first time, using more 
controlled differentiation stages than in previous work by EB formation. Future work will 
be focused on further characterisation of hepatocytes from 3D culture differentiation, and 
to generate them in a scalable format. 3D configuration of hESC-derived hepatocytes also 
has an additional advantage of being readily embedded into BAL devices and for drug 
screening.   
 
7.2. Challenges and future work  
Over the last decades, the differentiation of hESCs along the hepatocyte lineage 
has undergone striking changes, ranging from EB generation to growth factor directed 
differentiation. Progress has been substantial, with the greatest improvement of 
hepatocyte generation resulting in an efficiency of up to 70-80%. Although progress 
towards the development of improved protocols is impressive, a good efficient 
reproducibility and further functional improvement is still hindered due to existing 
problems. Identification of these problems, from both our studies and others, holds great 
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initiative for future work before these can be used for cell therapy, BAL device 
incorporation or for toxicology studies.  
Often an inherent characteristic of hESCs, the starting material of hepatic 
differentiation, is poorly defined in terms of heterogeneity, passage number and plasticity. 
In particular, their differentiation kinetics and factors required for efficient differentiation 
were different between the hESCs lines we have tested so far, namely H1, H7 and H9 
lines. This has been seen by us and by others (Deb and Sarda, 2008; Guhr et al., 2006; 
Skottman et al., 2007). Thus, this represents a major hurdle in developing a customised 
differentiation protocol. Current and future work has been undertaken to have standard 
culture conditions for hESCs for research and clinical use. 
Another major hurdle in yielding a functional and sufficient number of 
hepatocytes in culture is its heterogeneous outcome, yielding phenotypically different cell 
types. This is a major problem, particularly in the earliest EB-based methods, and much 
work has been done to improve it. For example, FACS sorting cells based on their cell 
surface markers or genetically engineered markers can enrich for certain cell types, which  
then can be expanded and differentiated (D'Amour et al., 2005; Gouon-Evans et al., 2006; 
Heo et al., 2006; Yin et al., 2002). Incorporation of this technique would be, therefore, 
very promising in order to obtain relatively pure cell population.  
The technological advancement in several aspects of hESC-hepatocytes 
differentiation has promoted further investigation into better strategies to yield the mature 
hepatocytes which are in greatest demand.  Hepatocyte functionality improvement shown 
in 3D culture (Hanada et al., 2003; Huang et al., 2006; Sakai et al., 2002; Thomas et al., 
2008) indicates that the final maturation steps require an in vivo environment. This 
includes homotypic and heterotypic cell interactions to provide a micro-niche suitable for 
functionality modulation.  This seems to be a very complex network of cellular 
interactions, and is still largely not understood both in vivo and in vitro.  
The major issue in this study, which is also in agreement with others, is the loss of 
the proliferative capacity of hepatic intermediates when they become significantly 
differentiated in 3D culture (Nakamura et al., 1984a; Xia et al., 2006). This leads to the 
question of whether a sufficient number of mature hepatocyte-like cells derived from 
hESC can be obtained, so that the downstream applications such as cell therapy, BAL 
technology and toxicology studies can be effective. To overcome this hurdle, possibly it 
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may be better to expand the cell number of desired stage cells before 3D induction or by 
incorporating mitogens into the 3D culture for a period of time. This could be achieved by 
the supplementation of growth factors such as FGF and EGF to induce proliferation, as 
shown by some monolayer studies (Block et al., 1996; Deurholt et al., 2006). In addition, 
another variant regarding this aspect is the differentiation stage of the cell that is to be 
subjected to 3D induction for  improved maturation. There are two choices; as early 
progenitor stage with high proliferative capacity but lower differentiation capacity, or a 
later stage of hepatocyte which is differentiated yet much less proliferative. Therefore, 
future studies should focus on the proliferation/differentiation reciprocal modulation 
event, to control their behaviour and generate a high yield of mature hepatocytes.  
Another challenge relating to hepatocyte differentiation is the undefined culture 
conditions, either by  co-culture or the use of serum. A strategy using a culture that 
mimics the in vivo niche, which was not addressed by the work in this thesis, is co-culture 
with non-parenchymal cells that are present in liver. These cells are the major source of 
ECM needed for hepatocytes  (Arenson et al., 1988; Gressner and Schäfer, 1989),  
although hepatocytes can secrete ECM to a certain extent (Lee et al., 1993). Taking the 
complete differentiation model depicted in Figure 7.1, intuitively co-culture by either 
direct contact with non-parenchymal cells or using their conditioned medium would 
improve the response of hepatocytes. It has been shown by several studies that non-
parenchymal cells indeed improve maturation of hepatocytes (Begue et al., 1984; Fraslin 
et al., 1985; Morin and Normand, 1986). However, cautious steps are needed as co-culture 
methodology produces variable outcomes due to its undefined conditions, mainly caused 
by factors produced by the co-culture cells themselves. This could be overcome by the 
development and use of small molecules and synthetic biocompatible ECMs which can 
substitute for xeno-derived ECMs. Undefined culture condition through serum usage is 
also a major hurdle in the hepatic differentiation of hESCs. In our hands, the 
differentiation of hepatocytes at stage 3 (hepatocyte maturation stage) provides a 
remarkable challenge, due to the inconsistency in differentiation efficiency. We mainly 
reasoned this by serum usage.  Serum contains hormones, growth factors, and other 
undefined substances that might contribute to stochastic differentiation into hepatocytes. 
However, nowadays, many efforts are being made to work under serum-free conditions, 
particularly with the use of serum-replacement factors.  
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As for the future, despite continual improvement in in vitro differentiation of 
hESCs into the hepatic lineage, we need to take the state-of-art into consideration. It is 
vital to be aware  of new technological improvements and approaches that may be inter-
related and could be the success of applications of hESCs-derived hepatocytes. One such 
technology or approach is the induced Pluripotent stem cell (iPSC), which is the stem cell 
derived from somatic cells through ectopic expression of a defined set of transcription 
factors to induce and maintain pluripotency. Recently, the generation of hepatocytes has 
been also demonstrated to be feasible with human iPSC methodology, developed based on 
hESC in vitro differentiation (Si Tayeb et al., 2010; Song et al., 2009; Sullivan et al., 
2010; Touboul et al., 2010). Indeed, this appears to be a promising source for patient-
specific hepatocytes, and therefore clinically useful.  
Another technological advancement that would be very constructive for liver 
technology is the development of bioreactors. The increasing recent interest in in vitro 
culture of hepatocytes in 3D format has resulted in the introduction of innovative 
bioreactors in an attempt to more closely stimulate in vivo liver architecture. This would 
further extend the survival and functional lifetime of hepatocytes past those of the static 
culture of 3D hepatocytes. Such systems have been shown to incorporate into BAL 
support systems and resulted in a promising outcome both in vitro and in experimental 
animal models of acute liver failure (Jauregui and Mullon, 1995; Li et al., 1993) 
In conclusion, hESCs hold a potential as an unlimited source to generate 
hepatocytes to be used in cell therapy and toxicity screening.  The concept of the 
differentiation process of hESCs recapitulating in vivo liver development has been 
replicated in many studies (Cai et al., 2007; Hay et al., 2008a; Hay et al., 2008b; Touboul 
et al., 2010). However, a more rigorous understanding of the instructive signals that 
govern the hESCs into the hepatocyte lineage is in demand. I herein present some 
understanding and approaches that improve the current knowledge and protocols that are 
ultimately aimed at obtaining functional hepatocytes. Thus, this work has provided a 
scientific contribution in the field with some better understanding on the molecular 
mechanisms underlying hepatic fate determination, hence providing an improved 
technology for the liver-related field. Thus, we anticipate that these findings will bring us 
closer to our ultimate goal of efficient generation of hepatocytes from hESCs.
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Appendix I : qRT-PCR primers 
Table III: List of primers used in qRT-PCR. 
Gene  Accession number Sequence  
Brachyury NM_003181.2 For  TGCTTCCCTGAGACCCAGTT 
  
Rev GATCACTTCTTTCCTTTGCATCAAG 
E-cadherin  NM_004360  For  AGGAATTCTTGCTTTGCTAATTCTG  
  
Rev CGAAGAAACAGCAAGAGCAGC  
Eomes NM_005442.2 For  CGCCACCAAACTGAGATGAT 
  
Rev CACATTGTAGTGGGCAGTGG 
Fgf5 NM_004464.3 For  CAGCACCAAAGGCTCAGCTT  
  
Rev CCTTGCTTCTAACCCATCATATCC  
FoxA2  NP_068556 For   GGGAGCGGTGAAGATGGA  
  
Rev TCATGTTGCTCACGGAGGAGTA  
GSC  NM_173849.2 For   GAGGAGAAAGTGGAGGTCTGGTT  
  
Rev CTCTGATGAGGACCGCTTCTG  
Nanog XM_002344636.1 For  TGATTTGTGGGCCTGAAGAAAA 
  
Rev GAGGCATCTCAGCAGAAGACA 
Oct4 NM_203289.3 For  TCGAGAACCGAGTGAGAGGC 
  
Rev CACACTCGGACCACATCCTTC 
Pax6 NM_001127612.1 For  ATTACTGTCCGAGGGGGTCTGTAC 
  
Rev TCCGTTGGAACTGATGGAGTTGGT 
Sox17  NM_022454.3 For   GGCGCAGCAGAATCCAGA  
  
Rev CCACGACTTGCCCAGCAT  





For  TGTCTGGCGGCACCACCATG 
  
Rev AGGATGGAGCCGCCGATCCA 
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Appendix II : semi-quantitative RT-PCR primers 
 Table IV: List of primers used in semi-quantitative RT-PCR 
  
Gene  Accession number Sequence Size  
AFP NM 001134.1 For  AGAACCTGTCACAAGCTGTG 675 bp 
  
Rev GACAGCAAGCTGAGGATGTC 
 ALB NM 000477.3 For  CCTTTGGCACAATGAAGTGGGTAACC 354 bp 
  
Rev CAGCAGTCAGCCATTTCACCATAGG 
 ApoF NM001638 For  GGAAGCGATCAAACCTACCA 347 bp 
  
Rev ATCAGCCTGACAACCAGCTT 
 CK19 NM_002276.3 For  CTCCCGCGACTACAGCCACT 211 bp 
  
Rev TCAGCTCATCCAGCACCCTG 
 Gapdh NM_002046.3 For  TCTGCTCCTCCTGTTCGACA 120bp 
  
Rev AAAAGCAGCCCTGGTGACC 
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Appendix III: Antibodies 
Table V: list of antibodies 
 
Primary antibodies  Supplier  cat # 
ICC 
/FACS* WB 
AFP  Sigma A8452 1:500   
ALB  DAKO (Bio-Stat) A0001 1:500   
b-actin Sigma A1978   1:10000 
beta-catenin  abcam ab6302 1:1000  1:2000 
brachyury R&D Systems  AF2085 1:50 1:500 
beta-tubulin  abcam ab6046   1:2000 
CXCR4 -PE R&D systems  FAB170P  1:25*   
CYP7A1 Santa Cruz  sc-25536 1:250   
E-cadherin  cell signaling  5296 1:250 1:500 
HNF4a  santa cruz  sc-8987 1:5000   
LaminB2 Millipore  MAB3536   1:1000 
Oct3/4 santa cruz  sc-5279 1:500 1:1000 
pAKT  (Ser 473) cell signalling  4060   1:1000 
pGSK3a/b (21/9) Cell signalling  9331   1:1000 
pSMAD2 (Ser465/467) cell signalling  3108   1:1000 
pSmad3 (ser423/425) Millipore 04-1042   1:1000 
Smad4  cell signalling  9515   1:1000 
Sox17 R&D Systems  MAB1924  1:100 1:500 
Sox2  Abcam  ab97959   1:1000 
tAKT cell signalling  9272   1:1000 
tGSK3a/b Santa Cruz  sc-71190   1:1000 
tSMAD2/3 Cell signalling  3102   1:1000 
tSmad3  Cell signalling  9523   1:1000 
Conjugated Secondary 
Antibodies  
    Goat anti-mouse IgG 
Alexa 488 Invitrogen  A11029 1:400   
Goat anti-mouse IgG 
Alexa 568 Invitrogen  A11031 1:400   
Goat anti-mouse IgG 
HRP Santa Cruz sc-2005   1:2000 
Goat anti-rabbit IgG  
Alexa 488 Invitrogen  A11034 1:400   
Goat anti-rabbit IgG 
Alexa 568 Invitrogen  A11036 1:400   
Goat anti-rabbit IgG 
HRP Santa Cruz sc-2004   1:2000 
